Process  ||| S:252 E:260 ||| NN
for  ||| S:260 E:264 ||| IN
coating  ||| S:264 E:272 ||| JJ
cell-culture  ||| S:272 E:285 ||| JJ
support  ||| S:285 E:297 ||| NN
Bouwstra  ||| S:297 E:306 ||| NNP
Jan  ||| S:306 E:310 ||| NNP
Bastiaan  ||| S:310 E:320 ||| NNPS
Bilthoven  ||| S:320 E:330 ||| NNP
NL  ||| S:330 E:336 ||| NNP
Dorst  ||| S:379 E:385 ||| NNP
NL  ||| S:385 E:391 ||| NNP
Senzui  ||| S:414 E:421 ||| NNP
JP  ||| S:421 E:427 ||| NNP
The  ||| S:605 E:609 ||| DT
invention  ||| S:609 E:619 ||| NN
relates  ||| S:619 E:627 ||| VBZ
to  ||| S:627 E:630 ||| TO
a  ||| S:630 E:632 ||| DT
support  ||| S:632 E:640 ||| NN
for  ||| S:640 E:644 ||| IN
culturing  ||| S:644 E:654 ||| JJ
cells ||| S:654 E:659 ||| NNS
,  ||| S:659 E:661 ||| ,
in  ||| S:661 E:664 ||| IN
particular  ||| S:664 E:675 ||| JJ
to  ||| S:675 E:678 ||| TO
microcarriers  ||| S:678 E:692 ||| VB
coated  ||| S:692 E:699 ||| VBN
with  ||| S:699 E:704 ||| IN
gelatine  ||| S:704 E:713 ||| NN
or  ||| S:713 E:716 ||| CC
gelatine-like  ||| S:716 E:730 ||| JJ
proteins ||| S:730 E:738 ||| NNS
.  ||| S:738 E:740 ||| .
Such  ||| S:740 E:745 ||| JJ
microcarriers  ||| S:745 E:759 ||| NNS
serve  ||| S:759 E:765 ||| VBP
as  ||| S:765 E:768 ||| RB
support  ||| S:768 E:776 ||| VB
for  ||| S:776 E:780 ||| IN
culturing  ||| S:780 E:790 ||| JJ
anchorage  ||| S:790 E:800 ||| JJ
dependent  ||| S:800 E:810 ||| JJ
cells ||| S:810 E:815 ||| NNS
.  ||| S:815 E:817 ||| .
In  ||| S:817 E:820 ||| IN
particular  ||| S:820 E:831 ||| JJ
the  ||| S:831 E:835 ||| DT
invention  ||| S:835 E:845 ||| NN
relates  ||| S:845 E:853 ||| VBZ
to  ||| S:853 E:856 ||| TO
a  ||| S:856 E:858 ||| DT
process  ||| S:858 E:866 ||| NN
for  ||| S:866 E:870 ||| IN
the  ||| S:870 E:874 ||| DT
preparation  ||| S:874 E:886 ||| NN
of  ||| S:886 E:889 ||| IN
a  ||| S:889 E:891 ||| DT
cell  ||| S:891 E:896 ||| NN
culture  ||| S:896 E:904 ||| NN
support  ||| S:904 E:912 ||| NN
comprising  ||| S:912 E:923 ||| VBG
the  ||| S:923 E:927 ||| DT
step  ||| S:927 E:932 ||| NN
of  ||| S:932 E:935 ||| IN
coating  ||| S:935 E:943 ||| VBG
a  ||| S:943 E:945 ||| DT
microcarrier  ||| S:945 E:958 ||| JJ
bead  ||| S:958 E:963 ||| NN
with  ||| S:963 E:968 ||| IN
gelatine  ||| S:968 E:977 ||| NN
or  ||| S:977 E:980 ||| CC
gelatine-like  ||| S:980 E:994 ||| JJ
protein ||| S:994 E:1001 ||| NN
,  ||| S:1001 E:1003 ||| ,
said  ||| S:1003 E:1008 ||| VBD
gelatine  ||| S:1008 E:1017 ||| JJ
or  ||| S:1017 E:1020 ||| CC
gelatine-like  ||| S:1020 E:1034 ||| JJ
protein  ||| S:1034 E:1042 ||| NN
having  ||| S:1042 E:1049 ||| VBG
a  ||| S:1049 E:1051 ||| DT
molecular  ||| S:1051 E:1061 ||| JJ
weight  ||| S:1061 E:1068 ||| NN
of  ||| S:1068 E:1071 ||| IN
about  ||| S:1071 E:1077 ||| IN
40  ||| S:1077 E:1080 ||| CD
kDa  ||| S:1080 E:1084 ||| JJ
to  ||| S:1084 E:1087 ||| TO
about  ||| S:1087 E:1093 ||| RB
200  ||| S:1093 E:1097 ||| CD
kDa ||| S:1097 E:1100 ||| NN
.  ||| S:1100 E:1106 ||| .
The  ||| S:1131 E:1135 ||| DT
present  ||| S:1135 E:1143 ||| JJ
invention  ||| S:1143 E:1153 ||| NN
relates  ||| S:1153 E:1161 ||| VBZ
to  ||| S:1161 E:1164 ||| TO
a  ||| S:1164 E:1166 ||| DT
support  ||| S:1166 E:1174 ||| NN
for  ||| S:1174 E:1178 ||| IN
culturing  ||| S:1178 E:1188 ||| JJ
cells ||| S:1188 E:1193 ||| NNS
,  ||| S:1193 E:1195 ||| ,
in  ||| S:1195 E:1198 ||| IN
particular  ||| S:1198 E:1209 ||| JJ
to  ||| S:1209 E:1212 ||| TO
microcarriers  ||| S:1212 E:1226 ||| VB
coated  ||| S:1226 E:1233 ||| VBN
with  ||| S:1233 E:1238 ||| IN
gelatine  ||| S:1238 E:1247 ||| NN
or  ||| S:1247 E:1250 ||| CC
gelatine-like  ||| S:1250 E:1264 ||| JJ
proteins ||| S:1264 E:1272 ||| NNS
.  ||| S:1272 E:1274 ||| .
Such  ||| S:1274 E:1279 ||| JJ
microcarriers  ||| S:1279 E:1293 ||| NNS
serve  ||| S:1293 E:1299 ||| VBP
as  ||| S:1299 E:1302 ||| RB
support  ||| S:1302 E:1310 ||| VB
for  ||| S:1310 E:1314 ||| IN
culturing  ||| S:1314 E:1324 ||| JJ
anchorage  ||| S:1324 E:1334 ||| JJ
dependent  ||| S:1334 E:1344 ||| JJ
cells ||| S:1344 E:1349 ||| NNS
.  ||| S:1349 E:1352 ||| .
Cell  ||| S:1382 E:1387 ||| NN
culture  ||| S:1387 E:1395 ||| NN
of  ||| S:1395 E:1398 ||| IN
animal  ||| S:1398 E:1405 ||| JJ
cells ||| S:1405 E:1410 ||| NNS
,  ||| S:1410 E:1412 ||| ,
in  ||| S:1412 E:1415 ||| IN
particular  ||| S:1415 E:1426 ||| JJ
mammalian  ||| S:1426 E:1436 ||| JJ
cells ||| S:1436 E:1441 ||| NNS
,  ||| S:1441 E:1443 ||| ,
is  ||| S:1443 E:1446 ||| VBZ
important  ||| S:1446 E:1456 ||| JJ
for  ||| S:1456 E:1460 ||| IN
the  ||| S:1460 E:1464 ||| DT
production  ||| S:1464 E:1475 ||| NN
of  ||| S:1475 E:1478 ||| IN
many  ||| S:1478 E:1483 ||| JJ
important  ||| S:1483 E:1493 ||| JJ
( ||| S:1493 E:1494 ||| -LRB-
genetically  ||| S:1494 E:1506 ||| RB
engineered ||| S:1506 E:1516 ||| VBN
)  ||| S:1516 E:1518 ||| -RRB-
biological  ||| S:1518 E:1529 ||| JJ
materials  ||| S:1529 E:1539 ||| NNS
such  ||| S:1539 E:1544 ||| JJ
as  ||| S:1544 E:1547 ||| IN
vaccines ||| S:1547 E:1555 ||| NNS
,  ||| S:1555 E:1557 ||| ,
enzymes ||| S:1557 E:1564 ||| NN
,  ||| S:1564 E:1566 ||| ,
hormones  ||| S:1566 E:1575 ||| NNS
and  ||| S:1575 E:1579 ||| CC
antibodies ||| S:1579 E:1589 ||| NNS
.  ||| S:1589 E:1591 ||| .
The  ||| S:1591 E:1595 ||| DT
majority  ||| S:1595 E:1604 ||| NN
of  ||| S:1604 E:1607 ||| IN
animal  ||| S:1607 E:1614 ||| JJ
cells  ||| S:1614 E:1620 ||| NNS
are  ||| S:1620 E:1624 ||| VBP
anchorage-dependent  ||| S:1624 E:1644 ||| JJ
and  ||| S:1644 E:1648 ||| CC
require  ||| S:1648 E:1656 ||| VB
attachment  ||| S:1656 E:1667 ||| VBN
to  ||| S:1667 E:1670 ||| TO
a  ||| S:1670 E:1672 ||| DT
surface  ||| S:1672 E:1680 ||| NN
for  ||| S:1680 E:1684 ||| IN
their  ||| S:1684 E:1690 ||| PRP$
survival  ||| S:1690 E:1699 ||| NN
and  ||| S:1699 E:1703 ||| CC
growth ||| S:1703 E:1709 ||| NN
.  ||| S:1709 E:1713 ||| .
Routinely ||| S:1713 E:1722 ||| RB
,  ||| S:1722 E:1724 ||| ,
anchorage-dependent  ||| S:1724 E:1744 ||| JJ
cells  ||| S:1744 E:1750 ||| NNS
have  ||| S:1750 E:1755 ||| VBP
been  ||| S:1755 E:1760 ||| VBN
cultivated  ||| S:1760 E:1771 ||| VBN
on  ||| S:1771 E:1774 ||| IN
the  ||| S:1774 E:1778 ||| DT
walls  ||| S:1778 E:1784 ||| NNS
of  ||| S:1784 E:1787 ||| IN
for  ||| S:1787 E:1791 ||| IN
instance  ||| S:1791 E:1800 ||| NN
tissue  ||| S:1800 E:1807 ||| NN
culture  ||| S:1807 E:1815 ||| NN
flasks  ||| S:1815 E:1822 ||| NNS
and  ||| S:1822 E:1826 ||| CC
roller  ||| S:1826 E:1833 ||| NN
bottles ||| S:1833 E:1840 ||| NNS
.  ||| S:1840 E:1842 ||| .
As  ||| S:1842 E:1845 ||| IN
the  ||| S:1845 E:1849 ||| DT
necessity  ||| S:1849 E:1859 ||| NN
has  ||| S:1859 E:1863 ||| VBZ
developed  ||| S:1863 E:1873 ||| VBN
to  ||| S:1873 E:1876 ||| TO
provide  ||| S:1876 E:1884 ||| VB
large  ||| S:1884 E:1890 ||| JJ
amounts  ||| S:1890 E:1898 ||| NNS
of  ||| S:1898 E:1901 ||| IN
certain  ||| S:1901 E:1909 ||| JJ
antiviral  ||| S:1909 E:1919 ||| JJ
vaccines ||| S:1919 E:1927 ||| NNS
,  ||| S:1927 E:1929 ||| ,
genetically  ||| S:1929 E:1941 ||| RB
engineered  ||| S:1941 E:1952 ||| VBN
proteins ||| S:1952 E:1960 ||| NNS
,  ||| S:1960 E:1962 ||| ,
and  ||| S:1962 E:1966 ||| CC
other  ||| S:1966 E:1972 ||| JJ
cell-derived  ||| S:1972 E:1985 ||| JJ
products ||| S:1985 E:1993 ||| NNS
,  ||| S:1993 E:1995 ||| ,
improvements  ||| S:1995 E:2008 ||| NNS
have  ||| S:2008 E:2013 ||| VBP
been  ||| S:2013 E:2018 ||| VBN
made  ||| S:2018 E:2023 ||| VBN
to  ||| S:2023 E:2026 ||| TO
develop  ||| S:2026 E:2034 ||| VB
new  ||| S:2034 E:2038 ||| JJ
systems  ||| S:2038 E:2046 ||| NNS
for  ||| S:2046 E:2050 ||| IN
larger  ||| S:2050 E:2057 ||| JJR
scale  ||| S:2057 E:2063 ||| NN
production  ||| S:2063 E:2074 ||| NN
of  ||| S:2074 E:2077 ||| IN
cells ||| S:2077 E:2082 ||| NNS
.  ||| S:2082 E:2086 ||| .
One  ||| S:2086 E:2090 ||| PRP
such  ||| S:2090 E:2095 ||| PDT
an  ||| S:2095 E:2098 ||| DT
improvement  ||| S:2098 E:2110 ||| NN
started  ||| S:2110 E:2118 ||| VBD
with  ||| S:2118 E:2123 ||| IN
the  ||| S:2123 E:2127 ||| DT
development  ||| S:2127 E:2139 ||| NN
of  ||| S:2139 E:2142 ||| IN
microcarriers  ||| S:2142 E:2156 ||| NN
in  ||| S:2156 E:2159 ||| IN
1967  ||| S:2159 E:2164 ||| CD
by  ||| S:2164 E:2167 ||| IN
Van  ||| S:2167 E:2171 ||| NNP
Wezel  ||| S:2171 E:2177 ||| NNP
( ||| S:2177 E:2178 ||| -LRB-
Van  ||| S:2178 E:2182 ||| NNP
Wezel ||| S:2182 E:2187 ||| NNP
,  ||| S:2187 E:2189 ||| ,
A.  ||| S:2189 E:2192 ||| NNP
L.  ||| S:2192 E:2195 ||| NNP
Nature  ||| S:2195 E:2202 ||| NNP
216 ||| S:2202 E:2205 ||| CD
: ||| S:2205 E:2206 ||| :
64-65  ||| S:2206 E:2212 ||| CD
( ||| S:2212 E:2213 ||| -LRB-
1967 ||| S:2213 E:2217 ||| CD
) ||| S:2217 E:2218 ||| -RRB-
) ||| S:2218 E:2219 ||| -RRB-
.  ||| S:2219 E:2221 ||| .
Van  ||| S:2221 E:2225 ||| NNP
Wezel  ||| S:2225 E:2231 ||| NNP
made  ||| S:2231 E:2236 ||| VBD
microcarriers  ||| S:2236 E:2250 ||| VBN
composed  ||| S:2250 E:2259 ||| VBN
of  ||| S:2259 E:2262 ||| IN
cross-linked  ||| S:2262 E:2275 ||| JJ
dextran  ||| S:2275 E:2283 ||| NNS
beads  ||| S:2283 E:2289 ||| VBP
charged  ||| S:2289 E:2297 ||| VBN
with  ||| S:2297 E:2302 ||| IN
tertiary  ||| S:2302 E:2311 ||| JJ
amine  ||| S:2311 E:2317 ||| JJ
groups  ||| S:2317 E:2324 ||| NNS
( ||| S:2324 E:2325 ||| -LRB-
DEAE ||| S:2325 E:2329 ||| NNP
) ||| S:2329 E:2330 ||| -RRB-
.  ||| S:2330 E:2332 ||| .
He  ||| S:2332 E:2335 ||| PRP
demonstrated  ||| S:2335 E:2348 ||| VBD
the  ||| S:2348 E:2352 ||| DT
attachment  ||| S:2352 E:2363 ||| NN
and  ||| S:2363 E:2367 ||| CC
growth  ||| S:2367 E:2374 ||| NN
of  ||| S:2374 E:2377 ||| IN
cells  ||| S:2377 E:2383 ||| NNS
on  ||| S:2383 E:2386 ||| IN
these  ||| S:2386 E:2392 ||| DT
positively  ||| S:2392 E:2403 ||| RB
charged  ||| S:2403 E:2411 ||| VBN
DEAE-dextran  ||| S:2411 E:2424 ||| JJ
beads  ||| S:2424 E:2430 ||| NNS
suspended  ||| S:2430 E:2440 ||| VBN
in  ||| S:2440 E:2443 ||| IN
culture  ||| S:2443 E:2451 ||| NN
media  ||| S:2451 E:2457 ||| NNS
in  ||| S:2457 E:2460 ||| IN
a  ||| S:2460 E:2462 ||| DT
stirred  ||| S:2462 E:2470 ||| JJ
vessel ||| S:2470 E:2476 ||| NN
.  ||| S:2476 E:2478 ||| .
Thus ||| S:2478 E:2482 ||| RB
,  ||| S:2482 E:2484 ||| ,
in  ||| S:2484 E:2487 ||| IN
microcarrier  ||| S:2487 E:2500 ||| JJ
cell  ||| S:2500 E:2505 ||| NN
cultures  ||| S:2505 E:2514 ||| NNS
cells  ||| S:2514 E:2520 ||| NNS
grow  ||| S:2520 E:2525 ||| VBP
as  ||| S:2525 E:2528 ||| RB
monolayers  ||| S:2528 E:2539 ||| VBN
on  ||| S:2539 E:2542 ||| IN
small  ||| S:2542 E:2548 ||| JJ
spheres  ||| S:2548 E:2556 ||| NN
which  ||| S:2556 E:2562 ||| WDT
are  ||| S:2562 E:2566 ||| VBP
in  ||| S:2566 E:2569 ||| IN
suspension ||| S:2569 E:2579 ||| NN
.  ||| S:2579 E:2581 ||| .
By  ||| S:2581 E:2584 ||| IN
using  ||| S:2584 E:2590 ||| VBG
microcarriers  ||| S:2590 E:2604 ||| NN
it  ||| S:2604 E:2607 ||| PRP
is  ||| S:2607 E:2610 ||| VBZ
possible  ||| S:2610 E:2619 ||| JJ
to  ||| S:2619 E:2622 ||| TO
achieve  ||| S:2622 E:2630 ||| VB
yields  ||| S:2630 E:2637 ||| NNS
of  ||| S:2637 E:2640 ||| IN
several  ||| S:2640 E:2648 ||| JJ
million  ||| S:2648 E:2656 ||| CD
cells  ||| S:2656 E:2662 ||| NNS
per  ||| S:2662 E:2666 ||| IN
millilitre ||| S:2666 E:2676 ||| NN
.  ||| S:2676 E:2678 ||| .
Over  ||| S:2678 E:2683 ||| IN
the  ||| S:2683 E:2687 ||| DT
years  ||| S:2687 E:2693 ||| NNS
various  ||| S:2693 E:2701 ||| JJ
types  ||| S:2701 E:2707 ||| NNS
of  ||| S:2707 E:2710 ||| IN
microcarriers  ||| S:2710 E:2724 ||| NNS
have  ||| S:2724 E:2729 ||| VBP
been  ||| S:2729 E:2734 ||| VBN
developed ||| S:2734 E:2743 ||| VBN
.  ||| S:2743 E:2745 ||| .
Crosslinked  ||| S:2745 E:2757 ||| JJ
dextran ||| S:2757 E:2764 ||| NN
,  ||| S:2764 E:2766 ||| ,
like  ||| S:2766 E:2771 ||| IN
the  ||| S:2771 E:2775 ||| DT
first  ||| S:2775 E:2781 ||| JJ
microcarriers ||| S:2781 E:2794 ||| NN
,  ||| S:2794 E:2796 ||| ,
is  ||| S:2796 E:2799 ||| VBZ
still  ||| S:2799 E:2805 ||| RB
the  ||| S:2805 E:2809 ||| DT
most  ||| S:2809 E:2814 ||| RBS
popular  ||| S:2814 E:2822 ||| JJ
bead  ||| S:2822 E:2827 ||| JJ
material ||| S:2827 E:2835 ||| NN
.  ||| S:2835 E:2839 ||| .
Some  ||| S:2839 E:2844 ||| DT
advantages  ||| S:2844 E:2855 ||| NNS
of  ||| S:2855 E:2858 ||| IN
microcarrier  ||| S:2858 E:2871 ||| JJ
cultures  ||| S:2871 E:2880 ||| NNS
over  ||| S:2880 E:2885 ||| IN
other  ||| S:2885 E:2891 ||| JJ
methods  ||| S:2891 E:2899 ||| NNS
of  ||| S:2899 E:2902 ||| IN
large-scale  ||| S:2902 E:2914 ||| JJ
cultivation  ||| S:2914 E:2926 ||| NNS
are ||| S:2926 E:2929 ||| VBP
:  ||| S:2929 E:2931 ||| :
i ||| S:2931 E:2932 ||| FW
)  ||| S:2932 E:2934 ||| -RRB-
high  ||| S:2934 E:2939 ||| JJ
surface  ||| S:2939 E:2947 ||| NN
area  ||| S:2947 E:2952 ||| NN
to  ||| S:2952 E:2955 ||| TO
volume  ||| S:2955 E:2962 ||| NN
ratio  ||| S:2962 E:2968 ||| NN
can  ||| S:2968 E:2972 ||| MD
be  ||| S:2972 E:2975 ||| VB
achieved  ||| S:2975 E:2984 ||| VBN
which  ||| S:2984 E:2990 ||| WDT
can  ||| S:2990 E:2994 ||| MD
be  ||| S:2994 E:2997 ||| VB
varied  ||| S:2997 E:3004 ||| VBN
by  ||| S:3004 E:3007 ||| IN
changing  ||| S:3007 E:3016 ||| VBG
the  ||| S:3016 E:3020 ||| DT
microcarrier  ||| S:3020 E:3033 ||| JJ
concentration  ||| S:3033 E:3047 ||| NN
leading  ||| S:3047 E:3055 ||| VBG
to  ||| S:3055 E:3058 ||| TO
high  ||| S:3058 E:3063 ||| JJ
cell  ||| S:3063 E:3068 ||| NN
densities  ||| S:3068 E:3078 ||| NN
per  ||| S:3078 E:3082 ||| IN
unit  ||| S:3082 E:3087 ||| NN
volume  ||| S:3087 E:3094 ||| NN
with  ||| S:3094 E:3099 ||| IN
a  ||| S:3099 E:3101 ||| DT
potential  ||| S:3101 E:3111 ||| NN
for  ||| S:3111 E:3115 ||| IN
obtaining  ||| S:3115 E:3125 ||| VBG
highly  ||| S:3125 E:3132 ||| RB
concentrated  ||| S:3132 E:3145 ||| JJ
cell  ||| S:3145 E:3150 ||| NN
products ||| S:3150 E:3158 ||| NNS
;  ||| S:3158 E:3160 ||| :
ii ||| S:3160 E:3162 ||| LS
)  ||| S:3162 E:3164 ||| -RRB-
cell  ||| S:3164 E:3169 ||| NN
propagation  ||| S:3169 E:3181 ||| NNS
can  ||| S:3181 E:3185 ||| MD
be  ||| S:3185 E:3188 ||| VB
carried  ||| S:3188 E:3196 ||| VBN
out  ||| S:3196 E:3200 ||| RP
in  ||| S:3200 E:3203 ||| IN
a  ||| S:3203 E:3205 ||| DT
single  ||| S:3205 E:3212 ||| JJ
high  ||| S:3212 E:3217 ||| JJ
productivity  ||| S:3217 E:3230 ||| NN
vessel  ||| S:3230 E:3237 ||| NN
instead  ||| S:3237 E:3245 ||| RB
of  ||| S:3245 E:3248 ||| IN
using  ||| S:3248 E:3254 ||| VBG
many  ||| S:3254 E:3259 ||| JJ
low  ||| S:3259 E:3263 ||| JJ
productivity  ||| S:3263 E:3276 ||| NN
units ||| S:3276 E:3281 ||| NNS
,  ||| S:3281 E:3283 ||| ,
thus  ||| S:3283 E:3288 ||| RB
achieving  ||| S:3288 E:3298 ||| VBG
a  ||| S:3298 E:3300 ||| DT
better  ||| S:3300 E:3307 ||| JJR
utilisation  ||| S:3307 E:3319 ||| NNS
and  ||| S:3319 E:3323 ||| CC
a  ||| S:3323 E:3325 ||| DT
considerable  ||| S:3325 E:3338 ||| JJ
saving  ||| S:3338 E:3345 ||| NN
of  ||| S:3345 E:3348 ||| IN
medium ||| S:3348 E:3354 ||| NN
;  ||| S:3354 E:3356 ||| :
iii ||| S:3356 E:3359 ||| LS
)  ||| S:3359 E:3361 ||| -RRB-
since  ||| S:3361 E:3367 ||| IN
the  ||| S:3367 E:3371 ||| DT
microcarrier  ||| S:3371 E:3384 ||| JJ
culture  ||| S:3384 E:3392 ||| NN
is  ||| S:3392 E:3395 ||| VBZ
well  ||| S:3395 E:3400 ||| RB
mixed ||| S:3400 E:3405 ||| VBN
,  ||| S:3405 E:3407 ||| ,
it  ||| S:3407 E:3410 ||| PRP
is  ||| S:3410 E:3413 ||| VBZ
easy  ||| S:3413 E:3418 ||| JJ
to  ||| S:3418 E:3421 ||| TO
monitor  ||| S:3421 E:3429 ||| VB
and  ||| S:3429 E:3433 ||| CC
control  ||| S:3433 E:3441 ||| VB
different  ||| S:3441 E:3451 ||| JJ
environmental  ||| S:3451 E:3465 ||| JJ
conditions  ||| S:3465 E:3476 ||| NNS
such  ||| S:3476 E:3481 ||| JJ
as  ||| S:3481 E:3484 ||| IN
pH ||| S:3484 E:3486 ||| NNP
,  ||| S:3486 E:3488 ||| ,
pO2 ||| S:3488 E:3491 ||| NNP
,  ||| S:3491 E:3493 ||| ,
pCO2  ||| S:3493 E:3498 ||| FW
etc. ||| S:3498 E:3502 ||| FW
;  ||| S:3502 E:3504 ||| :
iv ||| S:3504 E:3506 ||| LS
)  ||| S:3506 E:3508 ||| -RRB-
cell  ||| S:3508 E:3513 ||| NN
sampling  ||| S:3513 E:3522 ||| NN
is  ||| S:3522 E:3525 ||| VBZ
easy ||| S:3525 E:3529 ||| JJ
;  ||| S:3529 E:3531 ||| :
v ||| S:3531 E:3532 ||| LS
)  ||| S:3532 E:3534 ||| -RRB-
since  ||| S:3534 E:3540 ||| IN
the  ||| S:3540 E:3544 ||| DT
beads  ||| S:3544 E:3550 ||| NNS
settle  ||| S:3550 E:3557 ||| VBP
down  ||| S:3557 E:3562 ||| RB
easily ||| S:3562 E:3568 ||| RB
,  ||| S:3568 E:3570 ||| ,
cell  ||| S:3570 E:3575 ||| NN
harvesting  ||| S:3575 E:3586 ||| NN
and  ||| S:3586 E:3590 ||| CC
downstream  ||| S:3590 E:3601 ||| JJ
processing  ||| S:3601 E:3612 ||| NN
of  ||| S:3612 E:3615 ||| IN
products  ||| S:3615 E:3624 ||| NNS
is  ||| S:3624 E:3627 ||| VBZ
easy ||| S:3627 E:3631 ||| JJ
;  ||| S:3631 E:3633 ||| :
vi ||| S:3633 E:3635 ||| LS
)  ||| S:3635 E:3637 ||| -RRB-
microcarrier  ||| S:3637 E:3650 ||| JJ
cultures  ||| S:3650 E:3659 ||| NNS
can  ||| S:3659 E:3663 ||| MD
be  ||| S:3663 E:3666 ||| VB
relatively  ||| S:3666 E:3677 ||| RB
easily  ||| S:3677 E:3684 ||| RB
scaled  ||| S:3684 E:3691 ||| VBN
up  ||| S:3691 E:3694 ||| RP
using  ||| S:3694 E:3700 ||| VBG
conventional  ||| S:3700 E:3713 ||| JJ
equipment  ||| S:3713 E:3723 ||| NN
like  ||| S:3723 E:3728 ||| IN
fermenters  ||| S:3728 E:3739 ||| NNS
that  ||| S:3739 E:3744 ||| WDT
have  ||| S:3744 E:3749 ||| VBP
been  ||| S:3749 E:3754 ||| VBN
suitably  ||| S:3754 E:3763 ||| JJ
modified ||| S:3763 E:3771 ||| NN
.  ||| S:3771 E:3775 ||| .
When  ||| S:3775 E:3780 ||| WRB
developing  ||| S:3780 E:3791 ||| VBG
further  ||| S:3791 E:3799 ||| JJ
improvements  ||| S:3799 E:3812 ||| NNS
the  ||| S:3812 E:3816 ||| DT
following  ||| S:3816 E:3826 ||| JJ
requirements  ||| S:3826 E:3839 ||| NNS
for  ||| S:3839 E:3843 ||| IN
an  ||| S:3843 E:3846 ||| DT
optimum  ||| S:3846 E:3854 ||| JJ
microcarrier  ||| S:3854 E:3867 ||| NN
should  ||| S:3867 E:3874 ||| MD
be  ||| S:3874 E:3877 ||| VB
met ||| S:3877 E:3880 ||| VBN
:  ||| S:3880 E:3882 ||| :
i ||| S:3882 E:3883 ||| FW
)  ||| S:3883 E:3885 ||| -RRB-
the  ||| S:3885 E:3889 ||| DT
surface  ||| S:3889 E:3897 ||| NN
properties  ||| S:3897 E:3908 ||| NNS
of  ||| S:3908 E:3911 ||| IN
the  ||| S:3911 E:3915 ||| DT
beads  ||| S:3915 E:3921 ||| NN
should  ||| S:3921 E:3928 ||| MD
be  ||| S:3928 E:3931 ||| VB
such  ||| S:3931 E:3936 ||| PDT
that  ||| S:3936 E:3941 ||| DT
cells  ||| S:3941 E:3947 ||| NNS
can  ||| S:3947 E:3951 ||| MD
adhere  ||| S:3951 E:3958 ||| VB
and  ||| S:3958 E:3962 ||| CC
proliferate  ||| S:3962 E:3974 ||| VBP
rapidly ||| S:3974 E:3981 ||| RB
,  ||| S:3981 E:3983 ||| ,
preferably  ||| S:3983 E:3994 ||| RB
the  ||| S:3994 E:3998 ||| DT
contour  ||| S:3998 E:4006 ||| NN
should  ||| S:4006 E:4013 ||| MD
be  ||| S:4013 E:4016 ||| VB
even ||| S:4016 E:4020 ||| RB
;  ||| S:4020 E:4022 ||| :
ii ||| S:4022 E:4024 ||| LS
)  ||| S:4024 E:4026 ||| -RRB-
the  ||| S:4026 E:4030 ||| DT
density  ||| S:4030 E:4038 ||| NN
of  ||| S:4038 E:4041 ||| IN
the  ||| S:4041 E:4045 ||| DT
beads  ||| S:4045 E:4051 ||| NN
should  ||| S:4051 E:4058 ||| MD
be  ||| S:4058 E:4061 ||| VB
slightly  ||| S:4061 E:4070 ||| RB
more  ||| S:4070 E:4075 ||| JJR
than  ||| S:4075 E:4080 ||| IN
that  ||| S:4080 E:4085 ||| DT
of  ||| S:4085 E:4088 ||| IN
the  ||| S:4088 E:4092 ||| DT
culture  ||| S:4092 E:4100 ||| NN
medium ||| S:4100 E:4106 ||| NN
,  ||| S:4106 E:4108 ||| ,
so  ||| S:4108 E:4111 ||| RB
as  ||| S:4111 E:4114 ||| RB
to  ||| S:4114 E:4117 ||| TO
facilitate  ||| S:4117 E:4128 ||| VB
easy  ||| S:4128 E:4133 ||| JJ
separation ||| S:4133 E:4143 ||| NN
;  ||| S:4143 E:4145 ||| :
conventional  ||| S:4145 E:4158 ||| JJ
culture  ||| S:4158 E:4166 ||| NN
media  ||| S:4166 E:4172 ||| NNS
are  ||| S:4172 E:4176 ||| VBP
aqueous  ||| S:4176 E:4184 ||| VBN
in  ||| S:4184 E:4187 ||| IN
nature  ||| S:4187 E:4194 ||| NN
and  ||| S:4194 E:4198 ||| CC
have  ||| S:4198 E:4203 ||| VBP
densities  ||| S:4203 E:4213 ||| VBN
ranging  ||| S:4213 E:4221 ||| VBG
from  ||| S:4221 E:4226 ||| IN
1.03-1.09  ||| S:4226 E:4236 ||| CD
g ||| S:4236 E:4237 ||| CD
/ ||| S:4237 E:4238 ||| CD
cc ||| S:4238 E:4240 ||| NN
,  ||| S:4240 E:4242 ||| ,
however ||| S:4242 E:4249 ||| RB
,  ||| S:4249 E:4251 ||| ,
the  ||| S:4251 E:4255 ||| DT
density  ||| S:4255 E:4263 ||| NN
should  ||| S:4263 E:4270 ||| MD
not  ||| S:4270 E:4274 ||| RB
exceed  ||| S:4274 E:4281 ||| VB
a  ||| S:4281 E:4283 ||| DT
certain  ||| S:4283 E:4291 ||| JJ
limit  ||| S:4291 E:4297 ||| NN
the  ||| S:4297 E:4301 ||| DT
optimum  ||| S:4301 E:4309 ||| JJ
range  ||| S:4309 E:4315 ||| NN
being  ||| S:4315 E:4321 ||| VBG
1.03-1.045  ||| S:4321 E:4332 ||| CD
g ||| S:4332 E:4333 ||| CD
/ ||| S:4333 E:4334 ||| CD
ml ||| S:4334 E:4336 ||| NNS
;  ||| S:4336 E:4338 ||| :
gentle  ||| S:4338 E:4345 ||| JJ
stirring ||| S:4345 E:4353 ||| NN
,  ||| S:4353 E:4355 ||| ,
which  ||| S:4355 E:4361 ||| WDT
will  ||| S:4361 E:4366 ||| MD
not  ||| S:4366 E:4370 ||| RB
harm  ||| S:4370 E:4375 ||| VB
the  ||| S:4375 E:4379 ||| DT
shear-sensitive  ||| S:4379 E:4395 ||| JJ
cells ||| S:4395 E:4400 ||| NNS
,  ||| S:4400 E:4402 ||| ,
should  ||| S:4402 E:4409 ||| MD
be  ||| S:4409 E:4412 ||| VB
sufficient  ||| S:4412 E:4423 ||| JJ
to  ||| S:4423 E:4426 ||| TO
keep  ||| S:4426 E:4431 ||| VB
them  ||| S:4431 E:4436 ||| PRP
in  ||| S:4436 E:4439 ||| IN
suspension ||| S:4439 E:4449 ||| NN
,  ||| S:4449 E:4451 ||| ,
if  ||| S:4451 E:4454 ||| IN
the  ||| S:4454 E:4458 ||| DT
beads  ||| S:4458 E:4464 ||| NN
settle  ||| S:4464 E:4471 ||| VB
down  ||| S:4471 E:4476 ||| RP
cell  ||| S:4476 E:4481 ||| NN
growth  ||| S:4481 E:4488 ||| NN
will  ||| S:4488 E:4493 ||| MD
be  ||| S:4493 E:4496 ||| VB
prevented ||| S:4496 E:4505 ||| VBN
;  ||| S:4505 E:4507 ||| :
iii ||| S:4507 E:4510 ||| LS
)  ||| S:4510 E:4512 ||| -RRB-
the  ||| S:4512 E:4516 ||| DT
size-distribution  ||| S:4516 E:4534 ||| JJ
of  ||| S:4534 E:4537 ||| IN
the  ||| S:4537 E:4541 ||| DT
beads  ||| S:4541 E:4547 ||| NN
should  ||| S:4547 E:4554 ||| MD
be  ||| S:4554 E:4557 ||| VB
narrow  ||| S:4557 E:4564 ||| JJ
so  ||| S:4564 E:4567 ||| RB
that  ||| S:4567 E:4572 ||| IN
an  ||| S:4572 E:4575 ||| DT
even  ||| S:4575 E:4580 ||| JJ
suspension  ||| S:4580 E:4591 ||| NN
of  ||| S:4591 E:4594 ||| IN
all  ||| S:4594 E:4598 ||| DT
microcarriers  ||| S:4598 E:4612 ||| NN
is  ||| S:4612 E:4615 ||| VBZ
achieved  ||| S:4615 E:4624 ||| VBN
and  ||| S:4624 E:4628 ||| CC
cells  ||| S:4628 E:4634 ||| NNS
attain  ||| S:4634 E:4641 ||| VBP
confluency  ||| S:4641 E:4652 ||| VBN
at  ||| S:4652 E:4655 ||| IN
approximately  ||| S:4655 E:4669 ||| RB
the  ||| S:4669 E:4673 ||| DT
same  ||| S:4673 E:4678 ||| JJ
time ||| S:4678 E:4682 ||| NN
;  ||| S:4682 E:4684 ||| :
also ||| S:4684 E:4688 ||| RB
,  ||| S:4688 E:4690 ||| ,
clustering  ||| S:4690 E:4701 ||| VBG
of  ||| S:4701 E:4704 ||| IN
microcarriers  ||| S:4704 E:4718 ||| NN
in  ||| S:4718 E:4721 ||| IN
solution  ||| S:4721 E:4730 ||| NN
should  ||| S:4730 E:4737 ||| MD
be  ||| S:4737 E:4740 ||| VB
prevented ||| S:4740 E:4749 ||| VBN
;  ||| S:4749 E:4751 ||| :
iv ||| S:4751 E:4753 ||| LS
)  ||| S:4753 E:4755 ||| -RRB-
the  ||| S:4755 E:4759 ||| DT
optical  ||| S:4759 E:4767 ||| JJ
properties  ||| S:4767 E:4778 ||| NNS
should  ||| S:4778 E:4785 ||| MD
enable  ||| S:4785 E:4792 ||| VB
easy  ||| S:4792 E:4797 ||| JJ
microscopic  ||| S:4797 E:4809 ||| JJ
observation ||| S:4809 E:4820 ||| NN
;  ||| S:4820 E:4822 ||| :
v ||| S:4822 E:4823 ||| LS
)  ||| S:4823 E:4825 ||| -RRB-
they  ||| S:4825 E:4830 ||| PRP
should  ||| S:4830 E:4837 ||| MD
be  ||| S:4837 E:4840 ||| VB
non-toxic  ||| S:4840 E:4850 ||| JJ
not  ||| S:4850 E:4854 ||| RB
only  ||| S:4854 E:4859 ||| RB
for  ||| S:4859 E:4863 ||| IN
the  ||| S:4863 E:4867 ||| DT
survival  ||| S:4867 E:4876 ||| NN
and  ||| S:4876 E:4880 ||| CC
good  ||| S:4880 E:4885 ||| JJ
growth  ||| S:4885 E:4892 ||| NN
of  ||| S:4892 E:4895 ||| IN
the  ||| S:4895 E:4899 ||| DT
cells  ||| S:4899 E:4905 ||| NNS
but  ||| S:4905 E:4909 ||| CC
also  ||| S:4909 E:4914 ||| RB
for  ||| S:4914 E:4918 ||| IN
cell  ||| S:4918 E:4923 ||| NN
culture  ||| S:4923 E:4931 ||| NN
products  ||| S:4931 E:4940 ||| NNS
that  ||| S:4940 E:4945 ||| WDT
are  ||| S:4945 E:4949 ||| VBP
used  ||| S:4949 E:4954 ||| VBN
for  ||| S:4954 E:4958 ||| IN
veterinary  ||| S:4958 E:4969 ||| NN
or  ||| S:4969 E:4972 ||| CC
clinical  ||| S:4972 E:4981 ||| JJ
purposes ||| S:4981 E:4989 ||| NNS
;  ||| S:4989 E:4991 ||| :
vi ||| S:4991 E:4993 ||| LS
)  ||| S:4993 E:4995 ||| -RRB-
the  ||| S:4995 E:4999 ||| DT
matrix  ||| S:4999 E:5006 ||| NN
of  ||| S:5006 E:5009 ||| IN
the  ||| S:5009 E:5013 ||| DT
beads  ||| S:5013 E:5019 ||| NN
should  ||| S:5019 E:5026 ||| MD
be  ||| S:5026 E:5029 ||| VB
such  ||| S:5029 E:5034 ||| PDT
that  ||| S:5034 E:5039 ||| DT
collisions ||| S:5039 E:5049 ||| NN
,  ||| S:5049 E:5051 ||| ,
which  ||| S:5051 E:5057 ||| WDT
occur  ||| S:5057 E:5063 ||| VBP
during  ||| S:5063 E:5070 ||| IN
stirring  ||| S:5070 E:5079 ||| VBG
of  ||| S:5079 E:5082 ||| IN
the  ||| S:5082 E:5086 ||| DT
culture ||| S:5086 E:5093 ||| NN
,  ||| S:5093 E:5095 ||| ,
do  ||| S:5095 E:5098 ||| VBP
not  ||| S:5098 E:5102 ||| RB
cause  ||| S:5102 E:5108 ||| VB
fragmentation  ||| S:5108 E:5122 ||| VBN
of  ||| S:5122 E:5125 ||| IN
the  ||| S:5125 E:5129 ||| DT
beads ||| S:5129 E:5134 ||| NN
.  ||| S:5134 E:5138 ||| .
An  ||| S:5138 E:5141 ||| DT
important  ||| S:5141 E:5151 ||| JJ
modification  ||| S:5151 E:5164 ||| NN
in  ||| S:5164 E:5167 ||| IN
the  ||| S:5167 E:5171 ||| DT
development  ||| S:5171 E:5183 ||| NN
of  ||| S:5183 E:5186 ||| IN
improved  ||| S:5186 E:5195 ||| JJ
microcarriers  ||| S:5195 E:5209 ||| NN
is  ||| S:5209 E:5212 ||| VBZ
the  ||| S:5212 E:5216 ||| DT
coating  ||| S:5216 E:5224 ||| NN
of  ||| S:5224 E:5227 ||| IN
core  ||| S:5227 E:5232 ||| JJ
particles  ||| S:5232 E:5242 ||| NN
with  ||| S:5242 E:5247 ||| IN
collagen ||| S:5247 E:5255 ||| NN
.  ||| S:5255 E:5257 ||| .
The  ||| S:5257 E:5261 ||| DT
advantage  ||| S:5261 E:5271 ||| NN
of  ||| S:5271 E:5274 ||| IN
using  ||| S:5274 E:5280 ||| VBG
collagen  ||| S:5280 E:5289 ||| NN
is  ||| S:5289 E:5292 ||| VBZ
that  ||| S:5292 E:5297 ||| IN
it  ||| S:5297 E:5300 ||| PRP
is  ||| S:5300 E:5303 ||| VBZ
a  ||| S:5303 E:5305 ||| DT
promoter  ||| S:5305 E:5314 ||| NN
for  ||| S:5314 E:5318 ||| IN
both  ||| S:5318 E:5323 ||| DT
cell  ||| S:5323 E:5328 ||| NN
attachment  ||| S:5328 E:5339 ||| NN
and  ||| S:5339 E:5343 ||| CC
cell  ||| S:5343 E:5348 ||| NN
growth ||| S:5348 E:5354 ||| NN
.  ||| S:5354 E:5356 ||| .
In  ||| S:5356 E:5359 ||| IN
addition  ||| S:5359 E:5368 ||| NN
cells  ||| S:5368 E:5374 ||| NNS
can  ||| S:5374 E:5378 ||| MD
be  ||| S:5378 E:5381 ||| VB
easily  ||| S:5381 E:5388 ||| RB
detached  ||| S:5388 E:5397 ||| VBN
by  ||| S:5397 E:5400 ||| IN
proteolytic  ||| S:5400 E:5412 ||| JJ
enzymes ||| S:5412 E:5419 ||| NN
.  ||| S:5419 E:5421 ||| .
Several  ||| S:5421 E:5429 ||| JJ
collagen-coated  ||| S:5429 E:5445 ||| JJ
micorcarriers  ||| S:5445 E:5459 ||| NNS
are  ||| S:5459 E:5463 ||| VBP
commercially  ||| S:5463 E:5476 ||| RB
available  ||| S:5476 E:5486 ||| JJ
such  ||| S:5486 E:5491 ||| JJ
as  ||| S:5491 E:5494 ||| IN
for  ||| S:5494 E:5498 ||| IN
instance  ||| S:5498 E:5507 ||| NN
SoloHill  ||| S:5507 E:5524 ||| JJ
collagen-coated  ||| S:5524 E:5540 ||| JJ
microcarriers  ||| S:5540 E:5554 ||| NN
and  ||| S:5554 E:5558 ||| CC
Cytodex  ||| S:5558 E:5566 ||| NNP
3  ||| S:5566 E:5576 ||| CD
from  ||| S:5576 E:5581 ||| IN
Amersham  ||| S:5581 E:5590 ||| NNP
Biosciences ||| S:5590 E:5601 ||| NNP
.  ||| S:5601 E:5603 ||| .
There  ||| S:5603 E:5609 ||| EX
is  ||| S:5609 E:5612 ||| VBZ
however  ||| S:5612 E:5620 ||| RB
a  ||| S:5620 E:5622 ||| DT
strong  ||| S:5622 E:5629 ||| JJ
need  ||| S:5629 E:5634 ||| NN
for  ||| S:5634 E:5638 ||| IN
further  ||| S:5638 E:5646 ||| JJ
improvements  ||| S:5646 E:5659 ||| NNS
of  ||| S:5659 E:5662 ||| IN
microcarriers  ||| S:5662 E:5676 ||| VBG
to  ||| S:5676 E:5679 ||| TO
meet  ||| S:5679 E:5684 ||| VB
the  ||| S:5684 E:5688 ||| DT
requirements  ||| S:5688 E:5701 ||| NNS
for  ||| S:5701 E:5705 ||| IN
optimum  ||| S:5705 E:5713 ||| JJ
microcarriers  ||| S:5713 E:5727 ||| NN
outlined  ||| S:5727 E:5736 ||| VBD
above ||| S:5736 E:5741 ||| RB
.  ||| S:5741 E:5745 ||| .
A  ||| S:5745 E:5747 ||| DT
process  ||| S:5747 E:5755 ||| NN
for  ||| S:5755 E:5759 ||| IN
the  ||| S:5759 E:5763 ||| DT
preparation  ||| S:5763 E:5775 ||| NN
of  ||| S:5775 E:5778 ||| IN
collagen  ||| S:5778 E:5787 ||| JJ
coated  ||| S:5787 E:5794 ||| JJ
microcarriers  ||| S:5794 E:5808 ||| NN
is  ||| S:5808 E:5811 ||| VBZ
described  ||| S:5811 E:5821 ||| VBN
in  ||| S:5821 E:5824 ||| IN
U.S.  ||| S:5824 E:5829 ||| NNP
Pat ||| S:5829 E:5832 ||| NNP
.  ||| S:5832 E:5834 ||| .
No.  ||| S:5834 E:5838 ||| NNP
4,994,388 ||| S:5838 E:5847 ||| NNP
.  ||| S:5847 E:5849 ||| .
Providing  ||| S:5849 E:5859 ||| VBG
a  ||| S:5859 E:5861 ||| DT
core  ||| S:5861 E:5866 ||| NN
bead  ||| S:5866 E:5871 ||| NN
with  ||| S:5871 E:5876 ||| IN
a  ||| S:5876 E:5878 ||| DT
collagen  ||| S:5878 E:5887 ||| JJ
coating  ||| S:5887 E:5895 ||| NN
is  ||| S:5895 E:5898 ||| VBZ
performed  ||| S:5898 E:5908 ||| VBN
in  ||| S:5908 E:5911 ||| IN
two  ||| S:5911 E:5915 ||| CD
steps ||| S:5915 E:5920 ||| NNS
:  ||| S:5920 E:5922 ||| :
coating  ||| S:5922 E:5930 ||| NN
and  ||| S:5930 E:5934 ||| CC
fixing ||| S:5934 E:5940 ||| VBG
.  ||| S:5940 E:5942 ||| .
The  ||| S:5942 E:5946 ||| DT
core  ||| S:5946 E:5951 ||| NN
beads  ||| S:5951 E:5957 ||| NNS
are  ||| S:5957 E:5961 ||| VBP
suspended  ||| S:5961 E:5971 ||| VBN
in  ||| S:5971 E:5974 ||| IN
an  ||| S:5974 E:5977 ||| DT
acidic ||| S:5977 E:5983 ||| NN
,  ||| S:5983 E:5985 ||| ,
aqueous  ||| S:5985 E:5993 ||| JJ
collagen  ||| S:5993 E:6002 ||| NN
solution  ||| S:6002 E:6011 ||| NN
( ||| S:6011 E:6012 ||| -LRB-
0.01-0.1N  ||| S:6012 E:6022 ||| FW
acetic  ||| S:6022 E:6029 ||| FW
acid ||| S:6029 E:6033 ||| FW
) ||| S:6033 E:6034 ||| -RRB-
,  ||| S:6034 E:6036 ||| ,
and  ||| S:6036 E:6040 ||| CC
the  ||| S:6040 E:6044 ||| DT
solution  ||| S:6044 E:6053 ||| NN
is  ||| S:6053 E:6056 ||| VBZ
evaporated  ||| S:6056 E:6067 ||| VBN
to  ||| S:6067 E:6070 ||| TO
dryness ||| S:6070 E:6077 ||| VB
.  ||| S:6077 E:6079 ||| .
The  ||| S:6079 E:6083 ||| DT
dry ||| S:6083 E:6086 ||| JJ
,  ||| S:6086 E:6088 ||| ,
collagen-coated  ||| S:6088 E:6104 ||| JJ
beads  ||| S:6104 E:6110 ||| NNS
are  ||| S:6110 E:6114 ||| VBP
then  ||| S:6114 E:6119 ||| RB
suspended  ||| S:6119 E:6129 ||| VBN
in  ||| S:6129 E:6132 ||| IN
a  ||| S:6132 E:6134 ||| DT
solution  ||| S:6134 E:6143 ||| NN
which  ||| S:6143 E:6149 ||| WDT
contains  ||| S:6149 E:6158 ||| VBZ
a  ||| S:6158 E:6160 ||| DT
protein  ||| S:6160 E:6168 ||| NN
crosslinking  ||| S:6168 E:6181 ||| NN
agent  ||| S:6181 E:6187 ||| NN
such  ||| S:6187 E:6192 ||| JJ
as  ||| S:6192 E:6195 ||| IN
glutaraldehyde ||| S:6195 E:6209 ||| NN
,  ||| S:6209 E:6211 ||| ,
thus  ||| S:6211 E:6216 ||| RB
crosslinking  ||| S:6216 E:6229 ||| VB
the  ||| S:6229 E:6233 ||| DT
collagen  ||| S:6233 E:6242 ||| JJ
coating ||| S:6242 E:6249 ||| NN
.  ||| S:6249 E:6251 ||| .
Alternatively ||| S:6251 E:6264 ||| RB
,  ||| S:6264 E:6266 ||| ,
the  ||| S:6266 E:6270 ||| DT
core  ||| S:6270 E:6275 ||| JJ
beads  ||| S:6275 E:6281 ||| JJ
wetted  ||| S:6281 E:6288 ||| NN
with  ||| S:6288 E:6293 ||| IN
the  ||| S:6293 E:6297 ||| DT
collagen  ||| S:6297 E:6306 ||| JJ
solution  ||| S:6306 E:6315 ||| NN
are  ||| S:6315 E:6319 ||| VBP
not  ||| S:6319 E:6323 ||| RB
dried  ||| S:6323 E:6329 ||| VBD
entirely  ||| S:6329 E:6338 ||| RB
before  ||| S:6338 E:6345 ||| IN
the  ||| S:6345 E:6349 ||| DT
start  ||| S:6349 E:6355 ||| NN
of  ||| S:6355 E:6358 ||| IN
the  ||| S:6358 E:6362 ||| DT
fixing  ||| S:6362 E:6369 ||| JJ
step ||| S:6369 E:6373 ||| NN
.  ||| S:6373 E:6377 ||| .
Whereas  ||| S:6377 E:6385 ||| IN
in  ||| S:6385 E:6388 ||| IN
the  ||| S:6388 E:6392 ||| DT
art  ||| S:6392 E:6396 ||| NN
in  ||| S:6396 E:6399 ||| IN
this  ||| S:6399 E:6404 ||| DT
field  ||| S:6404 E:6410 ||| NN
often  ||| S:6410 E:6416 ||| RB
the  ||| S:6416 E:6420 ||| DT
term  ||| S:6420 E:6425 ||| NN
collagen  ||| S:6425 E:6434 ||| NN
or  ||| S:6434 E:6437 ||| CC
denatured  ||| S:6437 E:6447 ||| JJ
collagen  ||| S:6447 E:6456 ||| NN
is  ||| S:6456 E:6459 ||| VBZ
used ||| S:6459 E:6463 ||| VBN
,  ||| S:6463 E:6465 ||| ,
throughout  ||| S:6465 E:6476 ||| IN
the  ||| S:6476 E:6480 ||| DT
rest  ||| S:6480 E:6485 ||| NN
of  ||| S:6485 E:6488 ||| IN
this  ||| S:6488 E:6493 ||| DT
description  ||| S:6493 E:6505 ||| NN
the  ||| S:6505 E:6509 ||| DT
term  ||| S:6509 E:6514 ||| NN
gelatine  ||| S:6514 E:6523 ||| NNS
or  ||| S:6523 E:6526 ||| CC
gelatine-like  ||| S:6526 E:6540 ||| JJ
protein  ||| S:6540 E:6548 ||| NN
will  ||| S:6548 E:6553 ||| MD
be  ||| S:6553 E:6556 ||| VB
used ||| S:6556 E:6560 ||| VBN
.  ||| S:6560 E:6562 ||| .
The  ||| S:6562 E:6566 ||| DT
term  ||| S:6566 E:6571 ||| NN
gelatine  ||| S:6571 E:6580 ||| NN
more  ||| S:6580 E:6585 ||| RBR
truly  ||| S:6585 E:6591 ||| RB
reflects  ||| S:6591 E:6600 ||| VBZ
the  ||| S:6600 E:6604 ||| DT
appearance  ||| S:6604 E:6615 ||| NN
of  ||| S:6615 E:6618 ||| IN
the  ||| S:6618 E:6622 ||| DT
protein ||| S:6622 E:6629 ||| NN
,  ||| S:6629 E:6631 ||| ,
being  ||| S:6631 E:6637 ||| VBG
a  ||| S:6637 E:6639 ||| DT
single  ||| S:6639 E:6646 ||| JJ
polypeptide  ||| S:6646 E:6658 ||| JJ
chain ||| S:6658 E:6663 ||| NN
,  ||| S:6663 E:6665 ||| ,
whereas  ||| S:6665 E:6673 ||| IN
collagen  ||| S:6673 E:6682 ||| NN
normally  ||| S:6682 E:6691 ||| RB
is  ||| S:6691 E:6694 ||| VBZ
used  ||| S:6694 E:6699 ||| VBN
to  ||| S:6699 E:6702 ||| TO
describe  ||| S:6702 E:6711 ||| VB
a  ||| S:6711 E:6713 ||| DT
structure  ||| S:6713 E:6723 ||| NN
of  ||| S:6723 E:6726 ||| IN
three  ||| S:6726 E:6732 ||| CD
polypeptide  ||| S:6732 E:6744 ||| CD
chains  ||| S:6744 E:6751 ||| NNS
oriented  ||| S:6751 E:6760 ||| VBN
in  ||| S:6760 E:6763 ||| IN
a  ||| S:6763 E:6765 ||| DT
helical  ||| S:6765 E:6773 ||| JJ
bundle ||| S:6773 E:6779 ||| NN
.  ||| S:6779 E:6782 ||| .
It  ||| S:6809 E:6812 ||| PRP
is  ||| S:6812 E:6815 ||| VBZ
an  ||| S:6815 E:6818 ||| DT
object  ||| S:6818 E:6825 ||| NN
of  ||| S:6825 E:6828 ||| IN
the  ||| S:6828 E:6832 ||| DT
invention  ||| S:6832 E:6842 ||| NN
to  ||| S:6842 E:6845 ||| TO
provide  ||| S:6845 E:6853 ||| VB
an  ||| S:6853 E:6856 ||| DT
improved  ||| S:6856 E:6865 ||| JJ
process  ||| S:6865 E:6873 ||| NN
for  ||| S:6873 E:6877 ||| IN
coating  ||| S:6877 E:6885 ||| VBG
a  ||| S:6885 E:6887 ||| DT
microcarrier  ||| S:6887 E:6900 ||| NN
with  ||| S:6900 E:6905 ||| IN
gelatine  ||| S:6905 E:6914 ||| NN
or  ||| S:6914 E:6917 ||| CC
gelatine-like  ||| S:6917 E:6931 ||| JJ
proteins  ||| S:6931 E:6940 ||| NNS
allowing  ||| S:6940 E:6949 ||| VBG
clustering  ||| S:6949 E:6960 ||| NN
between  ||| S:6960 E:6968 ||| IN
microcarrier  ||| S:6968 E:6981 ||| JJ
particles  ||| S:6981 E:6991 ||| NN
in  ||| S:6991 E:6994 ||| IN
cell  ||| S:6994 E:6999 ||| NN
cultures  ||| S:6999 E:7008 ||| NNS
to  ||| S:7008 E:7011 ||| TO
be  ||| S:7011 E:7014 ||| VB
prevented ||| S:7014 E:7023 ||| VBN
.  ||| S:7023 E:7027 ||| .
It  ||| S:7027 E:7030 ||| PRP
is  ||| S:7030 E:7033 ||| VBZ
a  ||| S:7033 E:7035 ||| DT
further  ||| S:7035 E:7043 ||| JJ
object  ||| S:7043 E:7050 ||| NN
to  ||| S:7050 E:7053 ||| TO
provide  ||| S:7053 E:7061 ||| VB
gelatine-coated  ||| S:7061 E:7077 ||| JJ
microcarriers  ||| S:7077 E:7091 ||| NN
or  ||| S:7091 E:7094 ||| CC
micorcarriers  ||| S:7094 E:7108 ||| JJ
coated  ||| S:7108 E:7115 ||| NN
with  ||| S:7115 E:7120 ||| IN
gelatine-like  ||| S:7120 E:7134 ||| JJ
proteins  ||| S:7134 E:7143 ||| NNS
with  ||| S:7143 E:7148 ||| IN
improved  ||| S:7148 E:7157 ||| JJ
properties  ||| S:7157 E:7168 ||| NNS
for  ||| S:7168 E:7172 ||| IN
use  ||| S:7172 E:7176 ||| NN
in  ||| S:7176 E:7179 ||| IN
large  ||| S:7179 E:7185 ||| JJ
scale  ||| S:7185 E:7191 ||| NN
cell  ||| S:7191 E:7196 ||| NN
cultures ||| S:7196 E:7204 ||| NNS
.  ||| S:7204 E:7208 ||| .
A  ||| S:7208 E:7210 ||| DT
further  ||| S:7210 E:7218 ||| JJ
object  ||| S:7218 E:7225 ||| NN
is  ||| S:7225 E:7228 ||| VBZ
to  ||| S:7228 E:7231 ||| TO
develop  ||| S:7231 E:7239 ||| VB
new  ||| S:7239 E:7243 ||| JJ
recombinant  ||| S:7243 E:7255 ||| JJ
gelatines  ||| S:7255 E:7265 ||| NN
with  ||| S:7265 E:7270 ||| IN
improved  ||| S:7270 E:7279 ||| JJ
functionality  ||| S:7279 E:7293 ||| NN
for  ||| S:7293 E:7297 ||| IN
microcarriers ||| S:7297 E:7310 ||| NN
.  ||| S:7310 E:7314 ||| .
The  ||| S:7314 E:7318 ||| DT
present  ||| S:7318 E:7326 ||| JJ
invention  ||| S:7326 E:7336 ||| NN
surprisingly  ||| S:7336 E:7349 ||| RB
meets  ||| S:7349 E:7355 ||| VBZ
these  ||| S:7355 E:7361 ||| DT
objects  ||| S:7361 E:7369 ||| NNS
with  ||| S:7369 E:7374 ||| IN
a  ||| S:7374 E:7376 ||| DT
process  ||| S:7376 E:7384 ||| NN
for  ||| S:7384 E:7388 ||| IN
the  ||| S:7388 E:7392 ||| DT
preparation  ||| S:7392 E:7404 ||| NN
of  ||| S:7404 E:7407 ||| IN
a  ||| S:7407 E:7409 ||| DT
cell  ||| S:7409 E:7414 ||| NN
culture  ||| S:7414 E:7422 ||| NN
support  ||| S:7422 E:7430 ||| NN
comprising  ||| S:7430 E:7441 ||| VBG
the  ||| S:7441 E:7445 ||| DT
step  ||| S:7445 E:7450 ||| NN
of  ||| S:7450 E:7453 ||| IN
coating  ||| S:7453 E:7461 ||| VBG
a  ||| S:7461 E:7463 ||| DT
core  ||| S:7463 E:7468 ||| NN
bead  ||| S:7468 E:7473 ||| NN
with  ||| S:7473 E:7478 ||| IN
gelatine  ||| S:7478 E:7487 ||| NN
or  ||| S:7487 E:7490 ||| CC
gelatine-like  ||| S:7490 E:7504 ||| JJ
protein ||| S:7504 E:7511 ||| NN
,  ||| S:7511 E:7513 ||| ,
said  ||| S:7513 E:7518 ||| VBD
gelatine  ||| S:7518 E:7527 ||| JJ
or  ||| S:7527 E:7530 ||| CC
gelatine-like  ||| S:7530 E:7544 ||| JJ
protein  ||| S:7544 E:7552 ||| NN
having  ||| S:7552 E:7559 ||| VBG
a  ||| S:7559 E:7561 ||| DT
selected  ||| S:7561 E:7570 ||| JJ
molecular  ||| S:7570 E:7580 ||| JJ
weight  ||| S:7580 E:7587 ||| NN
of  ||| S:7587 E:7590 ||| IN
about  ||| S:7590 E:7596 ||| IN
40  ||| S:7596 E:7599 ||| CD
kDa  ||| S:7599 E:7603 ||| JJ
to  ||| S:7603 E:7606 ||| TO
about  ||| S:7606 E:7612 ||| RB
200  ||| S:7612 E:7616 ||| CD
kDa ||| S:7616 E:7619 ||| NN
.  ||| S:7619 E:7623 ||| .
In  ||| S:7662 E:7665 ||| IN
the  ||| S:7665 E:7669 ||| DT
process  ||| S:7669 E:7677 ||| NN
of  ||| S:7677 E:7680 ||| IN
the  ||| S:7680 E:7684 ||| DT
invention  ||| S:7684 E:7694 ||| NN
a  ||| S:7694 E:7696 ||| DT
gelatine  ||| S:7696 E:7705 ||| NN
or  ||| S:7705 E:7708 ||| CC
gelatine-like  ||| S:7708 E:7722 ||| JJ
protein  ||| S:7722 E:7730 ||| NN
is  ||| S:7730 E:7733 ||| VBZ
used  ||| S:7733 E:7738 ||| VBN
of  ||| S:7738 E:7741 ||| IN
about  ||| S:7741 E:7747 ||| IN
40  ||| S:7747 E:7750 ||| CD
kDa  ||| S:7750 E:7754 ||| JJ
to  ||| S:7754 E:7757 ||| TO
about  ||| S:7757 E:7763 ||| RB
200  ||| S:7763 E:7767 ||| CD
kDa  ||| S:7767 E:7771 ||| JJ
to  ||| S:7771 E:7774 ||| TO
coat  ||| S:7774 E:7779 ||| VB
a  ||| S:7779 E:7781 ||| DT
core  ||| S:7781 E:7786 ||| NN
bead  ||| S:7786 E:7791 ||| VBZ
resulting  ||| S:7791 E:7801 ||| VBG
in  ||| S:7801 E:7804 ||| IN
a  ||| S:7804 E:7806 ||| DT
cell  ||| S:7806 E:7811 ||| NN
culture  ||| S:7811 E:7819 ||| NN
support  ||| S:7819 E:7827 ||| NN
in  ||| S:7827 E:7830 ||| IN
the  ||| S:7830 E:7834 ||| DT
form  ||| S:7834 E:7839 ||| NN
of  ||| S:7839 E:7842 ||| IN
a  ||| S:7842 E:7844 ||| DT
microcarrier ||| S:7844 E:7856 ||| NN
.  ||| S:7856 E:7860 ||| .
The  ||| S:7860 E:7864 ||| DT
selected  ||| S:7864 E:7873 ||| JJ
molecular  ||| S:7873 E:7883 ||| JJ
weight  ||| S:7883 E:7890 ||| NN
range  ||| S:7890 E:7896 ||| NN
of  ||| S:7896 E:7899 ||| IN
the  ||| S:7899 E:7903 ||| DT
gelatine  ||| S:7903 E:7912 ||| NN
or  ||| S:7912 E:7915 ||| CC
gelatine-like  ||| S:7915 E:7929 ||| JJ
protein  ||| S:7929 E:7937 ||| NN
offers  ||| S:7937 E:7944 ||| VBZ
striking  ||| S:7944 E:7953 ||| JJ
advantages  ||| S:7953 E:7964 ||| NNS
in  ||| S:7964 E:7967 ||| IN
the  ||| S:7967 E:7971 ||| DT
process  ||| S:7971 E:7979 ||| NN
of  ||| S:7979 E:7982 ||| IN
preparing  ||| S:7982 E:7992 ||| VBG
the  ||| S:7992 E:7996 ||| DT
microcarriers  ||| S:7996 E:8010 ||| NN
and  ||| S:8010 E:8014 ||| CC
provides  ||| S:8014 E:8023 ||| VBZ
the  ||| S:8023 E:8027 ||| DT
resulting  ||| S:8027 E:8037 ||| JJ
microcarriers  ||| S:8037 E:8051 ||| NN
with  ||| S:8051 E:8056 ||| IN
advantageous  ||| S:8056 E:8069 ||| JJ
properties ||| S:8069 E:8079 ||| NNS
.  ||| S:8079 E:8081 ||| .
A  ||| S:8081 E:8083 ||| DT
key  ||| S:8083 E:8087 ||| JJ
problem  ||| S:8087 E:8095 ||| NN
in  ||| S:8095 E:8098 ||| IN
the  ||| S:8098 E:8102 ||| DT
coating  ||| S:8102 E:8110 ||| JJ
process  ||| S:8110 E:8118 ||| NN
is  ||| S:8118 E:8121 ||| VBZ
the  ||| S:8121 E:8125 ||| DT
clumping  ||| S:8125 E:8134 ||| NN
together  ||| S:8134 E:8143 ||| RB
of  ||| S:8143 E:8146 ||| IN
beads ||| S:8146 E:8151 ||| NN
.  ||| S:8151 E:8153 ||| .
In  ||| S:8153 E:8156 ||| IN
particular  ||| S:8156 E:8167 ||| JJ
such  ||| S:8167 E:8172 ||| JJ
clumping  ||| S:8172 E:8181 ||| NN
reduces  ||| S:8181 E:8189 ||| VBZ
the  ||| S:8189 E:8193 ||| DT
available  ||| S:8193 E:8203 ||| JJ
surface  ||| S:8203 E:8211 ||| NN
area  ||| S:8211 E:8216 ||| NN
for  ||| S:8216 E:8220 ||| IN
cell  ||| S:8220 E:8225 ||| NN
attachment  ||| S:8225 E:8236 ||| NN
and  ||| S:8236 E:8240 ||| CC
disturbs  ||| S:8240 E:8249 ||| VBZ
the  ||| S:8249 E:8253 ||| DT
size  ||| S:8253 E:8258 ||| NN
distribution  ||| S:8258 E:8271 ||| NN
of  ||| S:8271 E:8274 ||| IN
the  ||| S:8274 E:8278 ||| DT
microcarriers  ||| S:8278 E:8292 ||| NN
rendering  ||| S:8292 E:8302 ||| VBG
them  ||| S:8302 E:8307 ||| PRP
unusable ||| S:8307 E:8315 ||| VBD
.  ||| S:8315 E:8317 ||| .
Gelatine  ||| S:8317 E:8326 ||| RB
isolated  ||| S:8326 E:8335 ||| VBN
from  ||| S:8335 E:8340 ||| IN
natural  ||| S:8340 E:8348 ||| JJ
sources  ||| S:8348 E:8356 ||| NNS
has  ||| S:8356 E:8360 ||| VBZ
a  ||| S:8360 E:8362 ||| DT
wide  ||| S:8362 E:8367 ||| JJ
molecular  ||| S:8367 E:8377 ||| JJ
weight  ||| S:8377 E:8384 ||| NN
size  ||| S:8384 E:8389 ||| NN
distribution ||| S:8389 E:8401 ||| NN
,  ||| S:8401 E:8403 ||| ,
ranging  ||| S:8403 E:8411 ||| VBG
from  ||| S:8411 E:8416 ||| IN
peptide  ||| S:8416 E:8424 ||| NN
fragments  ||| S:8424 E:8434 ||| VBZ
smaller  ||| S:8434 E:8442 ||| JJR
than  ||| S:8442 E:8447 ||| IN
20  ||| S:8447 E:8450 ||| CD
kD  ||| S:8450 E:8453 ||| NN
up  ||| S:8453 E:8456 ||| RP
to  ||| S:8456 E:8459 ||| TO
macropolymers  ||| S:8459 E:8473 ||| VB
with  ||| S:8473 E:8478 ||| IN
molecular  ||| S:8478 E:8488 ||| JJ
weights  ||| S:8488 E:8496 ||| NNS
larger  ||| S:8496 E:8503 ||| JJR
than  ||| S:8503 E:8508 ||| IN
400  ||| S:8508 E:8512 ||| CD
kD ||| S:8512 E:8514 ||| NN
.  ||| S:8514 E:8518 ||| .
We  ||| S:8518 E:8521 ||| PRP
found  ||| S:8521 E:8527 ||| VBD
that  ||| S:8527 E:8532 ||| IN
the  ||| S:8532 E:8536 ||| DT
relatively  ||| S:8536 E:8547 ||| RB
small  ||| S:8547 E:8553 ||| JJ
fraction  ||| S:8553 E:8562 ||| NN
of  ||| S:8562 E:8565 ||| IN
high  ||| S:8565 E:8570 ||| JJ
MW  ||| S:8570 E:8573 ||| NNP
gelatine  ||| S:8573 E:8582 ||| VBD
polymer  ||| S:8582 E:8590 ||| JJ
molecules  ||| S:8590 E:8600 ||| NNS
within  ||| S:8600 E:8607 ||| IN
a  ||| S:8607 E:8609 ||| DT
natural  ||| S:8609 E:8617 ||| JJ
gelatine  ||| S:8617 E:8626 ||| JJ
batch  ||| S:8626 E:8632 ||| NN
is  ||| S:8632 E:8635 ||| VBZ
to  ||| S:8635 E:8638 ||| TO
a  ||| S:8638 E:8640 ||| DT
large  ||| S:8640 E:8646 ||| JJ
extent  ||| S:8646 E:8653 ||| NN
responsible  ||| S:8653 E:8665 ||| JJ
for  ||| S:8665 E:8669 ||| IN
the  ||| S:8669 E:8673 ||| DT
clumping  ||| S:8673 E:8682 ||| NN
together  ||| S:8682 E:8691 ||| RB
of  ||| S:8691 E:8694 ||| IN
beads  ||| S:8694 E:8700 ||| NN
during  ||| S:8700 E:8707 ||| IN
the  ||| S:8707 E:8711 ||| DT
microcarrier  ||| S:8711 E:8724 ||| JJ
production  ||| S:8724 E:8735 ||| NN
process ||| S:8735 E:8742 ||| NN
.  ||| S:8742 E:8744 ||| .
We  ||| S:8744 E:8747 ||| PRP
concluded  ||| S:8747 E:8757 ||| VBD
that  ||| S:8757 E:8762 ||| IN
when  ||| S:8762 E:8767 ||| WRB
such  ||| S:8767 E:8772 ||| PDT
a  ||| S:8772 E:8774 ||| DT
gelatine  ||| S:8774 E:8783 ||| JJ
polymer  ||| S:8783 E:8791 ||| NN
with  ||| S:8791 E:8796 ||| IN
high  ||| S:8796 E:8801 ||| JJ
molecular  ||| S:8801 E:8811 ||| JJ
weight  ||| S:8811 E:8818 ||| NN
adheres  ||| S:8818 E:8826 ||| NN
to  ||| S:8826 E:8829 ||| TO
a  ||| S:8829 E:8831 ||| DT
core  ||| S:8831 E:8836 ||| NN
bead ||| S:8836 E:8840 ||| NN
,  ||| S:8840 E:8842 ||| ,
a  ||| S:8842 E:8844 ||| DT
part  ||| S:8844 E:8849 ||| NN
of  ||| S:8849 E:8852 ||| IN
the  ||| S:8852 E:8856 ||| DT
peptide  ||| S:8856 E:8864 ||| JJ
chain  ||| S:8864 E:8870 ||| NN
may  ||| S:8870 E:8874 ||| MD
point  ||| S:8874 E:8880 ||| VB
away  ||| S:8880 E:8885 ||| RP
from  ||| S:8885 E:8890 ||| IN
the  ||| S:8890 E:8894 ||| DT
surface  ||| S:8894 E:8902 ||| NN
of  ||| S:8902 E:8905 ||| IN
the  ||| S:8905 E:8909 ||| DT
core  ||| S:8909 E:8914 ||| NN
bead  ||| S:8914 E:8919 ||| NNS
and  ||| S:8919 E:8923 ||| CC
as  ||| S:8923 E:8926 ||| IN
such  ||| S:8926 E:8931 ||| JJ
be  ||| S:8931 E:8934 ||| VB
an  ||| S:8934 E:8937 ||| DT
anchor  ||| S:8937 E:8944 ||| NN
for  ||| S:8944 E:8948 ||| IN
other  ||| S:8948 E:8954 ||| JJ
beads  ||| S:8954 E:8960 ||| NN
and  ||| S:8960 E:8964 ||| CC
thus  ||| S:8964 E:8969 ||| RB
induce  ||| S:8969 E:8976 ||| VB
coagulation ||| S:8976 E:8987 ||| NNS
.  ||| S:8987 E:8991 ||| .
It  ||| S:8991 E:8994 ||| PRP
is  ||| S:8994 E:8997 ||| VBZ
therefore  ||| S:8997 E:9007 ||| RB
preferred  ||| S:9007 E:9017 ||| VBN
according  ||| S:9017 E:9027 ||| VBG
to  ||| S:9027 E:9030 ||| TO
the  ||| S:9030 E:9034 ||| DT
present  ||| S:9034 E:9042 ||| JJ
invention  ||| S:9042 E:9052 ||| NN
to  ||| S:9052 E:9055 ||| TO
coat  ||| S:9055 E:9060 ||| VB
core  ||| S:9060 E:9065 ||| JJ
beads  ||| S:9065 E:9071 ||| NN
with  ||| S:9071 E:9076 ||| IN
gelatine  ||| S:9076 E:9085 ||| NNS
having  ||| S:9085 E:9092 ||| VBG
a  ||| S:9092 E:9094 ||| DT
molecular  ||| S:9094 E:9104 ||| JJ
weight  ||| S:9104 E:9111 ||| NN
of  ||| S:9111 E:9114 ||| IN
less  ||| S:9114 E:9119 ||| JJR
than  ||| S:9119 E:9124 ||| IN
200  ||| S:9124 E:9128 ||| CD
kDa ||| S:9128 E:9131 ||| NN
,  ||| S:9131 E:9133 ||| ,
more  ||| S:9133 E:9138 ||| RBR
preferably  ||| S:9138 E:9149 ||| RB
less  ||| S:9149 E:9154 ||| JJR
than  ||| S:9154 E:9159 ||| IN
150  ||| S:9159 E:9163 ||| CD
kDa ||| S:9163 E:9166 ||| NN
,  ||| S:9166 E:9168 ||| ,
most  ||| S:9168 E:9173 ||| RBS
preferably  ||| S:9173 E:9184 ||| RB
less  ||| S:9184 E:9189 ||| JJR
than  ||| S:9189 E:9194 ||| IN
100  ||| S:9194 E:9198 ||| CD
kDa ||| S:9198 E:9201 ||| NN
.  ||| S:9201 E:9205 ||| .
We  ||| S:9205 E:9208 ||| PRP
found  ||| S:9208 E:9214 ||| VBD
furthermore  ||| S:9214 E:9226 ||| RB
that  ||| S:9226 E:9231 ||| IN
the  ||| S:9231 E:9235 ||| DT
small  ||| S:9235 E:9241 ||| JJ
MW  ||| S:9241 E:9244 ||| NNP
fraction  ||| S:9244 E:9253 ||| NN
of  ||| S:9253 E:9256 ||| IN
a  ||| S:9256 E:9258 ||| DT
natural  ||| S:9258 E:9266 ||| JJ
gelatine  ||| S:9266 E:9275 ||| NN
shows  ||| S:9275 E:9281 ||| VBZ
unfavourable  ||| S:9281 E:9294 ||| JJ
microcarrier  ||| S:9294 E:9307 ||| JJ
coating  ||| S:9307 E:9315 ||| NN
characteristics ||| S:9315 E:9330 ||| NNS
.  ||| S:9330 E:9332 ||| .
This  ||| S:9332 E:9337 ||| DT
small  ||| S:9337 E:9343 ||| JJ
MW  ||| S:9343 E:9346 ||| NNP
fraction  ||| S:9346 E:9355 ||| NN
showed  ||| S:9355 E:9362 ||| VBD
a  ||| S:9362 E:9364 ||| DT
lower  ||| S:9364 E:9370 ||| JJR
adsorption  ||| S:9370 E:9381 ||| JJ
force  ||| S:9381 E:9387 ||| NN
to  ||| S:9387 E:9390 ||| TO
the  ||| S:9390 E:9394 ||| DT
microcarrier  ||| S:9394 E:9407 ||| JJ
beads ||| S:9407 E:9412 ||| NN
,  ||| S:9412 E:9414 ||| ,
and ||| S:9414 E:9417 ||| CC
,  ||| S:9417 E:9419 ||| ,
thus ||| S:9419 E:9423 ||| RB
,  ||| S:9423 E:9425 ||| ,
when  ||| S:9425 E:9430 ||| WRB
not  ||| S:9430 E:9434 ||| RB
being  ||| S:9434 E:9440 ||| VBG
adsorbed  ||| S:9440 E:9449 ||| NN
it  ||| S:9449 E:9452 ||| PRP
promotes  ||| S:9452 E:9461 ||| VBZ
microcarrier  ||| S:9461 E:9474 ||| JJ
clumping  ||| S:9474 E:9483 ||| NN
after  ||| S:9483 E:9489 ||| IN
the  ||| S:9489 E:9493 ||| DT
chemical  ||| S:9493 E:9502 ||| NN
crosslinking  ||| S:9502 E:9515 ||| NN
step ||| S:9515 E:9519 ||| NN
.  ||| S:9519 E:9521 ||| .
Additionally ||| S:9521 E:9533 ||| RB
,  ||| S:9533 E:9535 ||| ,
in  ||| S:9535 E:9538 ||| IN
case  ||| S:9538 E:9543 ||| NN
of  ||| S:9543 E:9546 ||| IN
the  ||| S:9546 E:9550 ||| DT
use  ||| S:9550 E:9554 ||| NN
of  ||| S:9554 E:9557 ||| IN
lower  ||| S:9557 E:9563 ||| JJR
concentrations  ||| S:9563 E:9578 ||| NNS
of  ||| S:9578 E:9581 ||| IN
the  ||| S:9581 E:9585 ||| DT
gelatine  ||| S:9585 E:9594 ||| NN
in  ||| S:9594 E:9597 ||| IN
the  ||| S:9597 E:9601 ||| DT
microcarrier  ||| S:9601 E:9614 ||| JJ
coating  ||| S:9614 E:9622 ||| NN
process  ||| S:9622 E:9630 ||| NN
to  ||| S:9630 E:9633 ||| TO
prevent  ||| S:9633 E:9641 ||| VB
clumping ||| S:9641 E:9649 ||| NNS
,  ||| S:9649 E:9651 ||| ,
the  ||| S:9651 E:9655 ||| DT
small  ||| S:9655 E:9661 ||| JJ
MW  ||| S:9661 E:9664 ||| NNP
fraction  ||| S:9664 E:9673 ||| NN
is  ||| S:9673 E:9676 ||| VBZ
at  ||| S:9676 E:9679 ||| IN
first  ||| S:9679 E:9685 ||| JJ
instance  ||| S:9685 E:9694 ||| NN
adsorbed  ||| S:9694 E:9703 ||| NN
to  ||| S:9703 E:9706 ||| TO
the  ||| S:9706 E:9710 ||| DT
microcarrier  ||| S:9710 E:9723 ||| NN
but  ||| S:9723 E:9727 ||| CC
has  ||| S:9727 E:9731 ||| VBZ
the  ||| S:9731 E:9735 ||| DT
unfavourable  ||| S:9735 E:9748 ||| JJ
characteristic  ||| S:9748 E:9763 ||| NN
of  ||| S:9763 E:9766 ||| IN
entering  ||| S:9766 E:9775 ||| VBG
the  ||| S:9775 E:9779 ||| DT
small  ||| S:9779 E:9785 ||| JJ
pores  ||| S:9785 E:9791 ||| NN
of  ||| S:9791 E:9794 ||| IN
a  ||| S:9794 E:9796 ||| DT
microcarrier  ||| S:9796 E:9809 ||| JJ
porous  ||| S:9809 E:9816 ||| JJ
core  ||| S:9816 E:9821 ||| NN
beads ||| S:9821 E:9826 ||| NN
,  ||| S:9826 E:9828 ||| ,
thereby  ||| S:9828 E:9836 ||| RB
not  ||| S:9836 E:9840 ||| RB
contributing  ||| S:9840 E:9853 ||| VBG
to  ||| S:9853 E:9856 ||| TO
the  ||| S:9856 E:9860 ||| DT
attachment  ||| S:9860 E:9871 ||| NN
of  ||| S:9871 E:9874 ||| IN
the  ||| S:9874 E:9878 ||| DT
cells  ||| S:9878 E:9884 ||| NNS
on  ||| S:9884 E:9887 ||| IN
the  ||| S:9887 E:9891 ||| DT
microcarrier  ||| S:9891 E:9904 ||| NN
during  ||| S:9904 E:9911 ||| IN
the  ||| S:9911 E:9915 ||| DT
cell  ||| S:9915 E:9920 ||| NN
culture  ||| S:9920 E:9928 ||| NN
step ||| S:9928 E:9932 ||| NN
.  ||| S:9932 E:9934 ||| .
Thus ||| S:9934 E:9938 ||| RB
,  ||| S:9938 E:9940 ||| ,
the  ||| S:9940 E:9944 ||| DT
molecular  ||| S:9944 E:9954 ||| JJ
weight  ||| S:9954 E:9961 ||| NN
of  ||| S:9961 E:9964 ||| IN
the  ||| S:9964 E:9968 ||| DT
gelatine  ||| S:9968 E:9977 ||| NN
should  ||| S:9977 E:9984 ||| MD
be  ||| S:9984 E:9987 ||| VB
high  ||| S:9987 E:9992 ||| JJ
enough  ||| S:9992 E:9999 ||| JJ
to  ||| S:9999 E:10002 ||| TO
perform  ||| S:10002 E:10010 ||| VB
the  ||| S:10010 E:10014 ||| DT
actual  ||| S:10014 E:10021 ||| JJ
coating  ||| S:10021 E:10029 ||| NN
process  ||| S:10029 E:10037 ||| NN
effectively  ||| S:10037 E:10049 ||| RB
resulting  ||| S:10049 E:10059 ||| VBG
in  ||| S:10059 E:10062 ||| IN
efficient  ||| S:10062 E:10072 ||| JJ
coating ||| S:10072 E:10079 ||| NN
,  ||| S:10079 E:10081 ||| ,
to  ||| S:10081 E:10084 ||| TO
prevent  ||| S:10084 E:10092 ||| VB
clumping  ||| S:10092 E:10101 ||| VBN
of  ||| S:10101 E:10104 ||| IN
the  ||| S:10104 E:10108 ||| DT
core  ||| S:10108 E:10113 ||| NN
beads  ||| S:10113 E:10119 ||| NNS
and  ||| S:10119 E:10123 ||| CC
to  ||| S:10123 E:10126 ||| TO
prevent  ||| S:10126 E:10134 ||| VB
loss  ||| S:10134 E:10139 ||| NN
of  ||| S:10139 E:10142 ||| IN
the  ||| S:10142 E:10146 ||| DT
gelatine ||| S:10146 E:10154 ||| NN
.  ||| S:10154 E:10156 ||| .
Thus  ||| S:10156 E:10161 ||| RB
the  ||| S:10161 E:10165 ||| DT
molecular  ||| S:10165 E:10175 ||| JJ
weight  ||| S:10175 E:10182 ||| NN
of  ||| S:10182 E:10185 ||| IN
the  ||| S:10185 E:10189 ||| DT
gelatine  ||| S:10189 E:10198 ||| NN
should  ||| S:10198 E:10205 ||| MD
be  ||| S:10205 E:10208 ||| VB
higher  ||| S:10208 E:10215 ||| JJR
than  ||| S:10215 E:10220 ||| IN
40  ||| S:10220 E:10223 ||| CD
kDa ||| S:10223 E:10226 ||| NN
,  ||| S:10226 E:10228 ||| ,
preferably  ||| S:10228 E:10239 ||| RB
higher  ||| S:10239 E:10246 ||| JJR
than  ||| S:10246 E:10251 ||| IN
60  ||| S:10251 E:10254 ||| CD
kDa ||| S:10254 E:10257 ||| NN
,  ||| S:10257 E:10259 ||| ,
most  ||| S:10259 E:10264 ||| RBS
preferably  ||| S:10264 E:10275 ||| RB
higher  ||| S:10275 E:10282 ||| JJR
than  ||| S:10282 E:10287 ||| IN
70  ||| S:10287 E:10290 ||| CD
kDa ||| S:10290 E:10293 ||| NN
.  ||| S:10293 E:10297 ||| .
Preferably  ||| S:10297 E:10308 ||| RB
the  ||| S:10308 E:10312 ||| DT
molecular  ||| S:10312 E:10322 ||| JJ
weight  ||| S:10322 E:10329 ||| NN
of  ||| S:10329 E:10332 ||| IN
the  ||| S:10332 E:10336 ||| DT
gelatine  ||| S:10336 E:10345 ||| NN
or  ||| S:10345 E:10348 ||| CC
gelatine-like  ||| S:10348 E:10362 ||| JJ
protein  ||| S:10362 E:10370 ||| NN
that  ||| S:10370 E:10375 ||| WDT
is  ||| S:10375 E:10378 ||| VBZ
used  ||| S:10378 E:10383 ||| VBN
is  ||| S:10383 E:10386 ||| VBZ
uniform ||| S:10386 E:10393 ||| JJ
,  ||| S:10393 E:10395 ||| ,
with  ||| S:10395 E:10400 ||| IN
more  ||| S:10400 E:10405 ||| JJR
than  ||| S:10405 E:10410 ||| IN
75 ||| S:10410 E:10412 ||| CD
% ||| S:10412 E:10413 ||| NN
,  ||| S:10413 E:10415 ||| ,
preferably  ||| S:10415 E:10426 ||| RB
more  ||| S:10426 E:10431 ||| JJR
than  ||| S:10431 E:10436 ||| IN
85 ||| S:10436 E:10438 ||| CD
% ||| S:10438 E:10439 ||| NN
,  ||| S:10439 E:10441 ||| ,
more  ||| S:10441 E:10446 ||| RBR
preferably  ||| S:10446 E:10457 ||| RB
more  ||| S:10457 E:10462 ||| JJR
than  ||| S:10462 E:10467 ||| IN
95 ||| S:10467 E:10469 ||| CD
%  ||| S:10469 E:10471 ||| NN
or  ||| S:10471 E:10474 ||| CC
even  ||| S:10474 E:10479 ||| RB
at  ||| S:10479 E:10482 ||| IN
least  ||| S:10482 E:10488 ||| JJS
98 ||| S:10488 E:10490 ||| CD
%  ||| S:10490 E:10492 ||| NN
of  ||| S:10492 E:10495 ||| IN
the  ||| S:10495 E:10499 ||| DT
gelatine  ||| S:10499 E:10508 ||| NN
or  ||| S:10508 E:10511 ||| CC
gelatine-like  ||| S:10511 E:10525 ||| JJ
protein  ||| S:10525 E:10533 ||| NN
having  ||| S:10533 E:10540 ||| VBG
a  ||| S:10540 E:10542 ||| DT
uniform  ||| S:10542 E:10550 ||| JJ
MW  ||| S:10550 E:10553 ||| NN
within  ||| S:10553 E:10560 ||| IN
2 ||| S:10560 E:10561 ||| CD
%  ||| S:10561 E:10563 ||| NN
from  ||| S:10563 E:10568 ||| IN
the  ||| S:10568 E:10572 ||| DT
selected  ||| S:10572 E:10581 ||| JJ
molecular  ||| S:10581 E:10591 ||| JJ
weight ||| S:10591 E:10597 ||| NN
.  ||| S:10597 E:10601 ||| .
Preferably  ||| S:10601 E:10612 ||| RB
a  ||| S:10612 E:10614 ||| DT
recombinant  ||| S:10614 E:10626 ||| JJ
production  ||| S:10626 E:10637 ||| NN
method  ||| S:10637 E:10644 ||| NN
is  ||| S:10644 E:10647 ||| VBZ
used  ||| S:10647 E:10652 ||| VBN
to  ||| S:10652 E:10655 ||| TO
obtain  ||| S:10655 E:10662 ||| VB
such  ||| S:10662 E:10667 ||| PDT
a  ||| S:10667 E:10669 ||| DT
uniform  ||| S:10669 E:10677 ||| JJ
molecular  ||| S:10677 E:10687 ||| JJ
weight ||| S:10687 E:10693 ||| NN
.  ||| S:10693 E:10695 ||| .
An  ||| S:10695 E:10698 ||| DT
advantage  ||| S:10698 E:10708 ||| NN
of  ||| S:10708 E:10711 ||| IN
recombinant  ||| S:10711 E:10723 ||| JJ
gelatine  ||| S:10723 E:10732 ||| NN
or  ||| S:10732 E:10735 ||| CC
gelatine-like  ||| S:10735 E:10749 ||| JJ
protein  ||| S:10749 E:10757 ||| NN
is  ||| S:10757 E:10760 ||| VBZ
the  ||| S:10760 E:10764 ||| DT
constant  ||| S:10764 E:10773 ||| JJ
composition  ||| S:10773 E:10785 ||| NN
of  ||| S:10785 E:10788 ||| IN
the  ||| S:10788 E:10792 ||| DT
material  ||| S:10792 E:10801 ||| NN
in  ||| S:10801 E:10804 ||| IN
contrast  ||| S:10804 E:10813 ||| NN
to  ||| S:10813 E:10816 ||| TO
isolated  ||| S:10816 E:10825 ||| VB
gelatine  ||| S:10825 E:10834 ||| VBN
from  ||| S:10834 E:10839 ||| IN
natural  ||| S:10839 E:10847 ||| JJ
sources  ||| S:10847 E:10855 ||| NNS
which  ||| S:10855 E:10861 ||| WDT
always  ||| S:10861 E:10868 ||| RB
will  ||| S:10868 E:10873 ||| MD
have  ||| S:10873 E:10878 ||| VB
some  ||| S:10878 E:10883 ||| DT
variation ||| S:10883 E:10892 ||| NN
.  ||| S:10892 E:10896 ||| .
It  ||| S:10896 E:10899 ||| PRP
is  ||| S:10899 E:10902 ||| VBZ
known  ||| S:10902 E:10908 ||| VBN
that  ||| S:10908 E:10913 ||| IN
prions  ||| S:10913 E:10920 ||| NN
and  ||| S:10920 E:10924 ||| CC
other  ||| S:10924 E:10930 ||| JJ
viruses  ||| S:10930 E:10938 ||| NN
could  ||| S:10938 E:10944 ||| MD
be  ||| S:10944 E:10947 ||| VB
part  ||| S:10947 E:10952 ||| NN
of  ||| S:10952 E:10955 ||| IN
a  ||| S:10955 E:10957 ||| DT
traditional  ||| S:10957 E:10969 ||| JJ
gelatine  ||| S:10969 E:10978 ||| JJ
batch ||| S:10978 E:10983 ||| NN
.  ||| S:10983 E:10985 ||| .
However ||| S:10985 E:10992 ||| RB
,  ||| S:10992 E:10994 ||| ,
the  ||| S:10994 E:10998 ||| DT
risks  ||| S:10998 E:11004 ||| NNS
are  ||| S:11004 E:11008 ||| VBP
so  ||| S:11008 E:11011 ||| RB
far  ||| S:11011 E:11015 ||| RB
not  ||| S:11015 E:11019 ||| RB
recognised  ||| S:11019 E:11030 ||| VBN
fully ||| S:11030 E:11035 ||| RB
,  ||| S:11035 E:11037 ||| ,
as  ||| S:11037 E:11040 ||| RB
still  ||| S:11040 E:11046 ||| RB
traditional  ||| S:11046 E:11058 ||| JJ
gelatines  ||| S:11058 E:11068 ||| NNS
are  ||| S:11068 E:11072 ||| VBP
applied  ||| S:11072 E:11080 ||| VBN
for  ||| S:11080 E:11084 ||| IN
microcarrier  ||| S:11084 E:11097 ||| JJ
applications  ||| S:11097 E:11110 ||| NNS
for  ||| S:11110 E:11114 ||| IN
cell  ||| S:11114 E:11119 ||| NN
culture  ||| S:11119 E:11127 ||| NN
use ||| S:11127 E:11130 ||| NN
.  ||| S:11130 E:11132 ||| .
However ||| S:11132 E:11139 ||| RB
,  ||| S:11139 E:11141 ||| ,
we  ||| S:11141 E:11144 ||| PRP
found  ||| S:11144 E:11150 ||| VBD
that  ||| S:11150 E:11155 ||| IN
by  ||| S:11155 E:11158 ||| IN
coating  ||| S:11158 E:11166 ||| VBG
the  ||| S:11166 E:11170 ||| DT
core  ||| S:11170 E:11175 ||| NN
beads  ||| S:11175 E:11181 ||| NN
of  ||| S:11181 E:11184 ||| IN
a  ||| S:11184 E:11186 ||| DT
microcarrier  ||| S:11186 E:11199 ||| NN
with  ||| S:11199 E:11204 ||| IN
traditional  ||| S:11204 E:11216 ||| JJ
gelatines ||| S:11216 E:11225 ||| NN
,  ||| S:11225 E:11227 ||| ,
potentially  ||| S:11227 E:11239 ||| RB
present  ||| S:11239 E:11247 ||| JJ
prions  ||| S:11247 E:11254 ||| NN
will  ||| S:11254 E:11259 ||| MD
not  ||| S:11259 E:11263 ||| RB
be  ||| S:11263 E:11266 ||| VB
chemically  ||| S:11266 E:11277 ||| RB
cross-linked  ||| S:11277 E:11290 ||| JJ
to  ||| S:11290 E:11293 ||| TO
the  ||| S:11293 E:11297 ||| DT
beads ||| S:11297 E:11302 ||| NN
.  ||| S:11302 E:11304 ||| .
A  ||| S:11304 E:11306 ||| DT
consequence  ||| S:11306 E:11318 ||| NN
of  ||| S:11318 E:11321 ||| IN
this  ||| S:11321 E:11326 ||| DT
surprising  ||| S:11326 E:11337 ||| JJ
and  ||| S:11337 E:11341 ||| CC
new  ||| S:11341 E:11345 ||| JJ
finding  ||| S:11345 E:11353 ||| NN
is  ||| S:11353 E:11356 ||| VBZ
that  ||| S:11356 E:11361 ||| DT
prions ||| S:11361 E:11367 ||| NN
,  ||| S:11367 E:11369 ||| ,
if  ||| S:11369 E:11372 ||| IN
present  ||| S:11372 E:11380 ||| JJ
in  ||| S:11380 E:11383 ||| IN
a  ||| S:11383 E:11385 ||| DT
traditional  ||| S:11385 E:11397 ||| JJ
gelatine  ||| S:11397 E:11406 ||| JJ
batch ||| S:11406 E:11411 ||| NN
,  ||| S:11411 E:11413 ||| ,
will  ||| S:11413 E:11418 ||| MD
be  ||| S:11418 E:11421 ||| VB
mixed  ||| S:11421 E:11427 ||| VBN
with  ||| S:11427 E:11432 ||| IN
the  ||| S:11432 E:11436 ||| DT
cell  ||| S:11436 E:11441 ||| NN
culture  ||| S:11441 E:11449 ||| NN
products ||| S:11449 E:11457 ||| NNS
,  ||| S:11457 E:11459 ||| ,
aimed  ||| S:11459 E:11465 ||| VBN
for  ||| S:11465 E:11469 ||| IN
human  ||| S:11469 E:11475 ||| JJ
use ||| S:11475 E:11478 ||| NN
.  ||| S:11478 E:11480 ||| .
To  ||| S:11480 E:11483 ||| TO
prevent  ||| S:11483 E:11491 ||| VB
any  ||| S:11491 E:11495 ||| DT
risk  ||| S:11495 E:11500 ||| NN
of  ||| S:11500 E:11503 ||| IN
a  ||| S:11503 E:11505 ||| DT
contamination  ||| S:11505 E:11519 ||| NN
with  ||| S:11519 E:11524 ||| IN
prions  ||| S:11524 E:11531 ||| JJ
such  ||| S:11531 E:11536 ||| JJ
as  ||| S:11536 E:11539 ||| IN
BSE ||| S:11539 E:11542 ||| NNP
,  ||| S:11542 E:11544 ||| ,
the  ||| S:11544 E:11548 ||| DT
preferred  ||| S:11548 E:11558 ||| JJ
gelatine  ||| S:11558 E:11567 ||| NN
for  ||| S:11567 E:11571 ||| IN
microcarrier  ||| S:11571 E:11584 ||| JJ
applications  ||| S:11584 E:11597 ||| NNS
is  ||| S:11597 E:11600 ||| VBZ
a  ||| S:11600 E:11602 ||| DT
recombinant  ||| S:11602 E:11614 ||| JJ
gelatine ||| S:11614 E:11622 ||| NN
.  ||| S:11622 E:11626 ||| .
By  ||| S:11626 E:11629 ||| IN
selecting  ||| S:11629 E:11639 ||| VBG
a  ||| S:11639 E:11641 ||| DT
molecular  ||| S:11641 E:11651 ||| JJ
weight ||| S:11651 E:11657 ||| NN
,  ||| S:11657 E:11659 ||| ,
within  ||| S:11659 E:11666 ||| IN
the  ||| S:11666 E:11670 ||| DT
range  ||| S:11670 E:11676 ||| NN
of  ||| S:11676 E:11679 ||| IN
the  ||| S:11679 E:11683 ||| DT
invention  ||| S:11683 E:11693 ||| NN
the  ||| S:11693 E:11697 ||| DT
viscosity  ||| S:11697 E:11707 ||| NN
of  ||| S:11707 E:11710 ||| IN
the  ||| S:11710 E:11714 ||| DT
gelatine  ||| S:11714 E:11723 ||| NN
or  ||| S:11723 E:11726 ||| CC
gelatine-like  ||| S:11726 E:11740 ||| JJ
protein  ||| S:11740 E:11748 ||| NN
coating  ||| S:11748 E:11756 ||| NN
solution  ||| S:11756 E:11765 ||| NN
can  ||| S:11765 E:11769 ||| MD
be  ||| S:11769 E:11772 ||| VB
accurately  ||| S:11772 E:11783 ||| RB
controlled ||| S:11783 E:11793 ||| VBN
.  ||| S:11793 E:11795 ||| .
Complete  ||| S:11795 E:11804 ||| JJ
or ||| S:11804 E:11806 ||| CC
,  ||| S:11806 E:11808 ||| ,
more  ||| S:11808 E:11813 ||| RBR
important ||| S:11813 E:11822 ||| JJ
,  ||| S:11822 E:11824 ||| ,
partial  ||| S:11824 E:11832 ||| JJ
gelling  ||| S:11832 E:11840 ||| NN
of  ||| S:11840 E:11843 ||| IN
such  ||| S:11843 E:11848 ||| PDT
a  ||| S:11848 E:11850 ||| DT
gelatine  ||| S:11850 E:11859 ||| JJ
solution  ||| S:11859 E:11868 ||| NN
can  ||| S:11868 E:11872 ||| MD
be  ||| S:11872 E:11875 ||| VB
prevented  ||| S:11875 E:11885 ||| VBN
while  ||| S:11885 E:11891 ||| IN
being  ||| S:11891 E:11897 ||| VBG
able  ||| S:11897 E:11902 ||| JJ
to  ||| S:11902 E:11905 ||| TO
select  ||| S:11905 E:11912 ||| VB
a  ||| S:11912 E:11914 ||| DT
high  ||| S:11914 E:11919 ||| JJ
as  ||| S:11919 E:11922 ||| IN
possible  ||| S:11922 E:11931 ||| JJ
concentration  ||| S:11931 E:11945 ||| NN
of  ||| S:11945 E:11948 ||| IN
the  ||| S:11948 E:11952 ||| DT
gelatine  ||| S:11952 E:11961 ||| NN
or  ||| S:11961 E:11964 ||| CC
gelatine-like  ||| S:11964 E:11978 ||| JJ
protein ||| S:11978 E:11985 ||| NN
.  ||| S:11985 E:11987 ||| .
The  ||| S:11987 E:11991 ||| DT
uniform  ||| S:11991 E:11999 ||| JJ
gelatine  ||| S:11999 E:12008 ||| NN
or  ||| S:12008 E:12011 ||| CC
gelatine-like  ||| S:12011 E:12025 ||| JJ
protein  ||| S:12025 E:12033 ||| NN
ensures  ||| S:12033 E:12041 ||| VBZ
a  ||| S:12041 E:12043 ||| DT
process  ||| S:12043 E:12051 ||| NN
of  ||| S:12051 E:12054 ||| IN
identically  ||| S:12054 E:12066 ||| JJ
coated  ||| S:12066 E:12073 ||| JJ
microcarriers ||| S:12073 E:12086 ||| NN
.  ||| S:12086 E:12088 ||| .
The  ||| S:12088 E:12092 ||| DT
uniform  ||| S:12092 E:12100 ||| JJ
coating  ||| S:12100 E:12108 ||| NN
process  ||| S:12108 E:12116 ||| NN
allows  ||| S:12116 E:12123 ||| VBZ
the  ||| S:12123 E:12127 ||| DT
use  ||| S:12127 E:12131 ||| NN
of  ||| S:12131 E:12134 ||| IN
a  ||| S:12134 E:12136 ||| DT
minimum  ||| S:12136 E:12144 ||| JJ
amount  ||| S:12144 E:12151 ||| NN
of  ||| S:12151 E:12154 ||| IN
gelatine  ||| S:12154 E:12163 ||| NN
or  ||| S:12163 E:12166 ||| CC
gelatine-like  ||| S:12166 E:12180 ||| JJ
protein  ||| S:12180 E:12188 ||| NN
and  ||| S:12188 E:12192 ||| CC
the  ||| S:12192 E:12196 ||| DT
use  ||| S:12196 E:12200 ||| NN
of  ||| S:12200 E:12203 ||| IN
a  ||| S:12203 E:12205 ||| DT
minimum  ||| S:12205 E:12213 ||| JJ
volume  ||| S:12213 E:12220 ||| NN
of  ||| S:12220 E:12223 ||| IN
gelatine  ||| S:12223 E:12232 ||| NN
or  ||| S:12232 E:12235 ||| CC
gelatine-like  ||| S:12235 E:12249 ||| JJ
protein  ||| S:12249 E:12257 ||| NN
coating  ||| S:12257 E:12265 ||| NN
solution ||| S:12265 E:12273 ||| NN
.  ||| S:12273 E:12275 ||| .
All  ||| S:12275 E:12279 ||| PDT
this  ||| S:12279 E:12284 ||| DT
results  ||| S:12284 E:12292 ||| NNS
in  ||| S:12292 E:12295 ||| IN
a  ||| S:12295 E:12297 ||| DT
far  ||| S:12297 E:12301 ||| RB
more  ||| S:12301 E:12306 ||| RBR
efficient  ||| S:12306 E:12316 ||| JJ
coating  ||| S:12316 E:12324 ||| NN
process  ||| S:12324 E:12332 ||| NN
than  ||| S:12332 E:12337 ||| IN
that  ||| S:12337 E:12342 ||| WDT
is  ||| S:12342 E:12345 ||| VBZ
known  ||| S:12345 E:12351 ||| VBN
in  ||| S:12351 E:12354 ||| IN
the  ||| S:12354 E:12358 ||| DT
art ||| S:12358 E:12361 ||| NN
.  ||| S:12361 E:12365 ||| .
In  ||| S:12365 E:12368 ||| IN
one  ||| S:12368 E:12372 ||| CD
embodiment  ||| S:12372 E:12383 ||| NN
of  ||| S:12383 E:12386 ||| IN
the  ||| S:12386 E:12390 ||| DT
invention  ||| S:12390 E:12400 ||| JJ
non-porous  ||| S:12400 E:12411 ||| JJ
core  ||| S:12411 E:12416 ||| NN
beads  ||| S:12416 E:12422 ||| NNS
are  ||| S:12422 E:12426 ||| VBP
coated  ||| S:12426 E:12433 ||| VBN
with  ||| S:12433 E:12438 ||| IN
gelatine  ||| S:12438 E:12447 ||| NN
or  ||| S:12447 E:12450 ||| CC
gelatine-like  ||| S:12450 E:12464 ||| JJ
protein ||| S:12464 E:12471 ||| NN
.  ||| S:12471 E:12473 ||| .
Suitably  ||| S:12473 E:12482 ||| JJ
non-porous  ||| S:12482 E:12493 ||| JJ
core  ||| S:12493 E:12498 ||| NN
beads  ||| S:12498 E:12504 ||| NNS
are  ||| S:12504 E:12508 ||| VBP
made  ||| S:12508 E:12513 ||| VBN
of  ||| S:12513 E:12516 ||| IN
polystyrene  ||| S:12516 E:12528 ||| NN
or  ||| S:12528 E:12531 ||| CC
glass ||| S:12531 E:12536 ||| NN
.  ||| S:12536 E:12538 ||| .
Other  ||| S:12538 E:12544 ||| JJ
suitable  ||| S:12544 E:12553 ||| JJ
non-porous  ||| S:12553 E:12564 ||| JJ
materials  ||| S:12564 E:12574 ||| NNS
are  ||| S:12574 E:12578 ||| VBP
known  ||| S:12578 E:12584 ||| VBN
to  ||| S:12584 E:12587 ||| TO
those  ||| S:12587 E:12593 ||| DT
skilled  ||| S:12593 E:12601 ||| JJ
in  ||| S:12601 E:12604 ||| IN
the  ||| S:12604 E:12608 ||| DT
art ||| S:12608 E:12611 ||| NN
.  ||| S:12611 E:12615 ||| .
A  ||| S:12615 E:12617 ||| DT
particular  ||| S:12617 E:12628 ||| JJ
advantageous  ||| S:12628 E:12641 ||| JJ
embodiment  ||| S:12641 E:12652 ||| NN
is  ||| S:12652 E:12655 ||| VBZ
the  ||| S:12655 E:12659 ||| DT
process  ||| S:12659 E:12667 ||| NN
of  ||| S:12667 E:12670 ||| IN
the  ||| S:12670 E:12674 ||| DT
invention  ||| S:12674 E:12684 ||| FW
wherein  ||| S:12684 E:12692 ||| FW
porous  ||| S:12692 E:12699 ||| FW
core  ||| S:12699 E:12704 ||| FW
beads ||| S:12704 E:12709 ||| FW
,  ||| S:12709 E:12711 ||| ,
such  ||| S:12711 E:12716 ||| JJ
as  ||| S:12716 E:12719 ||| IN
beads  ||| S:12719 E:12725 ||| NN
from  ||| S:12725 E:12730 ||| IN
modified  ||| S:12730 E:12739 ||| JJ
dextran  ||| S:12739 E:12747 ||| NN
or  ||| S:12747 E:12750 ||| CC
cross-linked  ||| S:12750 E:12763 ||| JJ
cellulose ||| S:12763 E:12772 ||| NN
,  ||| S:12772 E:12774 ||| ,
or  ||| S:12774 E:12777 ||| CC
( ||| S:12777 E:12778 ||| -LRB-
porous ||| S:12778 E:12784 ||| LS
)  ||| S:12784 E:12786 ||| -RRB-
polystyrene ||| S:12786 E:12797 ||| NN
,  ||| S:12797 E:12799 ||| ,
in  ||| S:12799 E:12802 ||| IN
particular  ||| S:12802 E:12813 ||| JJ
DEAE-dextran ||| S:12813 E:12825 ||| NN
,  ||| S:12825 E:12827 ||| ,
are  ||| S:12827 E:12831 ||| VBP
coated  ||| S:12831 E:12838 ||| VBN
with  ||| S:12838 E:12843 ||| IN
gelatine  ||| S:12843 E:12852 ||| NN
or  ||| S:12852 E:12855 ||| CC
gelatine-like  ||| S:12855 E:12869 ||| JJ
protein ||| S:12869 E:12876 ||| NN
.  ||| S:12876 E:12878 ||| .
Other  ||| S:12878 E:12884 ||| JJ
suitable  ||| S:12884 E:12893 ||| JJ
porous  ||| S:12893 E:12900 ||| JJ
materials  ||| S:12900 E:12910 ||| NNS
are  ||| S:12910 E:12914 ||| VBP
known  ||| S:12914 E:12920 ||| VBN
to  ||| S:12920 E:12923 ||| TO
those  ||| S:12923 E:12929 ||| DT
skilled  ||| S:12929 E:12937 ||| JJ
in  ||| S:12937 E:12940 ||| IN
the  ||| S:12940 E:12944 ||| DT
art ||| S:12944 E:12947 ||| NN
,  ||| S:12947 E:12949 ||| ,
and  ||| S:12949 E:12953 ||| CC
include  ||| S:12953 E:12961 ||| VBP
e.g.  ||| S:12961 E:12966 ||| RB
other  ||| S:12966 E:12972 ||| JJ
chemically  ||| S:12972 E:12983 ||| NNS
modified  ||| S:12983 E:12992 ||| VBN
or  ||| S:12992 E:12995 ||| CC
non-modified  ||| S:12995 E:13008 ||| JJ
polysaccharides ||| S:13008 E:13023 ||| NN
.  ||| S:13023 E:13025 ||| .
The  ||| S:13025 E:13029 ||| DT
lower  ||| S:13029 E:13035 ||| JJR
molecular  ||| S:13035 E:13045 ||| JJ
weight  ||| S:13045 E:13052 ||| NN
limit  ||| S:13052 E:13058 ||| NN
prevents  ||| S:13058 E:13067 ||| VBZ
that  ||| S:13067 E:13072 ||| DT
gelatine  ||| S:13072 E:13081 ||| NN
or  ||| S:13081 E:13084 ||| CC
gelatine-like  ||| S:13084 E:13098 ||| JJ
protein  ||| S:13098 E:13106 ||| NN
enters  ||| S:13106 E:13113 ||| VBZ
the  ||| S:13113 E:13117 ||| DT
pores  ||| S:13117 E:13123 ||| NN
of  ||| S:13123 E:13126 ||| IN
the  ||| S:13126 E:13130 ||| DT
porous  ||| S:13130 E:13137 ||| JJ
core  ||| S:13137 E:13142 ||| NN
beads  ||| S:13142 E:13148 ||| VBZ
thereby  ||| S:13148 E:13156 ||| RB
preventing  ||| S:13156 E:13167 ||| VBG
inefficient  ||| S:13167 E:13179 ||| JJ
coating  ||| S:13179 E:13187 ||| NN
of  ||| S:13187 E:13190 ||| IN
the  ||| S:13190 E:13194 ||| DT
beads  ||| S:13194 E:13200 ||| NN
and  ||| S:13200 E:13204 ||| CC
unnecessary  ||| S:13204 E:13216 ||| JJ
loss  ||| S:13216 E:13221 ||| NN
of  ||| S:13221 E:13224 ||| IN
gelatine  ||| S:13224 E:13233 ||| NN
or  ||| S:13233 E:13236 ||| CC
gelatine-like  ||| S:13236 E:13250 ||| JJ
protein ||| S:13250 E:13257 ||| NN
.  ||| S:13257 E:13261 ||| .
In  ||| S:13261 E:13264 ||| IN
a  ||| S:13264 E:13266 ||| DT
further  ||| S:13266 E:13274 ||| JJ
preferred  ||| S:13274 E:13284 ||| JJ
embodiment  ||| S:13284 E:13295 ||| NNS
the  ||| S:13295 E:13299 ||| DT
gelatine  ||| S:13299 E:13308 ||| NN
or  ||| S:13308 E:13311 ||| CC
gelatine-like  ||| S:13311 E:13325 ||| JJ
protein  ||| S:13325 E:13333 ||| NN
is  ||| S:13333 E:13336 ||| VBZ
in  ||| S:13336 E:13339 ||| IN
essence  ||| S:13339 E:13347 ||| JJ
free  ||| S:13347 E:13352 ||| JJ
of  ||| S:13352 E:13355 ||| IN
hydroxyproline  ||| S:13355 E:13370 ||| JJ
residues ||| S:13370 E:13378 ||| NNS
.  ||| S:13378 E:13380 ||| .
Hydroxylation  ||| S:13380 E:13394 ||| NNP
is  ||| S:13394 E:13397 ||| VBZ
a  ||| S:13397 E:13399 ||| DT
requirement  ||| S:13399 E:13411 ||| NN
for  ||| S:13411 E:13415 ||| IN
the  ||| S:13415 E:13419 ||| DT
formation  ||| S:13419 E:13429 ||| NN
of  ||| S:13429 E:13432 ||| IN
triple  ||| S:13432 E:13439 ||| JJ
helices  ||| S:13439 E:13447 ||| NN
in  ||| S:13447 E:13450 ||| IN
collagen  ||| S:13450 E:13459 ||| NN
and  ||| S:13459 E:13463 ||| CC
plays  ||| S:13463 E:13469 ||| VBZ
a  ||| S:13469 E:13471 ||| DT
role  ||| S:13471 E:13476 ||| NN
in  ||| S:13476 E:13479 ||| IN
gelation  ||| S:13479 E:13488 ||| NN
of  ||| S:13488 E:13491 ||| IN
gelatine ||| S:13491 E:13499 ||| NN
.  ||| S:13499 E:13503 ||| .
In  ||| S:13503 E:13506 ||| IN
yet  ||| S:13506 E:13510 ||| RB
a  ||| S:13510 E:13512 ||| DT
further  ||| S:13512 E:13520 ||| JJ
embodiment  ||| S:13520 E:13531 ||| NNS
the  ||| S:13531 E:13535 ||| DT
process  ||| S:13535 E:13543 ||| NN
of  ||| S:13543 E:13546 ||| IN
the  ||| S:13546 E:13550 ||| DT
invention  ||| S:13550 E:13560 ||| NN
comprises  ||| S:13560 E:13570 ||| VBZ
the  ||| S:13570 E:13574 ||| DT
step  ||| S:13574 E:13579 ||| NN
of  ||| S:13579 E:13582 ||| IN
immobilising  ||| S:13582 E:13595 ||| VBG
the  ||| S:13595 E:13599 ||| DT
gelatine  ||| S:13599 E:13608 ||| NN
or  ||| S:13608 E:13611 ||| CC
gelatine-like  ||| S:13611 E:13625 ||| JJ
protein  ||| S:13625 E:13633 ||| NN
on  ||| S:13633 E:13636 ||| IN
the  ||| S:13636 E:13640 ||| DT
microcarrier ||| S:13640 E:13652 ||| NN
.  ||| S:13652 E:13654 ||| .
Such  ||| S:13654 E:13659 ||| JJ
inmobilisation  ||| S:13659 E:13674 ||| JJ
methods  ||| S:13674 E:13682 ||| NNS
are  ||| S:13682 E:13686 ||| VBP
known  ||| S:13686 E:13692 ||| VBN
per  ||| S:13692 E:13696 ||| IN
se ||| S:13696 E:13698 ||| FW
.  ||| S:13698 E:13700 ||| .
A  ||| S:13700 E:13702 ||| DT
preferred  ||| S:13702 E:13712 ||| JJ
method  ||| S:13712 E:13719 ||| NN
is  ||| S:13719 E:13722 ||| VBZ
crosslinking  ||| S:13722 E:13735 ||| VBN
of  ||| S:13735 E:13738 ||| IN
the  ||| S:13738 E:13742 ||| DT
gelatine  ||| S:13742 E:13751 ||| NN
or  ||| S:13751 E:13754 ||| CC
gelatine-like  ||| S:13754 E:13768 ||| JJ
protein  ||| S:13768 E:13776 ||| NN
with  ||| S:13776 E:13781 ||| IN
glutaraldehyde  ||| S:13781 E:13796 ||| VBG
as  ||| S:13796 E:13799 ||| RB
described  ||| S:13799 E:13809 ||| VBN
in  ||| S:13809 E:13812 ||| IN
U.S.  ||| S:13812 E:13817 ||| NNP
Pat ||| S:13817 E:13820 ||| NNP
.  ||| S:13820 E:13822 ||| .
No.  ||| S:13822 E:13826 ||| NNP
4,994,388 ||| S:13826 E:13835 ||| NNP
.  ||| S:13835 E:13839 ||| .
Processes  ||| S:13839 E:13849 ||| NNS
for  ||| S:13849 E:13853 ||| IN
coating  ||| S:13853 E:13861 ||| JJ
core  ||| S:13861 E:13866 ||| NN
beads  ||| S:13866 E:13872 ||| NN
with  ||| S:13872 E:13877 ||| IN
gelatines  ||| S:13877 E:13887 ||| NNS
( ||| S:13887 E:13888 ||| -LRB-
or  ||| S:13888 E:13891 ||| CC
collagens ||| S:13891 E:13900 ||| CD
)  ||| S:13900 E:13902 ||| -RRB-
are  ||| S:13902 E:13906 ||| VBP
known  ||| S:13906 E:13912 ||| VBN
per  ||| S:13912 E:13916 ||| IN
se ||| S:13916 E:13918 ||| FW
.  ||| S:13918 E:13920 ||| .
For  ||| S:13920 E:13924 ||| IN
instance  ||| S:13924 E:13933 ||| NN
the  ||| S:13933 E:13937 ||| DT
process  ||| S:13937 E:13945 ||| NN
described  ||| S:13945 E:13955 ||| VBD
in  ||| S:13955 E:13958 ||| IN
U.S.  ||| S:13958 E:13963 ||| NNP
Pat ||| S:13963 E:13966 ||| NNP
.  ||| S:13966 E:13968 ||| .
No.  ||| S:13968 E:13972 ||| NNP
4,994,388  ||| S:13972 E:13982 ||| NNP
may  ||| S:13982 E:13986 ||| MD
be  ||| S:13986 E:13989 ||| VB
used ||| S:13989 E:13993 ||| VBN
.  ||| S:13993 E:13995 ||| .
In  ||| S:13995 E:13998 ||| IN
short  ||| S:13998 E:14004 ||| JJ
a  ||| S:14004 E:14006 ||| DT
core  ||| S:14006 E:14011 ||| NN
bead  ||| S:14011 E:14016 ||| NN
is  ||| S:14016 E:14019 ||| VBZ
coated  ||| S:14019 E:14026 ||| VBN
with  ||| S:14026 E:14031 ||| IN
a  ||| S:14031 E:14033 ||| DT
gelatine  ||| S:14033 E:14042 ||| NN
in  ||| S:14042 E:14045 ||| IN
two  ||| S:14045 E:14049 ||| CD
steps ||| S:14049 E:14054 ||| NNS
:  ||| S:14054 E:14056 ||| :
coating  ||| S:14056 E:14064 ||| NN
and  ||| S:14064 E:14068 ||| CC
fixing ||| S:14068 E:14074 ||| VBG
.  ||| S:14074 E:14076 ||| .
The  ||| S:14076 E:14080 ||| DT
core  ||| S:14080 E:14085 ||| NN
beads  ||| S:14085 E:14091 ||| NNS
are  ||| S:14091 E:14095 ||| VBP
suspended  ||| S:14095 E:14105 ||| VBN
in  ||| S:14105 E:14108 ||| IN
an  ||| S:14108 E:14111 ||| DT
acidic ||| S:14111 E:14117 ||| NN
,  ||| S:14117 E:14119 ||| ,
aqueous  ||| S:14119 E:14127 ||| JJ
collagen  ||| S:14127 E:14136 ||| NN
solution  ||| S:14136 E:14145 ||| NN
( ||| S:14145 E:14146 ||| -LRB-
0.01-0.1N  ||| S:14146 E:14156 ||| FW
acetic  ||| S:14156 E:14163 ||| FW
acid ||| S:14163 E:14167 ||| FW
) ||| S:14167 E:14168 ||| -RRB-
,  ||| S:14168 E:14170 ||| ,
and  ||| S:14170 E:14174 ||| CC
the  ||| S:14174 E:14178 ||| DT
solution  ||| S:14178 E:14187 ||| NN
is  ||| S:14187 E:14190 ||| VBZ
evaporated  ||| S:14190 E:14201 ||| VBN
to  ||| S:14201 E:14204 ||| TO
dryness ||| S:14204 E:14211 ||| VB
.  ||| S:14211 E:14213 ||| .
The  ||| S:14213 E:14217 ||| DT
dry ||| S:14217 E:14220 ||| JJ
,  ||| S:14220 E:14222 ||| ,
gelatine-coated  ||| S:14222 E:14238 ||| JJ
beads  ||| S:14238 E:14244 ||| NNS
are  ||| S:14244 E:14248 ||| VBP
then  ||| S:14248 E:14253 ||| RB
suspended  ||| S:14253 E:14263 ||| VBN
in  ||| S:14263 E:14266 ||| IN
a  ||| S:14266 E:14268 ||| DT
solution  ||| S:14268 E:14277 ||| NN
which  ||| S:14277 E:14283 ||| WDT
contains  ||| S:14283 E:14292 ||| VBZ
a  ||| S:14292 E:14294 ||| DT
protein  ||| S:14294 E:14302 ||| NN
cross-linking  ||| S:14302 E:14316 ||| JJ
agent  ||| S:14316 E:14322 ||| NN
such  ||| S:14322 E:14327 ||| JJ
as  ||| S:14327 E:14330 ||| IN
glutaraldehyde ||| S:14330 E:14344 ||| NN
,  ||| S:14344 E:14346 ||| ,
thus  ||| S:14346 E:14351 ||| RB
crosslinking  ||| S:14351 E:14364 ||| VB
the  ||| S:14364 E:14368 ||| DT
gelatine  ||| S:14368 E:14377 ||| JJ
coating ||| S:14377 E:14384 ||| NN
.  ||| S:14384 E:14386 ||| .
Alternatively ||| S:14386 E:14399 ||| RB
,  ||| S:14399 E:14401 ||| ,
the  ||| S:14401 E:14405 ||| DT
core  ||| S:14405 E:14410 ||| JJ
beads  ||| S:14410 E:14416 ||| JJ
wetted  ||| S:14416 E:14423 ||| NN
with  ||| S:14423 E:14428 ||| IN
the  ||| S:14428 E:14432 ||| DT
gelatine  ||| S:14432 E:14441 ||| JJ
solution  ||| S:14441 E:14450 ||| NN
are  ||| S:14450 E:14454 ||| VBP
not  ||| S:14454 E:14458 ||| RB
dried  ||| S:14458 E:14464 ||| VBD
entirely  ||| S:14464 E:14473 ||| RB
before  ||| S:14473 E:14480 ||| IN
the  ||| S:14480 E:14484 ||| DT
start  ||| S:14484 E:14490 ||| NN
of  ||| S:14490 E:14493 ||| IN
the  ||| S:14493 E:14497 ||| DT
fixing  ||| S:14497 E:14504 ||| JJ
step ||| S:14504 E:14508 ||| NN
.  ||| S:14508 E:14510 ||| .
Variations  ||| S:14510 E:14521 ||| NNS
in  ||| S:14521 E:14524 ||| IN
coating  ||| S:14524 E:14532 ||| JJ
conditions  ||| S:14532 E:14543 ||| NNS
and  ||| S:14543 E:14547 ||| CC
alternative  ||| S:14547 E:14559 ||| JJ
coating  ||| S:14559 E:14567 ||| NN
processes  ||| S:14567 E:14577 ||| NNS
are  ||| S:14577 E:14581 ||| VBP
well  ||| S:14581 E:14586 ||| RB
within  ||| S:14586 E:14593 ||| IN
the  ||| S:14593 E:14597 ||| DT
competence  ||| S:14597 E:14608 ||| NN
of  ||| S:14608 E:14611 ||| IN
those  ||| S:14611 E:14617 ||| DT
skilled  ||| S:14617 E:14625 ||| JJ
in  ||| S:14625 E:14628 ||| IN
the  ||| S:14628 E:14632 ||| DT
art ||| S:14632 E:14635 ||| NN
.  ||| S:14635 E:14639 ||| .
It  ||| S:14639 E:14642 ||| PRP
is  ||| S:14642 E:14645 ||| VBZ
known  ||| S:14645 E:14651 ||| VBN
in  ||| S:14651 E:14654 ||| IN
the  ||| S:14654 E:14658 ||| DT
art  ||| S:14658 E:14662 ||| NN
that  ||| S:14662 E:14667 ||| IN
incorporation  ||| S:14667 E:14681 ||| NN
of  ||| S:14681 E:14684 ||| IN
positive  ||| S:14684 E:14693 ||| JJ
charges  ||| S:14693 E:14701 ||| NNS
onto  ||| S:14701 E:14706 ||| IN
gelatine  ||| S:14706 E:14715 ||| JJ
microcarriers  ||| S:14715 E:14729 ||| NNS
greatly  ||| S:14729 E:14737 ||| RB
improves  ||| S:14737 E:14746 ||| VBZ
the  ||| S:14746 E:14750 ||| DT
rate  ||| S:14750 E:14755 ||| NN
of  ||| S:14755 E:14758 ||| IN
cell  ||| S:14758 E:14763 ||| NN
attachment  ||| S:14763 E:14774 ||| NN
to  ||| S:14774 E:14777 ||| TO
these  ||| S:14777 E:14783 ||| DT
microcarriers ||| S:14783 E:14796 ||| NN
,  ||| S:14796 E:14798 ||| ,
see  ||| S:14798 E:14802 ||| VB
U.S.  ||| S:14802 E:14807 ||| NNP
Pat ||| S:14807 E:14810 ||| NNP
.  ||| S:14810 E:14812 ||| .
No.  ||| S:14812 E:14816 ||| NNP
5,512,474 ||| S:14816 E:14825 ||| NNP
.  ||| S:14825 E:14827 ||| .
Recombinant  ||| S:14827 E:14839 ||| JJ
production  ||| S:14839 E:14850 ||| NN
of  ||| S:14850 E:14853 ||| IN
gelatines  ||| S:14853 E:14863 ||| NN
allows  ||| S:14863 E:14870 ||| VBZ
easy  ||| S:14870 E:14875 ||| JJ
manipulation  ||| S:14875 E:14888 ||| NN
of  ||| S:14888 E:14891 ||| IN
the  ||| S:14891 E:14895 ||| DT
number  ||| S:14895 E:14902 ||| NN
of  ||| S:14902 E:14905 ||| IN
positively  ||| S:14905 E:14916 ||| RB
charged  ||| S:14916 E:14924 ||| VBN
amino  ||| S:14924 E:14930 ||| JJ
acids ||| S:14930 E:14935 ||| NNS
,  ||| S:14935 E:14937 ||| ,
meaning  ||| S:14937 E:14945 ||| VBG
positively  ||| S:14945 E:14956 ||| RB
charged  ||| S:14956 E:14964 ||| VBN
at  ||| S:14964 E:14967 ||| IN
the  ||| S:14967 E:14971 ||| DT
pH  ||| S:14971 E:14974 ||| JJ
of  ||| S:14974 E:14977 ||| IN
the  ||| S:14977 E:14981 ||| DT
cell  ||| S:14981 E:14986 ||| NN
culture ||| S:14986 E:14993 ||| NN
,  ||| S:14993 E:14995 ||| ,
in  ||| S:14995 E:14998 ||| IN
the  ||| S:14998 E:15002 ||| DT
produced  ||| S:15002 E:15011 ||| VBN
protein ||| S:15011 E:15018 ||| NN
.  ||| S:15018 E:15020 ||| .
In  ||| S:15020 E:15023 ||| IN
particular  ||| S:15023 E:15034 ||| JJ
arginine ||| S:15034 E:15042 ||| NN
,  ||| S:15042 E:15044 ||| ,
lysine  ||| S:15044 E:15051 ||| NN
and  ||| S:15051 E:15055 ||| CC
histidine  ||| S:15055 E:15065 ||| NNS
carry  ||| S:15065 E:15071 ||| VBP
positive  ||| S:15071 E:15080 ||| JJ
charges ||| S:15080 E:15087 ||| NNS
.  ||| S:15087 E:15089 ||| .
It  ||| S:15089 E:15092 ||| PRP
is  ||| S:15092 E:15095 ||| VBZ
well  ||| S:15095 E:15100 ||| RB
within  ||| S:15100 E:15107 ||| IN
the  ||| S:15107 E:15111 ||| DT
reach  ||| S:15111 E:15117 ||| NN
of  ||| S:15117 E:15120 ||| IN
the  ||| S:15120 E:15124 ||| DT
skilled  ||| S:15124 E:15132 ||| JJ
person  ||| S:15132 E:15139 ||| NN
to  ||| S:15139 E:15142 ||| TO
design  ||| S:15142 E:15149 ||| VB
a  ||| S:15149 E:15151 ||| DT
gelatine  ||| S:15151 E:15160 ||| NN
with  ||| S:15160 E:15165 ||| IN
a  ||| S:15165 E:15167 ||| DT
net  ||| S:15167 E:15171 ||| JJ
positive  ||| S:15171 E:15180 ||| JJ
charge  ||| S:15180 E:15187 ||| NN
at  ||| S:15187 E:15190 ||| IN
the  ||| S:15190 E:15194 ||| DT
pH  ||| S:15194 E:15197 ||| JJ
of  ||| S:15197 E:15200 ||| IN
the  ||| S:15200 E:15204 ||| DT
particular  ||| S:15204 E:15215 ||| JJ
cell  ||| S:15215 E:15220 ||| NN
culture  ||| S:15220 E:15228 ||| NN
of  ||| S:15228 E:15231 ||| IN
interest ||| S:15231 E:15239 ||| NN
.  ||| S:15239 E:15241 ||| .
Cells  ||| S:15241 E:15247 ||| NNS
are  ||| S:15247 E:15251 ||| VBP
normally  ||| S:15251 E:15260 ||| RB
cultured  ||| S:15260 E:15269 ||| VBN
at  ||| S:15269 E:15272 ||| IN
a  ||| S:15272 E:15274 ||| DT
pH  ||| S:15274 E:15277 ||| JJ
of  ||| S:15277 E:15280 ||| IN
7-7.5 ||| S:15280 E:15285 ||| CD
.  ||| S:15285 E:15287 ||| .
Thus  ||| S:15287 E:15292 ||| RB
in  ||| S:15292 E:15295 ||| IN
a  ||| S:15295 E:15297 ||| DT
further  ||| S:15297 E:15305 ||| JJ
embodiment  ||| S:15305 E:15316 ||| NN
of  ||| S:15316 E:15319 ||| IN
the  ||| S:15319 E:15323 ||| DT
invention  ||| S:15323 E:15333 ||| NN
a  ||| S:15333 E:15335 ||| DT
gelatine  ||| S:15335 E:15344 ||| NN
or  ||| S:15344 E:15347 ||| CC
gelatine-like  ||| S:15347 E:15361 ||| JJ
protein  ||| S:15361 E:15369 ||| NN
is  ||| S:15369 E:15372 ||| VBZ
used  ||| S:15372 E:15377 ||| VBN
that  ||| S:15377 E:15382 ||| WDT
has  ||| S:15382 E:15386 ||| VBZ
a  ||| S:15386 E:15388 ||| DT
net  ||| S:15388 E:15392 ||| JJ
positive  ||| S:15392 E:15401 ||| JJ
charge  ||| S:15401 E:15408 ||| NN
at  ||| S:15408 E:15411 ||| IN
pH  ||| S:15411 E:15414 ||| JJ
7-7.5 ||| S:15414 E:15419 ||| NN
.  ||| S:15419 E:15421 ||| .
Preferably  ||| S:15421 E:15432 ||| RB
the  ||| S:15432 E:15436 ||| DT
net  ||| S:15436 E:15440 ||| JJ
positive  ||| S:15440 E:15449 ||| JJ
charge  ||| S:15449 E:15456 ||| NN
is  ||| S:15456 E:15459 ||| VBZ
+2 ||| S:15459 E:15461 ||| NNP
,  ||| S:15461 E:15463 ||| ,
+3 ||| S:15463 E:15465 ||| NNP
,  ||| S:15465 E:15467 ||| ,
+4 ||| S:15467 E:15469 ||| NNP
,  ||| S:15469 E:15471 ||| ,
+5 ||| S:15471 E:15473 ||| NNP
,  ||| S:15473 E:15475 ||| ,
+10  ||| S:15475 E:15479 ||| NNP
or  ||| S:15479 E:15482 ||| CC
higher ||| S:15482 E:15488 ||| JJR
.  ||| S:15488 E:15492 ||| .
Also  ||| S:15492 E:15497 ||| RB
chemical  ||| S:15497 E:15506 ||| JJ
modification  ||| S:15506 E:15519 ||| NN
can  ||| S:15519 E:15523 ||| MD
be  ||| S:15523 E:15526 ||| VB
used  ||| S:15526 E:15531 ||| VBN
to  ||| S:15531 E:15534 ||| TO
control  ||| S:15534 E:15542 ||| VB
the  ||| S:15542 E:15546 ||| DT
number  ||| S:15546 E:15553 ||| NN
of  ||| S:15553 E:15556 ||| IN
positively  ||| S:15556 E:15567 ||| RB
charged  ||| S:15567 E:15575 ||| VBN
amino  ||| S:15575 E:15581 ||| JJ
acids  ||| S:15581 E:15587 ||| NNS
in  ||| S:15587 E:15590 ||| IN
a  ||| S:15590 E:15592 ||| DT
protein ||| S:15592 E:15599 ||| NN
.  ||| S:15599 E:15601 ||| .
Methods  ||| S:15601 E:15609 ||| NNS
are  ||| S:15609 E:15613 ||| VBP
described  ||| S:15613 E:15623 ||| VBN
in  ||| S:15623 E:15626 ||| IN
The  ||| S:15626 E:15630 ||| DT
Practice  ||| S:15630 E:15639 ||| NNP
of  ||| S:15639 E:15642 ||| IN
Peptide  ||| S:15642 E:15650 ||| NNP
Synthesis ||| S:15650 E:15659 ||| NNP
,  ||| S:15659 E:15661 ||| ,
M.  ||| S:15661 E:15664 ||| NNP
Bodansky ||| S:15664 E:15672 ||| NNP
,  ||| S:15672 E:15674 ||| ,
Springer-Verlag ||| S:15674 E:15689 ||| NNP
,  ||| S:15689 E:15691 ||| ,
Berlin  ||| S:15691 E:15698 ||| NNP
1984 ||| S:15698 E:15702 ||| CD
.  ||| S:15702 E:15706 ||| .
A  ||| S:15706 E:15708 ||| DT
natural  ||| S:15708 E:15716 ||| JJ
gelatine  ||| S:15716 E:15725 ||| JJ
molecule  ||| S:15725 E:15734 ||| NN
in  ||| S:15734 E:15737 ||| IN
its  ||| S:15737 E:15741 ||| PRP$
primary  ||| S:15741 E:15749 ||| JJ
amino  ||| S:15749 E:15755 ||| JJ
acid  ||| S:15755 E:15760 ||| NN
sequence  ||| S:15760 E:15769 ||| NN
basically  ||| S:15769 E:15779 ||| RB
consists  ||| S:15779 E:15788 ||| VBZ
of  ||| S:15788 E:15791 ||| IN
repeats  ||| S:15791 E:15799 ||| NNS
of  ||| S:15799 E:15802 ||| IN
Gly-Xaa-Yaa  ||| S:15802 E:15814 ||| JJ
triplets ||| S:15814 E:15822 ||| NN
,  ||| S:15822 E:15824 ||| ,
thus  ||| S:15824 E:15829 ||| RB
approximately  ||| S:15829 E:15843 ||| RB
one  ||| S:15843 E:15847 ||| CD
third  ||| S:15847 E:15853 ||| JJ
of  ||| S:15853 E:15856 ||| IN
the  ||| S:15856 E:15860 ||| DT
total  ||| S:15860 E:15866 ||| JJ
number  ||| S:15866 E:15873 ||| NN
of  ||| S:15873 E:15876 ||| IN
amino  ||| S:15876 E:15882 ||| JJ
acids  ||| S:15882 E:15888 ||| NN
is  ||| S:15888 E:15891 ||| VBZ
a  ||| S:15891 E:15893 ||| DT
glycine ||| S:15893 E:15900 ||| NN
.  ||| S:15900 E:15902 ||| .
The  ||| S:15902 E:15906 ||| DT
molecular  ||| S:15906 E:15916 ||| JJ
weight  ||| S:15916 E:15923 ||| NN
of  ||| S:15923 E:15926 ||| IN
gelatine  ||| S:15926 E:15935 ||| NN
is  ||| S:15935 E:15938 ||| VBZ
typically  ||| S:15938 E:15948 ||| RB
large ||| S:15948 E:15953 ||| JJ
,  ||| S:15953 E:15955 ||| ,
values  ||| S:15955 E:15962 ||| NNS
of  ||| S:15962 E:15965 ||| IN
the  ||| S:15965 E:15969 ||| DT
molecular  ||| S:15969 E:15979 ||| JJ
weight  ||| S:15979 E:15986 ||| NN
vary  ||| S:15986 E:15991 ||| VBP
from  ||| S:15991 E:15996 ||| IN
10,000  ||| S:15996 E:16003 ||| CD
to  ||| S:16003 E:16006 ||| TO
300,000  ||| S:16006 E:16014 ||| CD
Dalton  ||| S:16014 E:16021 ||| NNP
and  ||| S:16021 E:16025 ||| CC
higher ||| S:16025 E:16031 ||| JJR
.  ||| S:16031 E:16033 ||| .
The  ||| S:16033 E:16037 ||| DT
fraction  ||| S:16037 E:16046 ||| NN
very  ||| S:16046 E:16051 ||| RB
high  ||| S:16051 E:16056 ||| JJ
molecular  ||| S:16056 E:16066 ||| JJ
weight  ||| S:16066 E:16073 ||| NN
may  ||| S:16073 E:16077 ||| MD
be  ||| S:16077 E:16080 ||| VB
relatively  ||| S:16080 E:16091 ||| RB
small ||| S:16091 E:16096 ||| JJ
,  ||| S:16096 E:16098 ||| ,
but  ||| S:16098 E:16102 ||| CC
is  ||| S:16102 E:16105 ||| VBZ
very  ||| S:16105 E:16110 ||| RB
detrimental  ||| S:16110 E:16122 ||| VBN
in  ||| S:16122 E:16125 ||| IN
the  ||| S:16125 E:16129 ||| DT
coating  ||| S:16129 E:16137 ||| JJ
process  ||| S:16137 E:16145 ||| NN
in  ||| S:16145 E:16148 ||| IN
view  ||| S:16148 E:16153 ||| NN
of  ||| S:16153 E:16156 ||| IN
the  ||| S:16156 E:16160 ||| DT
disadvantageous  ||| S:16160 E:16176 ||| JJ
clumping  ||| S:16176 E:16185 ||| NNS
together  ||| S:16185 E:16194 ||| RB
of  ||| S:16194 E:16197 ||| IN
beads ||| S:16197 E:16202 ||| NN
.  ||| S:16202 E:16204 ||| .
The  ||| S:16204 E:16208 ||| DT
main  ||| S:16208 E:16213 ||| JJ
fraction  ||| S:16213 E:16222 ||| NN
of  ||| S:16222 E:16225 ||| IN
natural  ||| S:16225 E:16233 ||| JJ
gelatine  ||| S:16233 E:16242 ||| JJ
molecules  ||| S:16242 E:16252 ||| NN
has  ||| S:16252 E:16256 ||| VBZ
a  ||| S:16256 E:16258 ||| DT
molecular  ||| S:16258 E:16268 ||| JJ
weight  ||| S:16268 E:16275 ||| NN
around  ||| S:16275 E:16282 ||| IN
90,000  ||| S:16282 E:16289 ||| NNP
Dalton ||| S:16289 E:16295 ||| NNP
.  ||| S:16295 E:16297 ||| .
The  ||| S:16297 E:16301 ||| DT
average  ||| S:16301 E:16309 ||| JJ
molecular  ||| S:16309 E:16319 ||| JJ
weight  ||| S:16319 E:16326 ||| NN
is  ||| S:16326 E:16329 ||| VBZ
higher  ||| S:16329 E:16336 ||| JJR
than  ||| S:16336 E:16341 ||| IN
90,000  ||| S:16341 E:16348 ||| NNP
Dalton ||| S:16348 E:16354 ||| NNP
.  ||| S:16354 E:16358 ||| .
Furthermore ||| S:16358 E:16369 ||| RB
,  ||| S:16369 E:16371 ||| ,
characteristic  ||| S:16371 E:16386 ||| JJ
for  ||| S:16386 E:16390 ||| IN
gelatine  ||| S:16390 E:16399 ||| NN
is  ||| S:16399 E:16402 ||| VBZ
the  ||| S:16402 E:16406 ||| DT
unusual  ||| S:16406 E:16414 ||| JJ
high  ||| S:16414 E:16419 ||| JJ
content  ||| S:16419 E:16427 ||| NN
of  ||| S:16427 E:16430 ||| IN
proline  ||| S:16430 E:16438 ||| JJ
residues ||| S:16438 E:16446 ||| NNS
.  ||| S:16446 E:16448 ||| .
Even  ||| S:16448 E:16453 ||| RB
more  ||| S:16453 E:16458 ||| JJR
characteristic  ||| S:16458 E:16473 ||| NN
is  ||| S:16473 E:16476 ||| VBZ
that  ||| S:16476 E:16481 ||| IN
in  ||| S:16481 E:16484 ||| IN
natural  ||| S:16484 E:16492 ||| JJ
gelatine  ||| S:16492 E:16501 ||| NNS
a  ||| S:16501 E:16503 ||| DT
number  ||| S:16503 E:16510 ||| NN
of  ||| S:16510 E:16513 ||| IN
the  ||| S:16513 E:16517 ||| DT
proline  ||| S:16517 E:16525 ||| JJ
residues  ||| S:16525 E:16534 ||| NN
is  ||| S:16534 E:16537 ||| VBZ
hydroxylated ||| S:16537 E:16549 ||| VBN
.  ||| S:16549 E:16551 ||| .
Most  ||| S:16551 E:16556 ||| RBS
prominent  ||| S:16556 E:16566 ||| JJ
site  ||| S:16566 E:16571 ||| NN
of  ||| S:16571 E:16574 ||| IN
hydroxylation  ||| S:16574 E:16588 ||| NN
is  ||| S:16588 E:16591 ||| VBZ
the  ||| S:16591 E:16595 ||| DT
4-position  ||| S:16595 E:16606 ||| NN
resulting  ||| S:16606 E:16616 ||| VBG
in  ||| S:16616 E:16619 ||| IN
the  ||| S:16619 E:16623 ||| DT
presence  ||| S:16623 E:16632 ||| NN
in  ||| S:16632 E:16635 ||| IN
the  ||| S:16635 E:16639 ||| DT
gelatine  ||| S:16639 E:16648 ||| JJ
molecule  ||| S:16648 E:16657 ||| NN
of  ||| S:16657 E:16660 ||| IN
the  ||| S:16660 E:16664 ||| DT
unusual  ||| S:16664 E:16672 ||| JJ
amino  ||| S:16672 E:16678 ||| JJ
acid  ||| S:16678 E:16683 ||| NN
4-hydroxyproline ||| S:16683 E:16699 ||| NN
.  ||| S:16699 E:16701 ||| .
In  ||| S:16701 E:16704 ||| IN
a  ||| S:16704 E:16706 ||| DT
triplet  ||| S:16706 E:16714 ||| JJ
4-hydroxyproline  ||| S:16714 E:16731 ||| NN
is  ||| S:16731 E:16734 ||| VBZ
always  ||| S:16734 E:16741 ||| RB
found  ||| S:16741 E:16747 ||| VBN
in  ||| S:16747 E:16750 ||| IN
the  ||| S:16750 E:16754 ||| DT
Yaa  ||| S:16754 E:16758 ||| JJ
position ||| S:16758 E:16766 ||| NN
.  ||| S:16766 E:16768 ||| .
Very  ||| S:16768 E:16773 ||| RB
few  ||| S:16773 E:16777 ||| JJ
proline  ||| S:16777 E:16785 ||| JJ
residues  ||| S:16785 E:16794 ||| NNS
are  ||| S:16794 E:16798 ||| VBP
hydroxylated  ||| S:16798 E:16811 ||| VBN
at  ||| S:16811 E:16814 ||| IN
the  ||| S:16814 E:16818 ||| DT
3  ||| S:16818 E:16820 ||| CD
position ||| S:16820 E:16828 ||| NN
.  ||| S:16828 E:16830 ||| .
In  ||| S:16830 E:16833 ||| IN
contrast  ||| S:16833 E:16842 ||| NN
with  ||| S:16842 E:16847 ||| IN
4-hydroxyproline ||| S:16847 E:16863 ||| NNP
,  ||| S:16863 E:16865 ||| ,
3-hydroxyproline  ||| S:16865 E:16882 ||| NNP
is  ||| S:16882 E:16885 ||| VBZ
always  ||| S:16885 E:16892 ||| RB
found  ||| S:16892 E:16898 ||| VBN
at  ||| S:16898 E:16901 ||| IN
the  ||| S:16901 E:16905 ||| DT
carboxyl  ||| S:16905 E:16914 ||| JJ
side  ||| S:16914 E:16919 ||| NN
of  ||| S:16919 E:16922 ||| IN
a  ||| S:16922 E:16924 ||| DT
glycine  ||| S:16924 E:16932 ||| JJ
residue ||| S:16932 E:16939 ||| NN
,  ||| S:16939 E:16941 ||| ,
thus  ||| S:16941 E:16946 ||| RB
in  ||| S:16946 E:16949 ||| IN
the  ||| S:16949 E:16953 ||| DT
Xaa  ||| S:16953 E:16957 ||| JJ
position  ||| S:16957 E:16966 ||| NN
in  ||| S:16966 E:16969 ||| IN
a  ||| S:16969 E:16971 ||| DT
triplet ||| S:16971 E:16978 ||| NN
.  ||| S:16978 E:16980 ||| .
Different  ||| S:16980 E:16990 ||| JJ
enzymes  ||| S:16990 E:16998 ||| NNS
are  ||| S:16998 E:17002 ||| VBP
responsible  ||| S:17002 E:17014 ||| JJ
for  ||| S:17014 E:17018 ||| IN
the  ||| S:17018 E:17022 ||| DT
formation  ||| S:17022 E:17032 ||| NN
of  ||| S:17032 E:17035 ||| IN
3-  ||| S:17035 E:17038 ||| NNP
or  ||| S:17038 E:17041 ||| CC
4-hydroxyproline ||| S:17041 E:17057 ||| NNP
.  ||| S:17057 E:17061 ||| .
Based  ||| S:17061 E:17067 ||| VBN
on  ||| S:17067 E:17070 ||| IN
known  ||| S:17070 E:17076 ||| VBN
amino  ||| S:17076 E:17082 ||| JJ
acid  ||| S:17082 E:17087 ||| NN
compositions ||| S:17087 E:17099 ||| NNS
,  ||| S:17099 E:17101 ||| ,
it  ||| S:17101 E:17104 ||| PRP
is  ||| S:17104 E:17107 ||| VBZ
estimated  ||| S:17107 E:17117 ||| VBN
that  ||| S:17117 E:17122 ||| IN
in  ||| S:17122 E:17125 ||| IN
a  ||| S:17125 E:17127 ||| DT
gelatine  ||| S:17127 E:17136 ||| JJ
molecule  ||| S:17136 E:17145 ||| NN
derived  ||| S:17145 E:17153 ||| VBN
from  ||| S:17153 E:17158 ||| IN
a  ||| S:17158 E:17160 ||| DT
mammal ||| S:17160 E:17166 ||| NN
,  ||| S:17166 E:17168 ||| ,
approximately  ||| S:17168 E:17182 ||| RB
22 ||| S:17182 E:17184 ||| CD
%  ||| S:17184 E:17186 ||| NN
of  ||| S:17186 E:17189 ||| IN
the  ||| S:17189 E:17193 ||| DT
amino  ||| S:17193 E:17199 ||| JJ
acids  ||| S:17199 E:17205 ||| NNS
are  ||| S:17205 E:17209 ||| VBP
a  ||| S:17209 E:17211 ||| DT
proline  ||| S:17211 E:17219 ||| NN
or  ||| S:17219 E:17222 ||| CC
a  ||| S:17222 E:17224 ||| DT
hydroxyproline  ||| S:17224 E:17239 ||| JJ
residue ||| S:17239 E:17246 ||| NN
.  ||| S:17246 E:17248 ||| .
However  ||| S:17248 E:17256 ||| RB
lower  ||| S:17256 E:17262 ||| JJR
contents  ||| S:17262 E:17271 ||| NNS
of  ||| S:17271 E:17274 ||| IN
proline  ||| S:17274 E:17282 ||| NN
and  ||| S:17282 E:17286 ||| CC
hydroxyproline  ||| S:17286 E:17301 ||| NNS
are  ||| S:17301 E:17305 ||| VBP
found  ||| S:17305 E:17311 ||| VBN
in  ||| S:17311 E:17314 ||| IN
fish ||| S:17314 E:17318 ||| NN
,  ||| S:17318 E:17320 ||| ,
in  ||| S:17320 E:17323 ||| IN
particular  ||| S:17323 E:17334 ||| JJ
cold  ||| S:17334 E:17339 ||| JJ
water  ||| S:17339 E:17345 ||| NN
fish ||| S:17345 E:17349 ||| NN
.  ||| S:17349 E:17351 ||| .
A  ||| S:17351 E:17353 ||| DT
rough  ||| S:17353 E:17359 ||| JJ
estimate  ||| S:17359 E:17368 ||| NN
is  ||| S:17368 E:17371 ||| VBZ
that  ||| S:17371 E:17376 ||| DT
proline  ||| S:17376 E:17384 ||| NN
and  ||| S:17384 E:17388 ||| CC
hydroxyproline  ||| S:17388 E:17403 ||| JJ
residues  ||| S:17403 E:17412 ||| NNS
are  ||| S:17412 E:17416 ||| VBP
present  ||| S:17416 E:17424 ||| JJ
in  ||| S:17424 E:17427 ||| IN
approximately  ||| S:17427 E:17441 ||| RB
equal  ||| S:17441 E:17447 ||| JJ
amounts ||| S:17447 E:17454 ||| NNS
,  ||| S:17454 E:17456 ||| ,
thus  ||| S:17456 E:17461 ||| RB
in  ||| S:17461 E:17464 ||| IN
a  ||| S:17464 E:17466 ||| DT
gelatine  ||| S:17466 E:17475 ||| JJ
molecule  ||| S:17475 E:17484 ||| NN
derived  ||| S:17484 E:17492 ||| VBN
from  ||| S:17492 E:17497 ||| IN
a  ||| S:17497 E:17499 ||| DT
mammal  ||| S:17499 E:17506 ||| NN
approximately  ||| S:17506 E:17520 ||| RB
11 ||| S:17520 E:17522 ||| CD
%  ||| S:17522 E:17524 ||| NN
of  ||| S:17524 E:17527 ||| IN
the  ||| S:17527 E:17531 ||| DT
amino  ||| S:17531 E:17537 ||| JJ
acids  ||| S:17537 E:17543 ||| NNS
are  ||| S:17543 E:17547 ||| VBP
prolines  ||| S:17547 E:17556 ||| VBN
and  ||| S:17556 E:17560 ||| CC
approximately  ||| S:17560 E:17574 ||| RB
11 ||| S:17574 E:17576 ||| CD
%  ||| S:17576 E:17578 ||| NN
are  ||| S:17578 E:17582 ||| VBP
hydroxyprolines ||| S:17582 E:17597 ||| VBN
.  ||| S:17597 E:17599 ||| .
As  ||| S:17599 E:17602 ||| RB
substantially  ||| S:17602 E:17616 ||| RB
all  ||| S:17616 E:17620 ||| DT
hydroxyproline  ||| S:17620 E:17635 ||| NN
is  ||| S:17635 E:17638 ||| VBZ
found  ||| S:17638 E:17644 ||| VBN
in  ||| S:17644 E:17647 ||| IN
the  ||| S:17647 E:17651 ||| DT
Yaa  ||| S:17651 E:17655 ||| JJ
position ||| S:17655 E:17663 ||| NN
,  ||| S:17663 E:17665 ||| ,
it  ||| S:17665 E:17668 ||| PRP
is  ||| S:17668 E:17671 ||| VBZ
estimated  ||| S:17671 E:17681 ||| VBN
that  ||| S:17681 E:17686 ||| IN
approximately  ||| S:17686 E:17700 ||| RB
one  ||| S:17700 E:17704 ||| CD
third  ||| S:17704 E:17710 ||| JJ
of  ||| S:17710 E:17713 ||| IN
all  ||| S:17713 E:17717 ||| DT
triplets  ||| S:17717 E:17726 ||| NN
in  ||| S:17726 E:17729 ||| IN
a  ||| S:17729 E:17731 ||| DT
gelatine  ||| S:17731 E:17740 ||| JJ
molecule  ||| S:17740 E:17749 ||| NNS
comprise  ||| S:17749 E:17758 ||| VBP
a  ||| S:17758 E:17760 ||| DT
hydroxyproline ||| S:17760 E:17774 ||| NN
.  ||| S:17774 E:17776 ||| .
The  ||| S:17776 E:17780 ||| DT
presence  ||| S:17780 E:17789 ||| NN
of  ||| S:17789 E:17792 ||| IN
the  ||| S:17792 E:17796 ||| DT
hydroxyproline  ||| S:17796 E:17811 ||| JJ
residues  ||| S:17811 E:17820 ||| NN
is  ||| S:17820 E:17823 ||| VBZ
responsible  ||| S:17823 E:17835 ||| JJ
for  ||| S:17835 E:17839 ||| IN
the  ||| S:17839 E:17843 ||| DT
fact  ||| S:17843 E:17848 ||| NN
that  ||| S:17848 E:17853 ||| IN
a  ||| S:17853 E:17855 ||| DT
gelatine  ||| S:17855 E:17864 ||| JJ
molecule  ||| S:17864 E:17873 ||| NN
in  ||| S:17873 E:17876 ||| IN
its  ||| S:17876 E:17880 ||| PRP$
secondary  ||| S:17880 E:17890 ||| JJ
structure  ||| S:17890 E:17900 ||| NN
can  ||| S:17900 E:17904 ||| MD
adopt  ||| S:17904 E:17910 ||| VB
a  ||| S:17910 E:17912 ||| DT
helical  ||| S:17912 E:17920 ||| JJ
conformation ||| S:17920 E:17932 ||| NN
.  ||| S:17932 E:17934 ||| .
Thus ||| S:17934 E:17938 ||| RB
,  ||| S:17938 E:17940 ||| ,
it  ||| S:17940 E:17943 ||| PRP
is  ||| S:17943 E:17946 ||| VBZ
preferred  ||| S:17946 E:17956 ||| VBN
that  ||| S:17956 E:17961 ||| IN
the  ||| S:17961 E:17965 ||| DT
gelatines  ||| S:17965 E:17975 ||| NN
to  ||| S:17975 E:17978 ||| TO
be  ||| S:17978 E:17981 ||| VB
used  ||| S:17981 E:17986 ||| VBN
according  ||| S:17986 E:17996 ||| VBG
to  ||| S:17996 E:17999 ||| TO
the  ||| S:17999 E:18003 ||| DT
invention  ||| S:18003 E:18013 ||| NNS
contain  ||| S:18013 E:18021 ||| VBP
less  ||| S:18021 E:18026 ||| JJR
than  ||| S:18026 E:18031 ||| IN
5 ||| S:18031 E:18032 ||| CD
% ||| S:18032 E:18033 ||| NN
,  ||| S:18033 E:18035 ||| ,
preferably  ||| S:18035 E:18046 ||| RB
less  ||| S:18046 E:18051 ||| JJR
than  ||| S:18051 E:18056 ||| IN
3 ||| S:18056 E:18057 ||| CD
% ||| S:18057 E:18058 ||| NN
,  ||| S:18058 E:18060 ||| ,
most  ||| S:18060 E:18065 ||| RBS
preferably  ||| S:18065 E:18076 ||| RB
less  ||| S:18076 E:18081 ||| JJR
than  ||| S:18081 E:18086 ||| IN
1 ||| S:18086 E:18087 ||| CD
%  ||| S:18087 E:18089 ||| NN
of  ||| S:18089 E:18092 ||| IN
hydroxyproline  ||| S:18092 E:18107 ||| JJ
residues ||| S:18107 E:18115 ||| NNS
,  ||| S:18115 E:18117 ||| ,
be  ||| S:18117 E:18120 ||| VB
it  ||| S:18120 E:18123 ||| PRP
3-  ||| S:18123 E:18126 ||| VBP
or  ||| S:18126 E:18129 ||| CC
4-hydroxyprolines ||| S:18129 E:18146 ||| NNP
.  ||| S:18146 E:18150 ||| .
Gelatine-like  ||| S:18150 E:18164 ||| JJ
proteins  ||| S:18164 E:18173 ||| NNS
for  ||| S:18173 E:18177 ||| IN
use  ||| S:18177 E:18181 ||| NN
according  ||| S:18181 E:18191 ||| VBG
to  ||| S:18191 E:18194 ||| TO
the  ||| S:18194 E:18198 ||| DT
invention  ||| S:18198 E:18208 ||| NNS
are  ||| S:18208 E:18212 ||| VBP
understood  ||| S:18212 E:18223 ||| VBN
as  ||| S:18223 E:18226 ||| IN
proteins  ||| S:18226 E:18235 ||| NNS
in  ||| S:18235 E:18238 ||| IN
which  ||| S:18238 E:18244 ||| WDT
at  ||| S:18244 E:18247 ||| IN
least  ||| S:18247 E:18253 ||| JJS
5 ||| S:18253 E:18254 ||| CD
%  ||| S:18254 E:18256 ||| NN
of  ||| S:18256 E:18259 ||| IN
the  ||| S:18259 E:18263 ||| DT
total  ||| S:18263 E:18269 ||| JJ
number  ||| S:18269 E:18276 ||| NN
of  ||| S:18276 E:18279 ||| IN
amino  ||| S:18279 E:18285 ||| JJ
acids  ||| S:18285 E:18291 ||| NN
is  ||| S:18291 E:18294 ||| VBZ
a  ||| S:18294 E:18296 ||| DT
proline  ||| S:18296 E:18304 ||| JJ
residue ||| S:18304 E:18311 ||| NN
.  ||| S:18311 E:18313 ||| .
By  ||| S:18313 E:18316 ||| IN
this  ||| S:18316 E:18321 ||| DT
percentage  ||| S:18321 E:18332 ||| NN
the  ||| S:18332 E:18336 ||| DT
gelatine-like  ||| S:18336 E:18350 ||| JJ
characteristics ||| S:18350 E:18365 ||| NNS
,  ||| S:18365 E:18367 ||| ,
for  ||| S:18367 E:18371 ||| IN
the  ||| S:18371 E:18375 ||| DT
purpose  ||| S:18375 E:18383 ||| NN
of  ||| S:18383 E:18386 ||| IN
this  ||| S:18386 E:18391 ||| DT
invention  ||| S:18391 E:18401 ||| NN
not  ||| S:18401 E:18405 ||| RB
being  ||| S:18405 E:18411 ||| VBG
defined  ||| S:18411 E:18419 ||| VBN
as  ||| S:18419 E:18422 ||| IN
the  ||| S:18422 E:18426 ||| DT
gelling  ||| S:18426 E:18434 ||| JJ
property  ||| S:18434 E:18443 ||| NN
but  ||| S:18443 E:18447 ||| CC
as  ||| S:18447 E:18450 ||| IN
the  ||| S:18450 E:18454 ||| DT
absence  ||| S:18454 E:18462 ||| NN
of  ||| S:18462 E:18465 ||| IN
non-preferred  ||| S:18465 E:18479 ||| FW
3-dimensional  ||| S:18479 E:18493 ||| FW
globular  ||| S:18493 E:18502 ||| FW
domains ||| S:18502 E:18509 ||| FW
,  ||| S:18509 E:18511 ||| ,
is  ||| S:18511 E:18514 ||| VBZ
assured ||| S:18514 E:18521 ||| VBN
.  ||| S:18521 E:18523 ||| .
Preferably  ||| S:18523 E:18534 ||| RB
in  ||| S:18534 E:18537 ||| IN
the  ||| S:18537 E:18541 ||| DT
gelatine-like  ||| S:18541 E:18555 ||| JJ
protein  ||| S:18555 E:18563 ||| NN
at  ||| S:18563 E:18566 ||| IN
least  ||| S:18566 E:18572 ||| JJS
10 ||| S:18572 E:18574 ||| CD
% ||| S:18574 E:18575 ||| NN
,  ||| S:18575 E:18577 ||| ,
more  ||| S:18577 E:18582 ||| JJR
preferably  ||| S:18582 E:18593 ||| NN
at  ||| S:18593 E:18596 ||| IN
least  ||| S:18596 E:18602 ||| JJS
15 ||| S:18602 E:18604 ||| CD
%  ||| S:18604 E:18606 ||| NN
of  ||| S:18606 E:18609 ||| IN
the  ||| S:18609 E:18613 ||| DT
total  ||| S:18613 E:18619 ||| JJ
number  ||| S:18619 E:18626 ||| NN
of  ||| S:18626 E:18629 ||| IN
amino  ||| S:18629 E:18635 ||| JJ
acids  ||| S:18635 E:18641 ||| NN
is  ||| S:18641 E:18644 ||| VBZ
a  ||| S:18644 E:18646 ||| DT
proline  ||| S:18646 E:18654 ||| JJ
residue ||| S:18654 E:18661 ||| NN
.  ||| S:18661 E:18663 ||| .
The  ||| S:18663 E:18667 ||| DT
lower  ||| S:18667 E:18673 ||| RBR
the  ||| S:18673 E:18677 ||| DT
proline  ||| S:18677 E:18685 ||| JJ
content  ||| S:18685 E:18693 ||| NN
of  ||| S:18693 E:18696 ||| IN
a  ||| S:18696 E:18698 ||| DT
protein  ||| S:18698 E:18706 ||| NN
the  ||| S:18706 E:18710 ||| DT
more  ||| S:18710 E:18715 ||| RBR
the  ||| S:18715 E:18719 ||| DT
distribution  ||| S:18719 E:18732 ||| NN
of  ||| S:18732 E:18735 ||| IN
the  ||| S:18735 E:18739 ||| DT
proline  ||| S:18739 E:18747 ||| JJ
residues  ||| S:18747 E:18756 ||| NNS
in  ||| S:18756 E:18759 ||| IN
the  ||| S:18759 E:18763 ||| DT
protein  ||| S:18763 E:18771 ||| NN
becomes  ||| S:18771 E:18779 ||| VBZ
relevant ||| S:18779 E:18787 ||| JJ
.  ||| S:18787 E:18789 ||| .
Thus  ||| S:18789 E:18794 ||| RB
in  ||| S:18794 E:18797 ||| IN
a  ||| S:18797 E:18799 ||| DT
protein  ||| S:18799 E:18807 ||| NN
in  ||| S:18807 E:18810 ||| IN
which  ||| S:18810 E:18816 ||| WDT
5 ||| S:18816 E:18817 ||| CD
%  ||| S:18817 E:18819 ||| NN
of  ||| S:18819 E:18822 ||| IN
the  ||| S:18822 E:18826 ||| DT
total  ||| S:18826 E:18832 ||| JJ
number  ||| S:18832 E:18839 ||| NN
of  ||| S:18839 E:18842 ||| IN
amino  ||| S:18842 E:18848 ||| JJ
acids  ||| S:18848 E:18854 ||| NN
is  ||| S:18854 E:18857 ||| VBZ
a  ||| S:18857 E:18859 ||| DT
proline  ||| S:18859 E:18867 ||| JJ
residue ||| S:18867 E:18874 ||| NN
,  ||| S:18874 E:18876 ||| ,
these  ||| S:18876 E:18882 ||| DT
residues  ||| S:18882 E:18891 ||| NNS
are  ||| S:18891 E:18895 ||| VBP
preferably  ||| S:18895 E:18906 ||| RB
evenly  ||| S:18906 E:18913 ||| RB
distributed ||| S:18913 E:18924 ||| VBN
.  ||| S:18924 E:18926 ||| .
In  ||| S:18926 E:18929 ||| IN
designing  ||| S:18929 E:18939 ||| VBG
a  ||| S:18939 E:18941 ||| DT
suitable  ||| S:18941 E:18950 ||| JJ
protein  ||| S:18950 E:18958 ||| NN
the  ||| S:18958 E:18962 ||| DT
skilled  ||| S:18962 E:18970 ||| JJ
person ||| S:18970 E:18976 ||| NN
,  ||| S:18976 E:18978 ||| ,
for  ||| S:18978 E:18982 ||| IN
instance  ||| S:18982 E:18991 ||| NN
with  ||| S:18991 E:18996 ||| IN
the  ||| S:18996 E:19000 ||| DT
aid  ||| S:19000 E:19004 ||| NN
of  ||| S:19004 E:19007 ||| IN
computer  ||| S:19007 E:19016 ||| NN
modelling  ||| S:19016 E:19026 ||| NN
systems ||| S:19026 E:19033 ||| NNS
,  ||| S:19033 E:19035 ||| ,
will  ||| S:19035 E:19040 ||| MD
be  ||| S:19040 E:19043 ||| VB
able  ||| S:19043 E:19048 ||| JJ
to  ||| S:19048 E:19051 ||| TO
design  ||| S:19051 E:19058 ||| VB
sequences  ||| S:19058 E:19068 ||| VBN
comprising  ||| S:19068 E:19079 ||| VBG
proline  ||| S:19079 E:19087 ||| JJ
residues  ||| S:19087 E:19096 ||| NNS
which  ||| S:19096 E:19102 ||| WDT
will  ||| S:19102 E:19107 ||| MD
not  ||| S:19107 E:19111 ||| RB
give  ||| S:19111 E:19116 ||| VB
rise  ||| S:19116 E:19121 ||| NN
to  ||| S:19121 E:19124 ||| TO
globular  ||| S:19124 E:19133 ||| VB
domains ||| S:19133 E:19140 ||| NNS
.  ||| S:19140 E:19142 ||| .
In  ||| S:19142 E:19145 ||| IN
order  ||| S:19145 E:19151 ||| NN
to  ||| S:19151 E:19154 ||| TO
prevent  ||| S:19154 E:19162 ||| VB
the  ||| S:19162 E:19166 ||| DT
formation  ||| S:19166 E:19176 ||| NN
of  ||| S:19176 E:19179 ||| IN
globular  ||| S:19179 E:19188 ||| JJ
domains  ||| S:19188 E:19196 ||| NN
as  ||| S:19196 E:19199 ||| IN
a  ||| S:19199 E:19201 ||| DT
guideline  ||| S:19201 E:19211 ||| NN
the  ||| S:19211 E:19215 ||| DT
gelatine-like  ||| S:19215 E:19229 ||| JJ
protein  ||| S:19229 E:19237 ||| NN
for  ||| S:19237 E:19241 ||| IN
use  ||| S:19241 E:19245 ||| NN
in  ||| S:19245 E:19248 ||| IN
the  ||| S:19248 E:19252 ||| DT
invention  ||| S:19252 E:19262 ||| NN
preferably  ||| S:19262 E:19273 ||| NNS
should  ||| S:19273 E:19280 ||| MD
not  ||| S:19280 E:19284 ||| RB
comprise  ||| S:19284 E:19293 ||| VBP
stretches  ||| S:19293 E:19303 ||| VBN
of  ||| S:19303 E:19306 ||| IN
more  ||| S:19306 E:19311 ||| JJR
than  ||| S:19311 E:19316 ||| IN
20  ||| S:19316 E:19319 ||| CD
amino  ||| S:19319 E:19325 ||| CD
acids  ||| S:19325 E:19331 ||| NNS
without  ||| S:19331 E:19339 ||| IN
a  ||| S:19339 E:19341 ||| DT
proline  ||| S:19341 E:19349 ||| JJ
residue ||| S:19349 E:19356 ||| NN
.  ||| S:19356 E:19360 ||| .
A  ||| S:19360 E:19362 ||| DT
predominant  ||| S:19362 E:19374 ||| JJ
feature  ||| S:19374 E:19382 ||| NN
of  ||| S:19382 E:19385 ||| IN
gelatines  ||| S:19385 E:19395 ||| NN
is  ||| S:19395 E:19398 ||| VBZ
the  ||| S:19398 E:19402 ||| DT
presence  ||| S:19402 E:19411 ||| NN
of  ||| S:19411 E:19414 ||| IN
Gly-Xaa-Yaa  ||| S:19414 E:19426 ||| JJ
triplets ||| S:19426 E:19434 ||| NN
.  ||| S:19434 E:19436 ||| .
Such  ||| S:19436 E:19441 ||| JJ
triplets  ||| S:19441 E:19450 ||| NNS
are  ||| S:19450 E:19454 ||| VBP
preferably  ||| S:19454 E:19465 ||| RB
also  ||| S:19465 E:19470 ||| RB
present  ||| S:19470 E:19478 ||| VB
in  ||| S:19478 E:19481 ||| IN
the  ||| S:19481 E:19485 ||| DT
gelatine-like  ||| S:19485 E:19499 ||| JJ
proteins  ||| S:19499 E:19508 ||| NNS
used  ||| S:19508 E:19513 ||| VBN
in  ||| S:19513 E:19516 ||| IN
the  ||| S:19516 E:19520 ||| DT
invention ||| S:19520 E:19529 ||| NN
.  ||| S:19529 E:19531 ||| .
It  ||| S:19531 E:19534 ||| PRP
is  ||| S:19534 E:19537 ||| VBZ
however  ||| S:19537 E:19545 ||| RB
possible  ||| S:19545 E:19554 ||| JJ
to  ||| S:19554 E:19557 ||| TO
design  ||| S:19557 E:19564 ||| VB
a  ||| S:19564 E:19566 ||| DT
protein  ||| S:19566 E:19574 ||| NN
in  ||| S:19574 E:19577 ||| IN
which  ||| S:19577 E:19583 ||| WDT
Gly-Xaa-Yaa  ||| S:19583 E:19595 ||| JJ
triplets  ||| S:19595 E:19604 ||| NN
or  ||| S:19604 E:19607 ||| CC
stretches  ||| S:19607 E:19617 ||| NNS
of  ||| S:19617 E:19620 ||| IN
Gly-Xaa-Yaa  ||| S:19620 E:19632 ||| JJ
triplets  ||| S:19632 E:19641 ||| NNS
are  ||| S:19641 E:19645 ||| VBP
separated  ||| S:19645 E:19655 ||| VBN
by  ||| S:19655 E:19658 ||| IN
one  ||| S:19658 E:19662 ||| CD
or  ||| S:19662 E:19665 ||| CC
more  ||| S:19665 E:19670 ||| RBR
amino  ||| S:19670 E:19676 ||| JJ
acids ||| S:19676 E:19681 ||| NNS
.  ||| S:19681 E:19683 ||| .
In  ||| S:19683 E:19686 ||| IN
such  ||| S:19686 E:19691 ||| PDT
a  ||| S:19691 E:19693 ||| DT
gelatine-like  ||| S:19693 E:19707 ||| JJ
protein  ||| S:19707 E:19715 ||| NN
having  ||| S:19715 E:19730 ||| VBG
interrupted  ||| S:19730 E:19750 ||| JJ
triplets  ||| S:19750 E:19759 ||| NN
or  ||| S:19759 E:19762 ||| CC
stretches  ||| S:19762 E:19772 ||| NNS
of  ||| S:19772 E:19775 ||| IN
triplets  ||| S:19775 E:19784 ||| VBG
the  ||| S:19784 E:19788 ||| DT
definition  ||| S:19788 E:19799 ||| NN
of  ||| S:19799 E:19802 ||| IN
gelatine-like  ||| S:19802 E:19816 ||| JJ
characteristics  ||| S:19816 E:19832 ||| NNS
given  ||| S:19832 E:19838 ||| VBN
above  ||| S:19838 E:19844 ||| RB
is  ||| S:19844 E:19847 ||| VBZ
useful ||| S:19847 E:19853 ||| JJ
.  ||| S:19853 E:19855 ||| .
In  ||| S:19855 E:19858 ||| IN
relation  ||| S:19858 E:19867 ||| NN
to  ||| S:19867 E:19870 ||| TO
a  ||| S:19870 E:19872 ||| DT
protein  ||| S:19872 E:19880 ||| NN
consisting  ||| S:19880 E:19891 ||| VBG
completely  ||| S:19891 E:19902 ||| RB
of  ||| S:19902 E:19905 ||| IN
Gly-Xaa-Yaa  ||| S:19905 E:19917 ||| JJ
triplets  ||| S:19917 E:19926 ||| NNS
the  ||| S:19926 E:19930 ||| DT
definition  ||| S:19930 E:19941 ||| NN
given  ||| S:19941 E:19947 ||| VBN
above  ||| S:19947 E:19953 ||| IN
of  ||| S:19953 E:19956 ||| IN
a  ||| S:19956 E:19958 ||| DT
gelatine-like  ||| S:19958 E:19972 ||| JJ
protein  ||| S:19972 E:19980 ||| NN
for  ||| S:19980 E:19984 ||| IN
use  ||| S:19984 E:19988 ||| NN
in  ||| S:19988 E:19991 ||| IN
the  ||| S:19991 E:19995 ||| DT
invention  ||| S:19995 E:20005 ||| NN
can  ||| S:20005 E:20009 ||| MD
be  ||| S:20009 E:20012 ||| VB
described  ||| S:20012 E:20022 ||| VBN
as  ||| S:20022 E:20025 ||| IN
a  ||| S:20025 E:20027 ||| DT
protein  ||| S:20027 E:20035 ||| NN
in  ||| S:20035 E:20038 ||| IN
which  ||| S:20038 E:20044 ||| WDT
at  ||| S:20044 E:20047 ||| IN
least  ||| S:20047 E:20053 ||| JJS
15 ||| S:20053 E:20055 ||| CD
%  ||| S:20055 E:20057 ||| NN
of  ||| S:20057 E:20060 ||| IN
the  ||| S:20060 E:20064 ||| DT
triplets  ||| S:20064 E:20073 ||| NNS
comprise  ||| S:20073 E:20082 ||| VBP
a  ||| S:20082 E:20084 ||| DT
proline  ||| S:20084 E:20092 ||| JJ
residue ||| S:20092 E:20099 ||| NN
.  ||| S:20099 E:20101 ||| .
Preferably  ||| S:20101 E:20112 ||| RB
such  ||| S:20112 E:20117 ||| PDT
a  ||| S:20117 E:20119 ||| DT
gelatine-like  ||| S:20119 E:20133 ||| JJ
protein  ||| S:20133 E:20141 ||| NN
does  ||| S:20141 E:20146 ||| VBZ
not  ||| S:20146 E:20150 ||| RB
comprise  ||| S:20150 E:20159 ||| VB
a  ||| S:20159 E:20161 ||| DT
stretch  ||| S:20161 E:20169 ||| NN
of  ||| S:20169 E:20172 ||| IN
more  ||| S:20172 E:20177 ||| JJR
than  ||| S:20177 E:20182 ||| IN
6  ||| S:20182 E:20184 ||| CD
triplets  ||| S:20184 E:20193 ||| NN
without  ||| S:20193 E:20201 ||| IN
a  ||| S:20201 E:20203 ||| DT
proline  ||| S:20203 E:20211 ||| JJ
residue ||| S:20211 E:20218 ||| NN
.  ||| S:20218 E:20220 ||| .
It  ||| S:20220 E:20223 ||| PRP
is  ||| S:20223 E:20226 ||| VBZ
preferred  ||| S:20226 E:20236 ||| VBN
a  ||| S:20236 E:20238 ||| DT
gelatine-like  ||| S:20238 E:20252 ||| JJ
protein  ||| S:20252 E:20260 ||| NN
for  ||| S:20260 E:20264 ||| IN
use  ||| S:20264 E:20268 ||| NN
in  ||| S:20268 E:20271 ||| IN
the  ||| S:20271 E:20275 ||| DT
invention  ||| S:20275 E:20285 ||| NN
comprises  ||| S:20285 E:20295 ||| VBZ
stretches  ||| S:20295 E:20305 ||| VBN
of  ||| S:20305 E:20308 ||| IN
at  ||| S:20308 E:20311 ||| IN
least  ||| S:20311 E:20317 ||| JJS
10 ||| S:20317 E:20319 ||| CD
,  ||| S:20319 E:20321 ||| ,
preferably  ||| S:20321 E:20332 ||| RB
at  ||| S:20332 E:20335 ||| IN
least  ||| S:20335 E:20341 ||| JJS
20 ||| S:20341 E:20343 ||| CD
,  ||| S:20343 E:20345 ||| ,
more  ||| S:20345 E:20350 ||| RBR
preferably  ||| S:20350 E:20361 ||| RB
more  ||| S:20361 E:20366 ||| JJR
than  ||| S:20366 E:20371 ||| IN
30  ||| S:20371 E:20374 ||| CD
consecutive  ||| S:20374 E:20386 ||| JJ
repeats  ||| S:20386 E:20394 ||| NNS
of  ||| S:20394 E:20397 ||| IN
Gly-Xaa-Yaa  ||| S:20397 E:20409 ||| JJ
triplets ||| S:20409 E:20417 ||| NN
.  ||| S:20417 E:20421 ||| .
The  ||| S:20421 E:20425 ||| DT
gelatine-like  ||| S:20425 E:20439 ||| JJ
proteins  ||| S:20439 E:20448 ||| NNS
for  ||| S:20448 E:20452 ||| IN
use  ||| S:20452 E:20456 ||| NN
according  ||| S:20456 E:20466 ||| VBG
to  ||| S:20466 E:20469 ||| TO
the  ||| S:20469 E:20473 ||| DT
invention  ||| S:20473 E:20483 ||| NN
can  ||| S:20483 E:20487 ||| MD
be  ||| S:20487 E:20490 ||| VB
produced  ||| S:20490 E:20499 ||| VBN
by  ||| S:20499 E:20502 ||| IN
recombinant  ||| S:20502 E:20514 ||| JJ
methods  ||| S:20514 E:20522 ||| NNS
as  ||| S:20522 E:20525 ||| RB
disclosed  ||| S:20525 E:20535 ||| VBN
in  ||| S:20535 E:20538 ||| IN
EP-A-0926543  ||| S:20538 E:20551 ||| NNP
and  ||| S:20551 E:20555 ||| CC
EP-A-1014176 ||| S:20555 E:20567 ||| NNP
.  ||| S:20567 E:20569 ||| .
For  ||| S:20569 E:20573 ||| IN
enablement  ||| S:20573 E:20584 ||| NN
of  ||| S:20584 E:20587 ||| IN
the  ||| S:20587 E:20591 ||| DT
production  ||| S:20591 E:20602 ||| NN
and  ||| S:20602 E:20606 ||| CC
purification  ||| S:20606 E:20619 ||| NN
of  ||| S:20619 E:20622 ||| IN
gelatine-like  ||| S:20622 E:20636 ||| JJ
proteins  ||| S:20636 E:20645 ||| NNS
that  ||| S:20645 E:20650 ||| WDT
can  ||| S:20650 E:20654 ||| MD
be  ||| S:20654 E:20657 ||| VB
suitably  ||| S:20657 E:20666 ||| VBN
used  ||| S:20666 E:20671 ||| VBN
in  ||| S:20671 E:20674 ||| IN
composition  ||| S:20674 E:20686 ||| NNS
according  ||| S:20686 E:20696 ||| VBG
to  ||| S:20696 E:20699 ||| TO
the  ||| S:20699 E:20703 ||| DT
invention  ||| S:20703 E:20713 ||| JJ
specific  ||| S:20713 E:20722 ||| JJ
reference  ||| S:20722 E:20732 ||| NN
is  ||| S:20732 E:20735 ||| VBZ
made  ||| S:20735 E:20740 ||| VBN
to  ||| S:20740 E:20743 ||| TO
the  ||| S:20743 E:20747 ||| DT
examples  ||| S:20747 E:20756 ||| NNS
in  ||| S:20756 E:20759 ||| IN
EP-A-0926543  ||| S:20759 E:20772 ||| NNP
and  ||| S:20772 E:20776 ||| CC
EP-A-1014176 ||| S:20776 E:20788 ||| NNP
.  ||| S:20788 E:20790 ||| .
Thus  ||| S:20790 E:20795 ||| RB
the  ||| S:20795 E:20799 ||| DT
gelatine-like  ||| S:20799 E:20813 ||| JJ
proteins  ||| S:20813 E:20822 ||| NNS
can  ||| S:20822 E:20826 ||| MD
be  ||| S:20826 E:20829 ||| VB
produced  ||| S:20829 E:20838 ||| VBN
by  ||| S:20838 E:20841 ||| IN
expression  ||| S:20841 E:20852 ||| NN
of  ||| S:20852 E:20855 ||| IN
nucleic  ||| S:20855 E:20863 ||| FW
acid  ||| S:20863 E:20868 ||| FW
sequence  ||| S:20868 E:20877 ||| FW
encoding  ||| S:20877 E:20886 ||| FW
such  ||| S:20886 E:20891 ||| JJ
polypeptide  ||| S:20891 E:20903 ||| NN
by  ||| S:20903 E:20906 ||| IN
a  ||| S:20906 E:20908 ||| DT
suitable  ||| S:20908 E:20917 ||| JJ
micro-organism ||| S:20917 E:20931 ||| NN
.  ||| S:20931 E:20933 ||| .
The  ||| S:20933 E:20937 ||| DT
process  ||| S:20937 E:20945 ||| NN
can  ||| S:20945 E:20949 ||| MD
suitably  ||| S:20949 E:20958 ||| RB
be  ||| S:20958 E:20961 ||| VB
carried  ||| S:20961 E:20969 ||| VBN
out  ||| S:20969 E:20973 ||| RP
with  ||| S:20973 E:20978 ||| IN
a  ||| S:20978 E:20980 ||| DT
fungal  ||| S:20980 E:20987 ||| JJ
cell  ||| S:20987 E:20992 ||| NN
or  ||| S:20992 E:20995 ||| CC
a  ||| S:20995 E:20997 ||| DT
yeast  ||| S:20997 E:21003 ||| NN
cell ||| S:21003 E:21007 ||| NN
.  ||| S:21007 E:21009 ||| .
Suitably  ||| S:21009 E:21018 ||| VBG
the  ||| S:21018 E:21022 ||| DT
host  ||| S:21022 E:21027 ||| NN
cell  ||| S:21027 E:21032 ||| NN
is  ||| S:21032 E:21035 ||| VBZ
a  ||| S:21035 E:21037 ||| DT
high  ||| S:21037 E:21042 ||| JJ
expression  ||| S:21042 E:21053 ||| NN
host  ||| S:21053 E:21058 ||| NN
cells  ||| S:21058 E:21064 ||| NNS
like  ||| S:21064 E:21069 ||| IN
Hansenula ||| S:21069 E:21078 ||| NNP
,  ||| S:21078 E:21080 ||| ,
Trichoderma ||| S:21080 E:21091 ||| NNP
,  ||| S:21091 E:21093 ||| ,
Aspergillus ||| S:21093 E:21104 ||| NNP
,  ||| S:21104 E:21106 ||| ,
Penicillium ||| S:21106 E:21117 ||| NNP
,  ||| S:21117 E:21119 ||| ,
Neurospora  ||| S:21119 E:21130 ||| NNP
or  ||| S:21130 E:21133 ||| CC
Pichia ||| S:21133 E:21139 ||| NN
.  ||| S:21139 E:21141 ||| .
Fungal  ||| S:21141 E:21148 ||| NNP
and  ||| S:21148 E:21152 ||| CC
yeast  ||| S:21152 E:21158 ||| NN
cells  ||| S:21158 E:21164 ||| NNS
are  ||| S:21164 E:21168 ||| VBP
preferred  ||| S:21168 E:21178 ||| VBN
to  ||| S:21178 E:21181 ||| TO
bacteria  ||| S:21181 E:21190 ||| NNS
as  ||| S:21190 E:21193 ||| IN
they  ||| S:21193 E:21198 ||| PRP
are  ||| S:21198 E:21202 ||| VBP
less  ||| S:21202 E:21207 ||| RBR
susceptible  ||| S:21207 E:21219 ||| JJ
to  ||| S:21219 E:21222 ||| TO
improper  ||| S:21222 E:21231 ||| JJ
expression  ||| S:21231 E:21242 ||| NN
of  ||| S:21242 E:21245 ||| IN
repetitive  ||| S:21245 E:21256 ||| JJ
sequences ||| S:21256 E:21265 ||| NN
.  ||| S:21265 E:21267 ||| .
Most  ||| S:21267 E:21272 ||| RBS
preferably  ||| S:21272 E:21283 ||| RB
the  ||| S:21283 E:21287 ||| DT
host  ||| S:21287 E:21292 ||| NN
will  ||| S:21292 E:21297 ||| MD
not  ||| S:21297 E:21301 ||| RB
have  ||| S:21301 E:21306 ||| VB
a  ||| S:21306 E:21308 ||| DT
high  ||| S:21308 E:21313 ||| JJ
level  ||| S:21313 E:21319 ||| NN
of  ||| S:21319 E:21322 ||| IN
proteases  ||| S:21322 E:21332 ||| NNS
that  ||| S:21332 E:21337 ||| WDT
attack  ||| S:21337 E:21344 ||| VBP
the  ||| S:21344 E:21348 ||| DT
collagen  ||| S:21348 E:21357 ||| JJ
structure  ||| S:21357 E:21367 ||| NN
expressed ||| S:21367 E:21376 ||| VBD
.  ||| S:21376 E:21378 ||| .
In  ||| S:21378 E:21381 ||| IN
this  ||| S:21381 E:21386 ||| DT
respect  ||| S:21386 E:21394 ||| NN
Pichia  ||| S:21394 E:21401 ||| NN
offers  ||| S:21401 E:21408 ||| VBZ
an  ||| S:21408 E:21411 ||| DT
example  ||| S:21411 E:21419 ||| NN
of  ||| S:21419 E:21422 ||| IN
a  ||| S:21422 E:21424 ||| DT
very  ||| S:21424 E:21429 ||| RB
suitable  ||| S:21429 E:21438 ||| JJ
expression  ||| S:21438 E:21449 ||| NN
system ||| S:21449 E:21455 ||| NN
.  ||| S:21455 E:21457 ||| .
As  ||| S:21457 E:21460 ||| RB
disclosed  ||| S:21460 E:21470 ||| VBN
in  ||| S:21470 E:21473 ||| IN
EP-A-0926543  ||| S:21473 E:21486 ||| NNP
and  ||| S:21486 E:21490 ||| CC
EP-A-1014176  ||| S:21490 E:21503 ||| NNP
specifically  ||| S:21503 E:21516 ||| RB
Pichia  ||| S:21516 E:21523 ||| JJ
pastoris  ||| S:21523 E:21532 ||| NN
is  ||| S:21532 E:21535 ||| VBZ
used  ||| S:21535 E:21540 ||| VBN
as  ||| S:21540 E:21543 ||| IN
expression  ||| S:21543 E:21554 ||| NN
system ||| S:21554 E:21560 ||| NN
.  ||| S:21560 E:21562 ||| .
In  ||| S:21562 E:21565 ||| IN
one  ||| S:21565 E:21569 ||| CD
embodiment  ||| S:21569 E:21580 ||| CD
the  ||| S:21580 E:21584 ||| DT
micro-organism  ||| S:21584 E:21599 ||| NN
is  ||| S:21599 E:21602 ||| VBZ
also  ||| S:21602 E:21607 ||| RB
transformed  ||| S:21607 E:21619 ||| VBN
to  ||| S:21619 E:21622 ||| TO
include  ||| S:21622 E:21630 ||| VB
a  ||| S:21630 E:21632 ||| DT
gene  ||| S:21632 E:21637 ||| NN
for  ||| S:21637 E:21641 ||| IN
expression  ||| S:21641 E:21652 ||| NN
of  ||| S:21652 E:21655 ||| IN
prolyl-4-hydroxylase1 ||| S:21655 E:21676 ||| CD
.  ||| S:21676 E:21678 ||| .
In  ||| S:21678 E:21681 ||| IN
embodiment  ||| S:21681 E:21692 ||| VBG
the  ||| S:21692 E:21696 ||| DT
micro-organism  ||| S:21696 E:21711 ||| NN
is  ||| S:21711 E:21714 ||| VBZ
free  ||| S:21714 E:21719 ||| JJ
of  ||| S:21719 E:21722 ||| IN
active  ||| S:21722 E:21729 ||| JJ
post-translational  ||| S:21729 E:21748 ||| JJ
processing  ||| S:21748 E:21759 ||| NN
mechanism  ||| S:21759 E:21769 ||| NN
such  ||| S:21769 E:21774 ||| JJ
as  ||| S:21774 E:21777 ||| IN
in  ||| S:21777 E:21780 ||| IN
particular  ||| S:21780 E:21791 ||| JJ
hydroxylation  ||| S:21791 E:21805 ||| NN
of  ||| S:21805 E:21808 ||| IN
proline ||| S:21808 E:21815 ||| NN
.  ||| S:21815 E:21819 ||| .
A  ||| S:22148 E:22150 ||| DT
wide  ||| S:22150 E:22155 ||| JJ
range  ||| S:22155 E:22161 ||| NN
of  ||| S:22161 E:22164 ||| IN
cells  ||| S:22164 E:22170 ||| NNS
may  ||| S:22170 E:22174 ||| MD
be  ||| S:22174 E:22177 ||| VB
cultured  ||| S:22177 E:22186 ||| VBN
on  ||| S:22186 E:22189 ||| IN
microcarriers ||| S:22189 E:22202 ||| NN
.  ||| S:22202 E:22204 ||| .
For  ||| S:22204 E:22208 ||| IN
instance ||| S:22208 E:22216 ||| NN
,  ||| S:22216 E:22218 ||| ,
cells  ||| S:22218 E:22224 ||| NNS
from  ||| S:22224 E:22229 ||| IN
invertebrates ||| S:22229 E:22242 ||| NN
,  ||| S:22242 E:22244 ||| ,
from  ||| S:22244 E:22249 ||| IN
fish ||| S:22249 E:22253 ||| NN
,  ||| S:22253 E:22255 ||| ,
birds  ||| S:22255 E:22261 ||| NNS
and  ||| S:22261 E:22265 ||| CC
cells  ||| S:22265 E:22271 ||| NNS
of  ||| S:22271 E:22274 ||| IN
mammalian  ||| S:22274 E:22284 ||| JJ
origin  ||| S:22284 E:22291 ||| NN
may  ||| S:22291 E:22295 ||| MD
be  ||| S:22295 E:22298 ||| VB
cultivated  ||| S:22298 E:22309 ||| VBN
on  ||| S:22309 E:22312 ||| IN
microcarriers ||| S:22312 E:22325 ||| NN
.  ||| S:22325 E:22327 ||| .
Transformed  ||| S:22327 E:22339 ||| NNP
and  ||| S:22339 E:22343 ||| CC
normal  ||| S:22343 E:22350 ||| JJ
cell  ||| S:22350 E:22355 ||| NN
lines ||| S:22355 E:22360 ||| NNS
,  ||| S:22360 E:22362 ||| ,
fibroblastic  ||| S:22362 E:22375 ||| NN
and  ||| S:22375 E:22379 ||| CC
epithelial  ||| S:22379 E:22390 ||| JJ
cells  ||| S:22390 E:22396 ||| NNS
and  ||| S:22396 E:22400 ||| CC
even  ||| S:22400 E:22405 ||| RB
genetically  ||| S:22405 E:22417 ||| RB
engineered  ||| S:22417 E:22428 ||| VBN
cells  ||| S:22428 E:22434 ||| NNS
may  ||| S:22434 E:22438 ||| MD
be  ||| S:22438 E:22441 ||| VB
cultivated  ||| S:22441 E:22452 ||| VBN
on  ||| S:22452 E:22455 ||| IN
microcarriers  ||| S:22455 E:22469 ||| NN
for  ||| S:22469 E:22473 ||| IN
various  ||| S:22473 E:22481 ||| JJ
biologicals  ||| S:22481 E:22493 ||| JJ
such  ||| S:22493 E:22498 ||| JJ
as  ||| S:22498 E:22501 ||| IN
for  ||| S:22501 E:22505 ||| IN
the  ||| S:22505 E:22509 ||| DT
production  ||| S:22509 E:22520 ||| NN
of  ||| S:22520 E:22523 ||| IN
immunologicals  ||| S:22523 E:22538 ||| NN
like  ||| S:22538 E:22543 ||| IN
interferons ||| S:22543 E:22554 ||| NN
,  ||| S:22554 E:22556 ||| ,
interleukins ||| S:22556 E:22568 ||| NN
,  ||| S:22568 E:22570 ||| ,
growth  ||| S:22570 E:22577 ||| NN
factors  ||| S:22577 E:22585 ||| FW
etc ||| S:22585 E:22588 ||| FW
.  ||| S:22588 E:22590 ||| .
Cells  ||| S:22590 E:22596 ||| NNS
cultured  ||| S:22596 E:22605 ||| VBN
on  ||| S:22605 E:22608 ||| IN
microcarriers  ||| S:22608 E:22622 ||| VBG
also  ||| S:22622 E:22627 ||| RB
serve  ||| S:22627 E:22633 ||| VB
as  ||| S:22633 E:22636 ||| IN
hosts  ||| S:22636 E:22642 ||| NNS
for  ||| S:22642 E:22646 ||| IN
a  ||| S:22646 E:22648 ||| DT
variety  ||| S:22648 E:22656 ||| NN
of  ||| S:22656 E:22659 ||| IN
viruses  ||| S:22659 E:22667 ||| NNS
that  ||| S:22667 E:22672 ||| WDT
are  ||| S:22672 E:22676 ||| VBP
used  ||| S:22676 E:22681 ||| VBN
as  ||| S:22681 E:22684 ||| IN
vaccines  ||| S:22684 E:22693 ||| NNS
like  ||| S:22693 E:22698 ||| IN
foot  ||| S:22698 E:22703 ||| NN
and  ||| S:22703 E:22707 ||| CC
mouth  ||| S:22707 E:22713 ||| NN
disease  ||| S:22713 E:22721 ||| NN
or  ||| S:22721 E:22724 ||| CC
rabies ||| S:22724 E:22730 ||| NN
.  ||| S:22730 E:22734 ||| .
Microcarrier  ||| S:22734 E:22747 ||| JJ
cultures  ||| S:22747 E:22756 ||| NNS
have  ||| S:22756 E:22761 ||| VBP
a  ||| S:22761 E:22763 ||| DT
wide  ||| S:22763 E:22768 ||| JJ
number  ||| S:22768 E:22775 ||| NN
of  ||| S:22775 E:22778 ||| IN
applications  ||| S:22778 E:22791 ||| NNS
other  ||| S:22791 E:22797 ||| JJ
than  ||| S:22797 E:22802 ||| IN
mass  ||| S:22802 E:22807 ||| JJ
cultivation  ||| S:22807 E:22819 ||| NN
as  ||| S:22819 E:22822 ||| IN
well ||| S:22822 E:22826 ||| RB
.  ||| S:22826 E:22828 ||| .
Cells  ||| S:22828 E:22834 ||| NNS
growing  ||| S:22834 E:22842 ||| VBG
on  ||| S:22842 E:22845 ||| IN
microcarriers  ||| S:22845 E:22859 ||| NNS
serve  ||| S:22859 E:22865 ||| VBP
as  ||| S:22865 E:22868 ||| IN
an  ||| S:22868 E:22871 ||| DT
excellent  ||| S:22871 E:22881 ||| JJ
tool  ||| S:22881 E:22886 ||| NN
for  ||| S:22886 E:22890 ||| IN
studying  ||| S:22890 E:22899 ||| VBG
different  ||| S:22899 E:22909 ||| JJ
aspects  ||| S:22909 E:22917 ||| NNS
of  ||| S:22917 E:22920 ||| IN
cell  ||| S:22920 E:22925 ||| NN
biology  ||| S:22925 E:22933 ||| NN
such  ||| S:22933 E:22938 ||| JJ
as  ||| S:22938 E:22941 ||| IN
cell-to-cell  ||| S:22941 E:22954 ||| JJ
or  ||| S:22954 E:22957 ||| CC
cell-to-substratum  ||| S:22957 E:22976 ||| JJ
interactions ||| S:22976 E:22988 ||| NNS
.  ||| S:22988 E:22990 ||| .
Cell  ||| S:22990 E:22995 ||| NN
differentiation  ||| S:22995 E:23011 ||| NNS
and  ||| S:23011 E:23015 ||| CC
maturation ||| S:23015 E:23025 ||| NN
,  ||| S:23025 E:23027 ||| ,
metabolic  ||| S:23027 E:23037 ||| JJ
studies  ||| S:23037 E:23045 ||| NNS
may  ||| S:23045 E:23049 ||| MD
also  ||| S:23049 E:23054 ||| RB
be  ||| S:23054 E:23057 ||| VB
carried  ||| S:23057 E:23065 ||| VBN
out  ||| S:23065 E:23069 ||| RP
using  ||| S:23069 E:23075 ||| VBG
microcarriers ||| S:23075 E:23088 ||| NNS
.  ||| S:23088 E:23090 ||| .
Such  ||| S:23090 E:23095 ||| JJ
cells  ||| S:23095 E:23101 ||| NNS
can  ||| S:23101 E:23105 ||| MD
also  ||| S:23105 E:23110 ||| RB
be  ||| S:23110 E:23113 ||| VB
used  ||| S:23113 E:23118 ||| VBN
for  ||| S:23118 E:23122 ||| IN
electron  ||| S:23122 E:23131 ||| JJ
microscopic  ||| S:23131 E:23143 ||| JJ
examinations  ||| S:23143 E:23156 ||| NNS
or  ||| S:23156 E:23159 ||| CC
for  ||| S:23159 E:23163 ||| IN
the  ||| S:23163 E:23167 ||| DT
isolation  ||| S:23167 E:23177 ||| NN
of  ||| S:23177 E:23180 ||| IN
cell  ||| S:23180 E:23185 ||| NN
organelles  ||| S:23185 E:23196 ||| VBZ
such  ||| S:23196 E:23201 ||| JJ
as  ||| S:23201 E:23204 ||| IN
the  ||| S:23204 E:23208 ||| DT
cell  ||| S:23208 E:23213 ||| NN
membrane ||| S:23213 E:23221 ||| NN
.  ||| S:23221 E:23223 ||| .
Also ||| S:23223 E:23227 ||| RB
,  ||| S:23227 E:23229 ||| ,
this  ||| S:23229 E:23234 ||| DT
system  ||| S:23234 E:23241 ||| NN
is  ||| S:23241 E:23244 ||| VBZ
essentially  ||| S:23244 E:23256 ||| RB
a  ||| S:23256 E:23258 ||| DT
three-dimensional  ||| S:23258 E:23276 ||| JJ
system  ||| S:23276 E:23283 ||| NN
and  ||| S:23283 E:23287 ||| CC
serves  ||| S:23287 E:23294 ||| VBZ
as  ||| S:23294 E:23297 ||| IN
a  ||| S:23297 E:23299 ||| DT
good  ||| S:23299 E:23304 ||| JJ
3-D  ||| S:23304 E:23308 ||| JJ
model ||| S:23308 E:23313 ||| NN
.  ||| S:23313 E:23315 ||| .
Similarly ||| S:23315 E:23324 ||| RB
,  ||| S:23324 E:23326 ||| ,
co-cultivation  ||| S:23326 E:23341 ||| JJ
of  ||| S:23341 E:23344 ||| IN
cells  ||| S:23344 E:23350 ||| NNS
can  ||| S:23350 E:23354 ||| MD
be  ||| S:23354 E:23357 ||| VB
done  ||| S:23357 E:23362 ||| VBN
using  ||| S:23362 E:23368 ||| VBG
this  ||| S:23368 E:23373 ||| DT
system ||| S:23373 E:23379 ||| NN
.  ||| S:23379 E:23381 ||| .
Thus  ||| S:23381 E:23386 ||| RB
applications  ||| S:23386 E:23399 ||| NNS
include  ||| S:23399 E:23407 ||| VBP
the  ||| S:23407 E:23411 ||| DT
production  ||| S:23411 E:23422 ||| NN
of  ||| S:23422 E:23425 ||| IN
large  ||| S:23425 E:23431 ||| JJ
quantities  ||| S:23431 E:23442 ||| NNS
of  ||| S:23442 E:23445 ||| IN
cells ||| S:23445 E:23450 ||| NNS
,  ||| S:23450 E:23452 ||| ,
viruses  ||| S:23452 E:23460 ||| NN
and  ||| S:23460 E:23464 ||| CC
cell  ||| S:23464 E:23469 ||| NN
products  ||| S:23469 E:23478 ||| NNS
( ||| S:23478 E:23479 ||| -LRB-
e.g.  ||| S:23479 E:23484 ||| NNP
interferon ||| S:23484 E:23494 ||| NN
,  ||| S:23494 E:23496 ||| ,
enzymes ||| S:23496 E:23503 ||| NN
,  ||| S:23503 E:23505 ||| ,
nucleic  ||| S:23505 E:23513 ||| JJ
acids ||| S:23513 E:23518 ||| NNS
,  ||| S:23518 E:23520 ||| ,
hormones ||| S:23520 E:23528 ||| CD
) ||| S:23528 E:23529 ||| -RRB-
,  ||| S:23529 E:23531 ||| ,
studies  ||| S:23531 E:23539 ||| NNS
on  ||| S:23539 E:23542 ||| IN
cell  ||| S:23542 E:23547 ||| NN
adhesion ||| S:23547 E:23555 ||| NN
,  ||| S:23555 E:23557 ||| ,
differentiation  ||| S:23557 E:23573 ||| NN
and  ||| S:23573 E:23577 ||| CC
cell  ||| S:23577 E:23582 ||| NN
function ||| S:23582 E:23590 ||| NN
,  ||| S:23590 E:23592 ||| ,
perfusion  ||| S:23592 E:23602 ||| JJ
column  ||| S:23602 E:23609 ||| NN
culture  ||| S:23609 E:23617 ||| NN
systems ||| S:23617 E:23624 ||| NNS
,  ||| S:23624 E:23626 ||| ,
microscopy  ||| S:23626 E:23637 ||| JJ
studies ||| S:23637 E:23644 ||| NNS
,  ||| S:23644 E:23646 ||| ,
harvesting  ||| S:23646 E:23657 ||| JJ
mitotic  ||| S:23657 E:23665 ||| JJ
cells ||| S:23665 E:23670 ||| NNS
,  ||| S:23670 E:23672 ||| ,
isolation  ||| S:23672 E:23682 ||| NN
of  ||| S:23682 E:23685 ||| IN
cells ||| S:23685 E:23690 ||| NNS
,  ||| S:23690 E:23692 ||| ,
membrane  ||| S:23692 E:23701 ||| JJ
studies ||| S:23701 E:23708 ||| NNS
,  ||| S:23708 E:23710 ||| ,
storage  ||| S:23710 E:23718 ||| NN
and  ||| S:23718 E:23722 ||| CC
transport  ||| S:23722 E:23732 ||| NN
of  ||| S:23732 E:23735 ||| IN
cells ||| S:23735 E:23740 ||| NNS
,  ||| S:23740 E:23742 ||| ,
assays  ||| S:23742 E:23749 ||| VBZ
involving  ||| S:23749 E:23759 ||| VBG
cell  ||| S:23759 E:23764 ||| NN
transfer  ||| S:23764 E:23773 ||| NN
and  ||| S:23773 E:23777 ||| CC
studies  ||| S:23777 E:23785 ||| NNS
on  ||| S:23785 E:23788 ||| IN
uptake  ||| S:23788 E:23795 ||| NN
of  ||| S:23795 E:23798 ||| IN
labelled  ||| S:23798 E:23807 ||| JJ
compounds ||| S:23807 E:23816 ||| NN
.  ||| S:23816 E:23820 ||| .
Microcarriers  ||| S:23820 E:23834 ||| NNP
may  ||| S:23834 E:23838 ||| MD
also  ||| S:23838 E:23843 ||| RB
be  ||| S:23843 E:23846 ||| VB
used  ||| S:23846 E:23851 ||| VBN
for  ||| S:23851 E:23855 ||| IN
the  ||| S:23855 E:23859 ||| DT
depletion  ||| S:23859 E:23869 ||| NN
of  ||| S:23869 E:23872 ||| IN
macrophages  ||| S:23872 E:23884 ||| NN
from  ||| S:23884 E:23889 ||| IN
a  ||| S:23889 E:23891 ||| DT
population  ||| S:23891 E:23902 ||| NN
of  ||| S:23902 E:23905 ||| IN
spleen  ||| S:23905 E:23912 ||| JJ
cells ||| S:23912 E:23917 ||| NNS
.  ||| S:23917 E:23919 ||| .
DEAE-dextran  ||| S:23919 E:23932 ||| JJ
microcarriers  ||| S:23932 E:23946 ||| NN
can  ||| S:23946 E:23950 ||| MD
potentiate  ||| S:23950 E:23961 ||| VB
stimulation  ||| S:23961 E:23973 ||| VBN
of  ||| S:23973 E:23976 ||| IN
lymphocytes  ||| S:23976 E:23988 ||| NN
by  ||| S:23988 E:23991 ||| IN
concanavalin  ||| S:23991 E:24004 ||| VBG
A  ||| S:24004 E:24006 ||| DT
( ||| S:24006 E:24007 ||| -LRB-
con  ||| S:24007 E:24011 ||| JJ
A ||| S:24011 E:24012 ||| NNP
) ||| S:24012 E:24013 ||| -RRB-
.  ||| S:24013 E:24015 ||| .
Microcarrier  ||| S:24015 E:24028 ||| JJ
beads  ||| S:24028 E:24034 ||| JJ
confluent  ||| S:24034 E:24044 ||| NN
with  ||| S:24044 E:24049 ||| IN
allogenic  ||| S:24049 E:24059 ||| JJ
tumour  ||| S:24059 E:24066 ||| JJ
cells  ||| S:24066 E:24072 ||| NNS
can  ||| S:24072 E:24076 ||| MD
be  ||| S:24076 E:24079 ||| VB
injected  ||| S:24079 E:24088 ||| VBN
in  ||| S:24088 E:24091 ||| IN
mice  ||| S:24091 E:24096 ||| NNS
to  ||| S:24096 E:24099 ||| TO
increase  ||| S:24099 E:24108 ||| VB
humoral  ||| S:24108 E:24116 ||| NNS
and  ||| S:24116 E:24120 ||| CC
cell-mediated  ||| S:24120 E:24134 ||| JJ
immunity ||| S:24134 E:24142 ||| NN
.  ||| S:24142 E:24144 ||| .
Plant  ||| S:24144 E:24150 ||| NN
protoplasts  ||| S:24150 E:24162 ||| NNS
can  ||| S:24162 E:24166 ||| MD
be  ||| S:24166 E:24169 ||| VB
immobilised  ||| S:24169 E:24181 ||| VBN
on  ||| S:24181 E:24184 ||| IN
DEAE-dextran  ||| S:24184 E:24197 ||| JJ
microcarriers ||| S:24197 E:24210 ||| NN
.  ||| S:24210 E:24214 ||| .
Due  ||| S:24214 E:24218 ||| JJ
to  ||| S:24218 E:24221 ||| TO
the  ||| S:24221 E:24225 ||| DT
large  ||| S:24225 E:24231 ||| JJ
surface  ||| S:24231 E:24239 ||| NN
area  ||| S:24239 E:24244 ||| NN
to  ||| S:24244 E:24247 ||| TO
volume  ||| S:24247 E:24254 ||| NN
ratio  ||| S:24254 E:24260 ||| NN
provided  ||| S:24260 E:24269 ||| VBN
by  ||| S:24269 E:24272 ||| IN
microcarriers ||| S:24272 E:24285 ||| NN
,  ||| S:24285 E:24287 ||| ,
they  ||| S:24287 E:24292 ||| PRP
can  ||| S:24292 E:24296 ||| MD
successfully  ||| S:24296 E:24309 ||| RB
be  ||| S:24309 E:24312 ||| VB
used  ||| S:24312 E:24317 ||| VBN
for  ||| S:24317 E:24321 ||| IN
a  ||| S:24321 E:24323 ||| DT
variety  ||| S:24323 E:24331 ||| NN
of  ||| S:24331 E:24334 ||| IN
biologicals  ||| S:24334 E:24346 ||| NN
on  ||| S:24346 E:24349 ||| IN
a  ||| S:24349 E:24351 ||| DT
laboratory  ||| S:24351 E:24362 ||| NN
as  ||| S:24362 E:24365 ||| IN
well  ||| S:24365 E:24370 ||| RB
as  ||| S:24370 E:24373 ||| IN
an  ||| S:24373 E:24376 ||| DT
industrial  ||| S:24376 E:24387 ||| JJ
scale  ||| S:24387 E:24393 ||| NN
of  ||| S:24393 E:24396 ||| IN
for  ||| S:24396 E:24400 ||| IN
instance  ||| S:24400 E:24409 ||| NN
even  ||| S:24409 E:24414 ||| RB
4000  ||| S:24414 E:24419 ||| CD
litres ||| S:24419 E:24425 ||| NNS
.  ||| S:24425 E:24429 ||| .
Large  ||| S:24429 E:24435 ||| JJ
scale  ||| S:24435 E:24441 ||| NN
production  ||| S:24441 E:24452 ||| NN
of  ||| S:24452 E:24455 ||| IN
expressed  ||| S:24455 E:24465 ||| JJ
products  ||| S:24465 E:24474 ||| NNS
can  ||| S:24474 E:24478 ||| MD
be  ||| S:24478 E:24481 ||| VB
accomplished  ||| S:24481 E:24494 ||| VBN
with  ||| S:24494 E:24499 ||| IN
gelatine-coated  ||| S:24499 E:24515 ||| JJ
microcarriers ||| S:24515 E:24528 ||| NN
.  ||| S:24528 E:24530 ||| .
Loading  ||| S:24530 E:24538 ||| VBG
of  ||| S:24538 E:24541 ||| IN
microcarriers  ||| S:24541 E:24555 ||| NN
in  ||| S:24555 E:24558 ||| IN
production  ||| S:24558 E:24569 ||| NN
scale  ||| S:24569 E:24575 ||| NN
bioreactors  ||| S:24575 E:24587 ||| NN
is  ||| S:24587 E:24590 ||| VBZ
generally  ||| S:24590 E:24600 ||| RB
20  ||| S:24600 E:24603 ||| CD
g ||| S:24603 E:24604 ||| CD
/ ||| S:24604 E:24605 ||| CD
l ||| S:24605 E:24606 ||| NN
,  ||| S:24606 E:24608 ||| ,
but  ||| S:24608 E:24612 ||| CC
may  ||| S:24612 E:24616 ||| MD
be  ||| S:24616 E:24619 ||| VB
increased  ||| S:24619 E:24629 ||| VBN
up  ||| S:24629 E:24632 ||| RP
to  ||| S:24632 E:24635 ||| TO
40  ||| S:24635 E:24638 ||| CD
g ||| S:24638 E:24639 ||| CD
/ ||| S:24639 E:24640 ||| CD
l ||| S:24640 E:24641 ||| NN
.  ||| S:24641 E:24643 ||| .
Microcarriers  ||| S:24643 E:24657 ||| NNP
may  ||| S:24657 E:24661 ||| MD
be  ||| S:24661 E:24664 ||| VB
used  ||| S:24664 E:24669 ||| VBN
in  ||| S:24669 E:24672 ||| IN
batch  ||| S:24672 E:24678 ||| NN
and  ||| S:24678 E:24682 ||| CC
perfusion  ||| S:24682 E:24692 ||| JJ
systems ||| S:24692 E:24699 ||| NNS
,  ||| S:24699 E:24701 ||| ,
in  ||| S:24701 E:24704 ||| IN
stirred  ||| S:24704 E:24712 ||| JJ
cultures ||| S:24712 E:24720 ||| NNS
,  ||| S:24720 E:24722 ||| ,
and  ||| S:24722 E:24726 ||| CC
wave  ||| S:24726 E:24731 ||| NN
bioreactors ||| S:24731 E:24742 ||| NN
,  ||| S:24742 E:24744 ||| ,
as  ||| S:24744 E:24747 ||| RB
well  ||| S:24747 E:24752 ||| RB
as  ||| S:24752 E:24755 ||| RB
to  ||| S:24755 E:24758 ||| TO
increase  ||| S:24758 E:24767 ||| VB
the  ||| S:24767 E:24771 ||| DT
surface  ||| S:24771 E:24779 ||| NN
area  ||| S:24779 E:24784 ||| NN
of  ||| S:24784 E:24787 ||| IN
traditional  ||| S:24787 E:24799 ||| JJ
stationary  ||| S:24799 E:24810 ||| JJ
monolayers  ||| S:24810 E:24821 ||| NN
and  ||| S:24821 E:24825 ||| CC
roller  ||| S:24825 E:24832 ||| NN
cultures  ||| S:24832 E:24842 ||| NNS
Preparation  ||| S:24864 E:24876 ||| NN
of  ||| S:24876 E:24879 ||| IN
Microcarriers  ||| S:24879 E:24893 ||| NNP
Beads  ||| S:24893 E:24901 ||| NNPS
Polystyrene  ||| S:26618 E:26630 ||| JJ
beads  ||| S:26630 E:26636 ||| NN
with  ||| S:26636 E:26641 ||| IN
an  ||| S:26641 E:26644 ||| DT
average  ||| S:26644 E:26652 ||| JJ
diameter  ||| S:26652 E:26661 ||| NN
of  ||| S:26661 E:26664 ||| IN
100  ||| S:26664 E:26668 ||| CD
micrometers  ||| S:26668 E:26680 ||| NNS
are  ||| S:26680 E:26684 ||| VBP
used ||| S:26684 E:26688 ||| VBN
.  ||| S:26688 E:26690 ||| .
The  ||| S:26690 E:26694 ||| DT
heterobifunctional  ||| S:26694 E:26713 ||| JJ
crosslinking  ||| S:26713 E:26726 ||| JJ
agent ||| S:26726 E:26731 ||| NN
,  ||| S:26731 E:26733 ||| ,
BBA-EAC-NOS ||| S:26733 E:26744 ||| NNP
,  ||| S:26744 E:26746 ||| ,
is  ||| S:26746 E:26749 ||| VBZ
used  ||| S:26749 E:26754 ||| VBN
to  ||| S:26754 E:26757 ||| TO
covalently  ||| S:26757 E:26768 ||| VB
immobilise  ||| S:26768 E:26779 ||| JJ
gelatine  ||| S:26779 E:26788 ||| NN
onto  ||| S:26788 E:26793 ||| IN
polystyrene  ||| S:26793 E:26805 ||| JJ
beads ||| S:26805 E:26810 ||| NN
.  ||| S:26810 E:26812 ||| .
The  ||| S:26812 E:26816 ||| DT
BBA-EAC-NOS  ||| S:26816 E:26828 ||| NN
is  ||| S:26828 E:26831 ||| VBZ
added  ||| S:26831 E:26837 ||| VBN
to  ||| S:26837 E:26840 ||| TO
the  ||| S:26840 E:26844 ||| DT
polystyrene  ||| S:26844 E:26856 ||| NN
beads  ||| S:26856 E:26862 ||| NNS
and  ||| S:26862 E:26866 ||| CC
allowed  ||| S:26866 E:26874 ||| VBN
to  ||| S:26874 E:26877 ||| TO
adsorb ||| S:26877 E:26883 ||| VB
.  ||| S:26883 E:26885 ||| .
Next ||| S:26885 E:26889 ||| JJ
,  ||| S:26889 E:26891 ||| ,
gelatine  ||| S:26891 E:26900 ||| JJ
Hu-3  ||| S:26900 E:26905 ||| NN
is  ||| S:26905 E:26908 ||| VBZ
added  ||| S:26908 E:26914 ||| VBN
and  ||| S:26914 E:26918 ||| CC
is  ||| S:26918 E:26921 ||| VBZ
allowed  ||| S:26921 E:26929 ||| VBN
to  ||| S:26929 E:26932 ||| TO
react  ||| S:26932 E:26938 ||| VB
with  ||| S:26938 E:26943 ||| IN
the  ||| S:26943 E:26947 ||| DT
NOS  ||| S:26947 E:26951 ||| NNP
synthetic  ||| S:26951 E:26961 ||| JJ
polymer  ||| S:26961 E:26969 ||| NN
to  ||| S:26969 E:26972 ||| TO
produce  ||| S:26972 E:26980 ||| VB
covalent  ||| S:26980 E:26989 ||| JJ
coupling  ||| S:26989 E:26998 ||| NN
to  ||| S:26998 E:27001 ||| TO
the  ||| S:27001 E:27005 ||| DT
spacer ||| S:27005 E:27011 ||| NN
.  ||| S:27011 E:27013 ||| .
Then  ||| S:27013 E:27018 ||| RB
the  ||| S:27018 E:27022 ||| DT
beads  ||| S:27022 E:27028 ||| NNS
are  ||| S:27028 E:27032 ||| VBP
photoactivated  ||| S:27032 E:27047 ||| NNS
( ||| S:27047 E:27048 ||| -LRB-
at  ||| S:27048 E:27051 ||| IN
320  ||| S:27051 E:27055 ||| CD
nm ||| S:27055 E:27057 ||| CD
)  ||| S:27057 E:27059 ||| -RRB-
to  ||| S:27059 E:27062 ||| TO
covalently  ||| S:27062 E:27073 ||| VB
immobilise  ||| S:27073 E:27084 ||| VBN
the  ||| S:27084 E:27088 ||| DT
spacer  ||| S:27088 E:27095 ||| NN
( ||| S:27095 E:27096 ||| -LRB-
and  ||| S:27096 E:27100 ||| CC
covalently  ||| S:27100 E:27111 ||| FW
coupled  ||| S:27111 E:27119 ||| FW
gelatine ||| S:27119 E:27127 ||| FW
)  ||| S:27127 E:27129 ||| -RRB-
to  ||| S:27129 E:27132 ||| TO
the  ||| S:27132 E:27136 ||| DT
polystyrene  ||| S:27136 E:27148 ||| NN
beads ||| S:27148 E:27153 ||| NN
.  ||| S:27153 E:27155 ||| .
Finally ||| S:27155 E:27162 ||| RB
,  ||| S:27162 E:27164 ||| ,
loosely  ||| S:27164 E:27172 ||| RB
adherent  ||| S:27172 E:27181 ||| JJ
gelatine  ||| S:27181 E:27190 ||| NN
is  ||| S:27190 E:27193 ||| VBZ
removed  ||| S:27193 E:27201 ||| VBN
by  ||| S:27201 E:27204 ||| IN
overnight  ||| S:27204 E:27214 ||| JJ
washing  ||| S:27214 E:27222 ||| NN
with  ||| S:27222 E:27227 ||| IN
the  ||| S:27227 E:27231 ||| DT
mild  ||| S:27231 E:27236 ||| JJ
detergent  ||| S:27236 E:27246 ||| NN
Tween  ||| S:27246 E:27252 ||| NNP
20  ||| S:27252 E:27255 ||| CD
in  ||| S:27255 E:27258 ||| IN
phosphate  ||| S:27258 E:27268 ||| FW
buffered  ||| S:27268 E:27277 ||| FW
saline  ||| S:27277 E:27284 ||| FW
( ||| S:27284 E:27285 ||| -LRB-
pH  ||| S:27285 E:27288 ||| NNP
7.2 ||| S:27288 E:27291 ||| CD
) ||| S:27291 E:27292 ||| -RRB-
.  ||| S:27292 E:27295 ||| .
Cell  ||| S:27307 E:27312 ||| NNP
Attachment  ||| S:27312 E:27323 ||| NNP
and  ||| S:27323 E:27327 ||| CC
Cell  ||| S:27327 E:27332 ||| NNP
Culture  ||| S:27332 E:27340 ||| NNP
Protocol  ||| S:27340 E:27349 ||| NNP
for  ||| S:27349 E:27353 ||| IN
Gelatine  ||| S:27353 E:27362 ||| NNP
or  ||| S:27362 E:27365 ||| CC
Gelatine-Like  ||| S:27365 E:27379 ||| NNP
Protein  ||| S:27379 E:27387 ||| NNP
Coated  ||| S:27387 E:27394 ||| NNP
Microcarriers  ||| S:27394 E:27410 ||| NNPS
Practical  ||| S:27410 E:27420 ||| JJ
information  ||| S:27420 E:27432 ||| NN
on  ||| S:27432 E:27435 ||| IN
how  ||| S:27435 E:27439 ||| WRB
to  ||| S:27439 E:27442 ||| TO
carry  ||| S:27442 E:27448 ||| VB
out  ||| S:27448 E:27452 ||| RP
cell  ||| S:27452 E:27457 ||| NN
cultures  ||| S:27457 E:27466 ||| NNS
using  ||| S:27466 E:27472 ||| VBG
microcarriers  ||| S:27472 E:27486 ||| NNS
can  ||| S:27486 E:27490 ||| MD
be  ||| S:27490 E:27493 ||| VB
found  ||| S:27493 E:27499 ||| VBN
in  ||| S:27499 E:27502 ||| IN
the  ||| S:27502 E:27506 ||| DT
handbook  ||| S:27506 E:27523 ||| JJ
Microcarrier  ||| S:27523 E:27536 ||| JJ
cell  ||| S:27536 E:27541 ||| NN
culture  ||| S:27541 E:27556 ||| NN
principles  ||| S:27556 E:27567 ||| NNS
and  ||| S:27567 E:27571 ||| CC
methods  ||| S:27571 E:27587 ||| NNS
which  ||| S:27587 E:27593 ||| WDT
can  ||| S:27593 E:27597 ||| MD
be  ||| S:27597 E:27600 ||| VB
obtained  ||| S:27600 E:27609 ||| VBN
from  ||| S:27609 E:27614 ||| IN
Amersham  ||| S:27614 E:27623 ||| NNP
Biosciences ||| S:27623 E:27634 ||| NNP
,  ||| S:27634 E:27636 ||| ,
code  ||| S:27636 E:27641 ||| NN
no.  ||| S:27641 E:27645 ||| CD
18-1140-62 ||| S:27645 E:27655 ||| CD
.  ||| S:27655 E:27659 ||| .
The  ||| S:27659 E:27663 ||| DT
following  ||| S:27663 E:27673 ||| NN
is  ||| S:27673 E:27676 ||| VBZ
a  ||| S:27676 E:27678 ||| DT
protocol  ||| S:27678 E:27687 ||| NN
which  ||| S:27687 E:27693 ||| WDT
can  ||| S:27693 E:27697 ||| MD
be  ||| S:27697 E:27700 ||| VB
used  ||| S:27700 E:27705 ||| VBN
to  ||| S:27705 E:27708 ||| TO
make  ||| S:27708 E:27713 ||| VB
a  ||| S:27713 E:27715 ||| DT
200  ||| S:27715 E:27719 ||| CD
ml  ||| S:27719 E:27722 ||| JJ
suspension  ||| S:27722 E:27733 ||| NN
culture  ||| S:27733 E:27741 ||| NN
in  ||| S:27741 E:27744 ||| IN
a  ||| S:27744 E:27746 ||| DT
spinner  ||| S:27746 E:27754 ||| JJ
flask ||| S:27754 E:27759 ||| NN
.  ||| S:27759 E:27761 ||| .
Cell  ||| S:27761 E:27766 ||| NN
cultures  ||| S:27766 E:27775 ||| NNS
at  ||| S:27775 E:27778 ||| IN
bead  ||| S:27778 E:27783 ||| JJ
loadings  ||| S:27783 E:27792 ||| NNS
of  ||| S:27792 E:27795 ||| IN
5-40  ||| S:27795 E:27800 ||| CD
grams  ||| S:27800 E:27806 ||| NNS
per  ||| S:27806 E:27810 ||| IN
litre  ||| S:27810 E:27816 ||| NNS
have  ||| S:27816 E:27821 ||| VBP
been  ||| S:27821 E:27826 ||| VBN
demonstrated  ||| S:27826 E:27839 ||| VBN
successfully ||| S:27839 E:27851 ||| RB
.  ||| S:27851 E:27853 ||| .
Twenty  ||| S:27853 E:27860 ||| NNP
( ||| S:27860 E:27861 ||| -LRB-
20 ||| S:27861 E:27863 ||| CD
)  ||| S:27863 E:27865 ||| -RRB-
grams  ||| S:27865 E:27871 ||| FW
per  ||| S:27871 E:27875 ||| FW
litre  ||| S:27875 E:27881 ||| FW
is  ||| S:27881 E:27884 ||| VBZ
suggested  ||| S:27884 E:27894 ||| VBN
as  ||| S:27894 E:27897 ||| IN
a  ||| S:27897 E:27899 ||| DT
starting  ||| S:27899 E:27908 ||| VBG
point ||| S:27908 E:27913 ||| NN
.  ||| S:27913 E:27915 ||| .
Therefore  ||| S:27915 E:27925 ||| RB
this  ||| S:27925 E:27930 ||| DT
200  ||| S:27930 E:27934 ||| CD
ml  ||| S:27934 E:27937 ||| JJ
culture  ||| S:27937 E:27945 ||| NN
will  ||| S:27945 E:27950 ||| MD
require  ||| S:27950 E:27958 ||| VB
4  ||| S:27958 E:27960 ||| CD
grams  ||| S:27960 E:27966 ||| NNS
of  ||| S:27966 E:27969 ||| IN
beads ||| S:27969 E:27974 ||| NN
.  ||| S:27974 E:27976 ||| .
Except  ||| S:27976 E:27983 ||| IN
for  ||| S:27983 E:27987 ||| IN
weighing  ||| S:27987 E:27996 ||| VBG
and  ||| S:27996 E:28000 ||| CC
suspending  ||| S:28000 E:28011 ||| VBG
the  ||| S:28011 E:28015 ||| DT
microcarrier  ||| S:28015 E:28028 ||| JJ
beads ||| S:28028 E:28033 ||| NN
,  ||| S:28033 E:28035 ||| ,
aseptic  ||| S:28035 E:28043 ||| JJ
techniques  ||| S:28043 E:28054 ||| NNS
should  ||| S:28054 E:28061 ||| MD
be  ||| S:28061 E:28064 ||| VB
used  ||| S:28064 E:28069 ||| VBN
throughout  ||| S:28069 E:28080 ||| IN
the  ||| S:28080 E:28084 ||| DT
protocol.*  ||| S:28084 E:28095 ||| FW
1 ||| S:28128 E:28129 ||| LS
.  ||| S:28129 E:28131 ||| .
Siliconising  ||| S:28131 E:28144 ||| JJ
glassware  ||| S:28144 E:28154 ||| NN
will  ||| S:28154 E:28159 ||| MD
prevent  ||| S:28159 E:28167 ||| VB
cell  ||| S:28167 E:28172 ||| NN
attachment  ||| S:28172 E:28183 ||| NN
to  ||| S:28183 E:28186 ||| TO
the  ||| S:28186 E:28190 ||| DT
treated  ||| S:28190 E:28198 ||| JJ
glassware ||| S:28198 E:28207 ||| NN
.  ||| S:28207 E:28209 ||| .
We  ||| S:28209 E:28212 ||| PRP
use  ||| S:28212 E:28216 ||| VBP
Prosil-28  ||| S:28216 E:28226 ||| RB
to  ||| S:28226 E:28229 ||| TO
siliconise  ||| S:28229 E:28240 ||| VB
but  ||| S:28240 E:28244 ||| CC
any  ||| S:28244 E:28248 ||| DT
other  ||| S:28248 E:28254 ||| JJ
commercially  ||| S:28254 E:28267 ||| JJ
available  ||| S:28267 E:28277 ||| JJ
agent  ||| S:28277 E:28283 ||| NN
is  ||| S:28283 E:28286 ||| VBZ
acceptable ||| S:28286 E:28296 ||| JJ
.  ||| S:28296 E:28298 ||| .
Clean ||| S:28298 E:28303 ||| NNP
,  ||| S:28303 E:28305 ||| ,
siliconise  ||| S:28305 E:28316 ||| NN
and  ||| S:28316 E:28320 ||| CC
autoclave  ||| S:28320 E:28330 ||| VB
all  ||| S:28330 E:28334 ||| PDT
the  ||| S:28334 E:28338 ||| DT
glassware  ||| S:28338 E:28348 ||| NN
and  ||| S:28348 E:28352 ||| CC
pipettes ||| S:28352 E:28360 ||| NN
.  ||| S:28360 E:28364 ||| .
3 ||| S:28596 E:28597 ||| LS
.  ||| S:28597 E:28599 ||| .
Discard  ||| S:28599 E:28607 ||| VB
the  ||| S:28607 E:28611 ||| DT
autoclaving  ||| S:28611 E:28623 ||| JJ
liquid  ||| S:28623 E:28630 ||| NN
and  ||| S:28630 E:28634 ||| CC
rinse  ||| S:28634 E:28640 ||| VBG
the  ||| S:28640 E:28644 ||| DT
4  ||| S:28644 E:28646 ||| CD
grams  ||| S:28646 E:28652 ||| NNS
of  ||| S:28652 E:28655 ||| IN
beads  ||| S:28655 E:28661 ||| NN
in  ||| S:28661 E:28664 ||| IN
a  ||| S:28664 E:28666 ||| DT
small  ||| S:28666 E:28672 ||| JJ
amount  ||| S:28672 E:28679 ||| NN
of  ||| S:28679 E:28682 ||| IN
media ||| S:28682 E:28687 ||| NNS
.  ||| S:28687 E:28689 ||| .
The  ||| S:28689 E:28693 ||| DT
type  ||| S:28693 E:28698 ||| NN
of  ||| S:28698 E:28701 ||| IN
media  ||| S:28701 E:28707 ||| NNS
used  ||| S:28707 E:28712 ||| VBN
should  ||| S:28712 E:28719 ||| MD
be  ||| S:28719 E:28722 ||| VB
the  ||| S:28722 E:28726 ||| DT
same  ||| S:28726 E:28731 ||| JJ
as  ||| S:28731 E:28734 ||| RB
was  ||| S:28734 E:28738 ||| VBD
used  ||| S:28738 E:28743 ||| VBN
in  ||| S:28743 E:28746 ||| IN
a  ||| S:28746 E:28748 ||| DT
monolayer  ||| S:28748 E:28758 ||| JJ
culture  ||| S:28758 E:28766 ||| NN
and  ||| S:28766 E:28770 ||| CC
the  ||| S:28770 E:28774 ||| DT
same  ||| S:28774 E:28779 ||| JJ
as  ||| S:28779 E:28782 ||| IN
this  ||| S:28782 E:28787 ||| DT
200  ||| S:28787 E:28791 ||| CD
ml  ||| S:28791 E:28794 ||| JJ
culture ||| S:28794 E:28801 ||| NN
.  ||| S:28801 E:28803 ||| .
The  ||| S:28803 E:28807 ||| DT
intent  ||| S:28807 E:28814 ||| NN
is  ||| S:28814 E:28817 ||| VBZ
to  ||| S:28817 E:28820 ||| TO
both  ||| S:28820 E:28825 ||| DT
rinse  ||| S:28825 E:28831 ||| NN
away  ||| S:28831 E:28836 ||| RB
the  ||| S:28836 E:28840 ||| DT
autoclaving  ||| S:28840 E:28852 ||| JJ
liquid  ||| S:28852 E:28859 ||| NN
and  ||| S:28859 E:28863 ||| CC
to  ||| S:28863 E:28866 ||| TO
condition  ||| S:28866 E:28876 ||| VB
the  ||| S:28876 E:28880 ||| DT
beads  ||| S:28880 E:28886 ||| NN
with  ||| S:28886 E:28891 ||| IN
the  ||| S:28891 E:28895 ||| DT
media ||| S:28895 E:28900 ||| NNS
.  ||| S:28900 E:28902 ||| .
Multiple  ||| S:28902 E:28911 ||| JJ
rinses  ||| S:28911 E:28918 ||| NNS
are  ||| S:28918 E:28922 ||| VBP
commonly  ||| S:28922 E:28931 ||| RB
used  ||| S:28931 E:28936 ||| VBN
and  ||| S:28936 E:28940 ||| CC
will  ||| S:28940 E:28945 ||| MD
eliminate  ||| S:28945 E:28955 ||| VB
debris  ||| S:28955 E:28962 ||| NN
or  ||| S:28962 E:28965 ||| CC
precipitants  ||| S:28965 E:28978 ||| NN
if  ||| S:28978 E:28981 ||| IN
present ||| S:28981 E:28988 ||| JJ
.  ||| S:28988 E:28992 ||| .
5 ||| S:29158 E:29159 ||| LS
.  ||| S:29159 E:29161 ||| .
The  ||| S:29161 E:29165 ||| DT
cell  ||| S:29165 E:29170 ||| NN
inoculum  ||| S:29170 E:29179 ||| NN
is  ||| S:29179 E:29182 ||| VBZ
generally  ||| S:29182 E:29192 ||| RB
1  ||| S:29192 E:29199 ||| CD
105  ||| S:29199 E:29203 ||| CD
cells ||| S:29203 E:29208 ||| NNS
/ ||| S:29208 E:29209 ||| VBP
ml ||| S:29209 E:29211 ||| VBN
.  ||| S:29211 E:29213 ||| .
For  ||| S:29213 E:29217 ||| IN
a  ||| S:29217 E:29219 ||| DT
total  ||| S:29219 E:29225 ||| JJ
culture  ||| S:29225 E:29233 ||| NN
volume  ||| S:29233 E:29240 ||| NN
of  ||| S:29240 E:29243 ||| IN
200  ||| S:29243 E:29247 ||| CD
ml  ||| S:29247 E:29250 ||| JJ
culture ||| S:29250 E:29257 ||| NN
,  ||| S:29257 E:29259 ||| ,
2  ||| S:29259 E:29266 ||| CD
107  ||| S:29266 E:29270 ||| CD
cells  ||| S:29270 E:29276 ||| NNS
are  ||| S:29276 E:29280 ||| VBP
needed ||| S:29280 E:29286 ||| VBN
.  ||| S:29286 E:29288 ||| .
Add  ||| S:29288 E:29292 ||| VB
the  ||| S:29292 E:29296 ||| DT
cells  ||| S:29296 E:29302 ||| NNS
to  ||| S:29302 E:29305 ||| TO
the  ||| S:29305 E:29309 ||| DT
warm ||| S:29309 E:29313 ||| JJ
,  ||| S:29313 E:29315 ||| ,
microcarrier ||| S:29315 E:29327 ||| CD
/ ||| S:29327 E:29328 ||| CD
media  ||| S:29328 E:29334 ||| NNS
bead  ||| S:29334 E:29339 ||| JJ
suspension  ||| S:29339 E:29350 ||| NN
and  ||| S:29350 E:29354 ||| CC
add  ||| S:29354 E:29358 ||| VB
enough  ||| S:29358 E:29365 ||| RB
warm  ||| S:29365 E:29370 ||| JJ
media  ||| S:29370 E:29376 ||| NNS
to  ||| S:29376 E:29379 ||| TO
make  ||| S:29379 E:29384 ||| VB
100  ||| S:29384 E:29388 ||| CD
ml ||| S:29388 E:29390 ||| NNS
.  ||| S:29390 E:29392 ||| .
( ||| S:29392 E:29393 ||| -LRB-
The  ||| S:29393 E:29397 ||| DT
cells  ||| S:29397 E:29403 ||| NNS
should  ||| S:29403 E:29410 ||| MD
be  ||| S:29410 E:29413 ||| VB
in  ||| S:29413 E:29416 ||| IN
the  ||| S:29416 E:29420 ||| DT
log  ||| S:29420 E:29424 ||| JJ
phase  ||| S:29424 E:29430 ||| NN
for  ||| S:29430 E:29434 ||| IN
optimum  ||| S:29434 E:29442 ||| JJ
attachment  ||| S:29442 E:29453 ||| NN
and  ||| S:29453 E:29457 ||| CC
growth ||| S:29457 E:29463 ||| NN
. ||| S:29463 E:29464 ||| .
)  ||| S:29464 E:29466 ||| -RRB-
The  ||| S:29466 E:29470 ||| DT
attachment  ||| S:29470 E:29481 ||| JJ
phase  ||| S:29481 E:29487 ||| NN
of  ||| S:29487 E:29490 ||| IN
the  ||| S:29490 E:29494 ||| DT
spinner  ||| S:29494 E:29502 ||| JJ
culture  ||| S:29502 E:29510 ||| NN
should  ||| S:29510 E:29517 ||| MD
occur  ||| S:29517 E:29523 ||| VB
at  ||| S:29523 E:29533 ||| IN
volume  ||| S:29533 E:29540 ||| NN
to  ||| S:29540 E:29543 ||| TO
facilitate  ||| S:29543 E:29554 ||| VB
cell  ||| S:29554 E:29559 ||| NN
to  ||| S:29559 E:29562 ||| TO
bead  ||| S:29562 E:29567 ||| VB
interactions ||| S:29567 E:29579 ||| NNS
.  ||| S:29579 E:29581 ||| .
Stir  ||| S:29581 E:29586 ||| VB
as  ||| S:29586 E:29589 ||| RB
slowly  ||| S:29589 E:29596 ||| RB
as  ||| S:29596 E:29599 ||| IN
possible  ||| S:29599 E:29608 ||| JJ
while  ||| S:29608 E:29614 ||| IN
preventing  ||| S:29614 E:29625 ||| VBG
the  ||| S:29625 E:29629 ||| DT
bead ||| S:29629 E:29633 ||| JJ
/ ||| S:29633 E:29634 ||| CD
cell  ||| S:29634 E:29639 ||| NN
slurry  ||| S:29639 E:29646 ||| NN
from  ||| S:29646 E:29651 ||| IN
forming  ||| S:29651 E:29659 ||| VBG
a  ||| S:29659 E:29661 ||| DT
static  ||| S:29661 E:29668 ||| JJ
layer  ||| S:29668 E:29674 ||| NN
on  ||| S:29674 E:29677 ||| IN
the  ||| S:29677 E:29681 ||| DT
bottom  ||| S:29681 E:29688 ||| NN
of  ||| S:29688 E:29691 ||| IN
the  ||| S:29691 E:29695 ||| DT
stir  ||| S:29695 E:29700 ||| JJ
flask ||| S:29700 E:29705 ||| NN
.  ||| S:29705 E:29707 ||| .
For  ||| S:29707 E:29711 ||| IN
fastidious  ||| S:29711 E:29722 ||| JJ
cells  ||| S:29722 E:29728 ||| NNS
which  ||| S:29728 E:29734 ||| WDT
attach  ||| S:29734 E:29741 ||| VBP
more  ||| S:29741 E:29746 ||| RBR
slowly ||| S:29746 E:29752 ||| RB
,  ||| S:29752 E:29754 ||| ,
an  ||| S:29754 E:29757 ||| DT
intermittent  ||| S:29757 E:29770 ||| JJ
stirring  ||| S:29770 E:29779 ||| JJ
protocol  ||| S:29779 E:29788 ||| NN
may  ||| S:29788 E:29792 ||| MD
be  ||| S:29792 E:29795 ||| VB
required ||| S:29795 E:29803 ||| VBN
.  ||| S:29803 E:29805 ||| .
If  ||| S:29805 E:29808 ||| IN
cells  ||| S:29808 E:29814 ||| NNS
are  ||| S:29814 E:29818 ||| VBP
slow  ||| S:29818 E:29823 ||| JJ
to  ||| S:29823 E:29826 ||| TO
attach  ||| S:29826 E:29833 ||| VB
and  ||| S:29833 E:29837 ||| CC
spread  ||| S:29837 E:29844 ||| NN
in  ||| S:29844 E:29847 ||| IN
monolayer ||| S:29847 E:29856 ||| NN
,  ||| S:29856 E:29858 ||| ,
they  ||| S:29858 E:29863 ||| PRP
will  ||| S:29863 E:29868 ||| MD
be  ||| S:29868 E:29871 ||| VB
slow  ||| S:29871 E:29876 ||| JJ
to  ||| S:29876 E:29879 ||| TO
attach  ||| S:29879 E:29886 ||| VB
on  ||| S:29886 E:29889 ||| IN
the  ||| S:29889 E:29893 ||| DT
microcarriers ||| S:29893 E:29906 ||| NN
.  ||| S:29906 E:29910 ||| .
7 ||| S:30257 E:30258 ||| CD
.  ||| S:30258 E:30260 ||| .
Maintain  ||| S:30260 E:30269 ||| VB
the  ||| S:30269 E:30273 ||| DT
cells  ||| S:30273 E:30279 ||| NNS
as  ||| S:30279 E:30282 ||| RB
required  ||| S:30282 E:30291 ||| VBN
by  ||| S:30291 E:30294 ||| IN
their  ||| S:30294 E:30300 ||| PRP$
growth  ||| S:30300 E:30307 ||| NN
and  ||| S:30307 E:30311 ||| CC
metabolism ||| S:30311 E:30321 ||| NN
.  ||| S:30321 E:30323 ||| .
Generally ||| S:30323 E:30332 ||| RB
,  ||| S:30332 E:30334 ||| ,
one  ||| S:30334 E:30338 ||| CD
half  ||| S:30338 E:30343 ||| NN
media  ||| S:30343 E:30349 ||| NNS
exchange  ||| S:30349 E:30358 ||| NN
is  ||| S:30358 E:30361 ||| VBZ
needed  ||| S:30361 E:30368 ||| VBN
every  ||| S:30368 E:30374 ||| DT
second  ||| S:30374 E:30381 ||| JJ
day ||| S:30381 E:30384 ||| NN
.  ||| S:30384 E:30386 ||| .
This  ||| S:30386 E:30391 ||| DT
cell  ||| S:30391 E:30396 ||| NN
attachment  ||| S:30396 E:30407 ||| NN
protocol  ||| S:30407 E:30416 ||| NN
has  ||| S:30416 E:30420 ||| VBZ
been  ||| S:30420 E:30425 ||| VBN
used  ||| S:30425 E:30430 ||| VBN
successfully  ||| S:30430 E:30443 ||| RB
with  ||| S:30443 E:30448 ||| IN
a  ||| S:30448 E:30450 ||| DT
variety  ||| S:30450 E:30458 ||| NN
of  ||| S:30458 E:30461 ||| IN
cell  ||| S:30461 E:30466 ||| NN
lines ||| S:30466 E:30471 ||| NNS
.  ||| S:30471 E:30473 ||| .
We  ||| S:30473 E:30476 ||| PRP
have  ||| S:30476 E:30481 ||| VBP
successfully  ||| S:30481 E:30494 ||| RB
used  ||| S:30494 E:30499 ||| VBN
Bellco ||| S:30499 E:30505 ||| NNP
,  ||| S:30505 E:30507 ||| ,
Corning ||| S:30507 E:30514 ||| NNP
,  ||| S:30514 E:30516 ||| ,
Kontes ||| S:30516 E:30522 ||| NNP
,  ||| S:30522 E:30524 ||| ,
Techne  ||| S:30524 E:30531 ||| NNP
and  ||| S:30531 E:30535 ||| CC
Wheaton  ||| S:30535 E:30543 ||| NNP
stirring  ||| S:30543 E:30552 ||| NN
systems  ||| S:30552 E:30560 ||| NNS
and  ||| S:30560 E:30564 ||| CC
expect  ||| S:30564 E:30571 ||| VBP
other  ||| S:30571 E:30577 ||| JJ
microcarrier  ||| S:30577 E:30590 ||| JJ
stirrers  ||| S:30590 E:30599 ||| NN
to  ||| S:30599 E:30602 ||| TO
be  ||| S:30602 E:30605 ||| VB
acceptable  ||| S:30605 E:30616 ||| JJ
also ||| S:30616 E:30620 ||| RB
.  ||| S:30620 E:30630 ||| .
12 ||| S:30651 E:30653 ||| CD
.  ||| S:30653 E:30655 ||| .
A  ||| S:30655 E:30657 ||| DT
process  ||| S:30657 E:30665 ||| NN
for  ||| S:30665 E:30669 ||| IN
the  ||| S:30669 E:30673 ||| DT
preparation  ||| S:30673 E:30685 ||| NN
of  ||| S:30685 E:30688 ||| IN
a  ||| S:30688 E:30690 ||| DT
cell  ||| S:30690 E:30695 ||| NN
culture  ||| S:30695 E:30703 ||| NN
support  ||| S:30703 E:30711 ||| NN
comprising  ||| S:30711 E:30722 ||| VBG
the  ||| S:30722 E:30726 ||| DT
step  ||| S:30726 E:30731 ||| NN
of  ||| S:30731 E:30734 ||| IN
coating  ||| S:30734 E:30742 ||| VBG
a  ||| S:30742 E:30744 ||| DT
microcarrier  ||| S:30744 E:30757 ||| JJ
bead  ||| S:30757 E:30762 ||| NN
with  ||| S:30762 E:30767 ||| IN
gelatine  ||| S:30767 E:30776 ||| NN
or  ||| S:30776 E:30779 ||| CC
gelatine-like  ||| S:30779 E:30793 ||| JJ
protein ||| S:30793 E:30800 ||| NN
,  ||| S:30800 E:30802 ||| ,
said  ||| S:30802 E:30807 ||| VBD
gelatine  ||| S:30807 E:30816 ||| JJ
or  ||| S:30816 E:30819 ||| CC
gelatine-like  ||| S:30819 E:30833 ||| JJ
protein  ||| S:30833 E:30841 ||| NN
having  ||| S:30841 E:30848 ||| VBG
a  ||| S:30848 E:30850 ||| DT
molecular  ||| S:30850 E:30860 ||| JJ
weight  ||| S:30860 E:30867 ||| NN
of  ||| S:30867 E:30870 ||| IN
about  ||| S:30870 E:30876 ||| IN
40  ||| S:30876 E:30879 ||| CD
kDa  ||| S:30879 E:30883 ||| JJ
to  ||| S:30883 E:30886 ||| TO
about  ||| S:30886 E:30892 ||| RB
200  ||| S:30892 E:30896 ||| CD
kDa ||| S:30896 E:30899 ||| NN
.  ||| S:30899 E:30905 ||| .
17 ||| S:31364 E:31366 ||| CD
.  ||| S:31366 E:31368 ||| .
The  ||| S:31368 E:31372 ||| DT
process  ||| S:31372 E:31380 ||| NN
according  ||| S:31380 E:31390 ||| VBG
to  ||| S:31390 E:31393 ||| TO
claim  ||| S:31393 E:31399 ||| VB
12 ||| S:31399 E:31401 ||| CD
,  ||| S:31401 E:31403 ||| ,
further  ||| S:31403 E:31411 ||| RB
comprising  ||| S:31411 E:31422 ||| VBG
the  ||| S:31422 E:31426 ||| DT
step  ||| S:31426 E:31431 ||| NN
of  ||| S:31431 E:31434 ||| IN
immobilising  ||| S:31434 E:31447 ||| VBG
the  ||| S:31447 E:31451 ||| DT
gelatine  ||| S:31451 E:31460 ||| NN
or  ||| S:31460 E:31463 ||| CC
gelatine-like  ||| S:31463 E:31477 ||| JJ
protein  ||| S:31477 E:31485 ||| NN
on  ||| S:31485 E:31488 ||| IN
the  ||| S:31488 E:31492 ||| DT
microcarrier ||| S:31492 E:31504 ||| NN
.  ||| S:31504 E:31510 ||| .
18 ||| S:31510 E:31512 ||| CD
.  ||| S:31512 E:31514 ||| .
The  ||| S:31514 E:31518 ||| DT
process  ||| S:31518 E:31526 ||| NN
according  ||| S:31526 E:31536 ||| VBG
to  ||| S:31536 E:31539 ||| TO
claim  ||| S:31539 E:31545 ||| VB
12 ||| S:31545 E:31547 ||| CD
,  ||| S:31547 E:31549 ||| ,
wherein  ||| S:31549 E:31557 ||| VBG
more  ||| S:31557 E:31562 ||| JJR
than  ||| S:31562 E:31567 ||| IN
75 ||| S:31567 E:31569 ||| CD
%  ||| S:31569 E:31571 ||| NN
of  ||| S:31571 E:31574 ||| IN
the  ||| S:31574 E:31578 ||| DT
gelatine  ||| S:31578 E:31587 ||| NN
or  ||| S:31587 E:31590 ||| CC
gelatine-like  ||| S:31590 E:31604 ||| JJ
protein  ||| S:31604 E:31612 ||| NN
has  ||| S:31612 E:31616 ||| VBZ
the  ||| S:31616 E:31620 ||| DT
same  ||| S:31620 E:31625 ||| JJ
molecular  ||| S:31625 E:31635 ||| JJ
weight ||| S:31635 E:31641 ||| NN
.  ||| S:31641 E:31647 ||| .
19 ||| S:31647 E:31649 ||| CD
.  ||| S:31649 E:31651 ||| .
The  ||| S:31651 E:31655 ||| DT
process  ||| S:31655 E:31663 ||| NN
according  ||| S:31663 E:31673 ||| VBG
to  ||| S:31673 E:31676 ||| TO
claim  ||| S:31676 E:31682 ||| VB
12 ||| S:31682 E:31684 ||| CD
,  ||| S:31684 E:31686 ||| ,
wherein  ||| S:31686 E:31694 ||| VBG
the  ||| S:31694 E:31698 ||| DT
gelatine  ||| S:31698 E:31707 ||| NN
or  ||| S:31707 E:31710 ||| CC
gelatine-like  ||| S:31710 E:31724 ||| JJ
protein  ||| S:31724 E:31732 ||| NN
is  ||| S:31732 E:31735 ||| VBZ
recombinantly  ||| S:31735 E:31749 ||| VBN
produced ||| S:31749 E:31757 ||| VBN
.  ||| S:31757 E:31763 ||| .
20 ||| S:31763 E:31765 ||| CD
.  ||| S:31765 E:31767 ||| .
The  ||| S:31767 E:31771 ||| DT
process  ||| S:31771 E:31779 ||| NN
according  ||| S:31779 E:31789 ||| VBG
to  ||| S:31789 E:31792 ||| TO
claim  ||| S:31792 E:31798 ||| VB
12 ||| S:31798 E:31800 ||| CD
,  ||| S:31800 E:31802 ||| ,
wherein  ||| S:31802 E:31810 ||| VBG
the  ||| S:31810 E:31814 ||| DT
gelatine  ||| S:31814 E:31823 ||| NN
or  ||| S:31823 E:31826 ||| CC
gelatine-like  ||| S:31826 E:31840 ||| JJ
protein  ||| S:31840 E:31848 ||| NN
comprises  ||| S:31848 E:31858 ||| VBZ
less  ||| S:31858 E:31863 ||| JJR
than  ||| S:31863 E:31868 ||| IN
5 ||| S:31868 E:31869 ||| CD
%  ||| S:31869 E:31871 ||| NN
hydroxyproline  ||| S:31871 E:31886 ||| NN
residues ||| S:31886 E:31894 ||| NNS
.  ||| S:31894 E:31900 ||| .
